Guide for Aviation Medical ExaminersVersion 09/30/2026
Section 31
ARCHIVES AND UPDATES
174 pagesPages 785–957
| Guide Version | Official Date | Revision Number | Description Of Change | Reason for Update |
|---|---|---|---|---|
| 2026 | 09/30/2026 | 1 | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, revised to Optometrist (OD) may be acceptable if no history of retinopathy in:A. PILOT INFORMATION - INITIAL CERTIFICATIONB. INITIAL CERTIFICATE CONSIDERATION REQUIREMENTSC. CERTIFICATION AIDD. INFORMATION SUBMISSION REQUIREMENTSE. RENEWAL CERTIFICATE REQUIREMENTSClarified should be a Diabetic Eye Exam. |
| 2026 | 09/30/2026 | 2 | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, C. Certification Aid, revised to remove requirement for contrast sensitivity and depth perception. |
| 2026 | 09/30/2026 | 3 | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, E. Renewal Certificate Requirements, revised to include some may be considered for 12 months. |
| 2026 | 09/30/2026 | 4 | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, revised to remove reference to international limitation. |
GUIDE FOR AVIATION EXAMINERS ARCHIVES AND UPDATES
| Guide Version | Official Date | Revision Number | Description Of Change | Reason for Update |
|---|---|---|---|---|
| 2026 | 09/30/2026 | 5 | Medical Policy | In Item 46. Neurologic, revised Head Injury or Brain Injury Disposition Table Row D Severe BRAIN injury, reduced recovery period from 5 to 4 years. Row B2 and C reduced to 4 years. |
| 2026 | 09/30/2026 | 6 | Medical Policy | In Item 46. Neurologic, revised Brain Injury Decision Tool for the AME to reduce injury to past 4 years. |
| 2026 | 09/30/2026 | 7 | Medical Policy | In Item 35. Lungs and Chest, added new Cystic Fibrosis Disposition Table |
| 2026 | 09/30/2026 | 8 | Medical Policy | In Item 35. Lungs and Chest, added new Pulmonary Hypertension Disposition Table |
| 2026 | 09/30/2026 | 9 | Medical Policy | In Item 35. Lungs and Chest, added new Pulmonary Nodule (Lung Nodule) Disposition Table |
| 2026 | 09/30/2026 | 10 | Medical Policy | In Item 38. Abdomen and Viscera added new Hernia (Abdominal; Incisional; Inguinal; Femoral; Perineal; Ventral; Congenital Diaphragmatic Hernia) Disposition Table. |
| 2026 | 09/30/2026 | 11 | Medical Policy | In Item 38. Abdomen and Viscera, added new Hiatal Hernia (Sliding or Paraesophageal) Disposition Table. |
| 2026 | 09/30/2026 | 12 | Medical Policy | In Item 38. Abdomen and Viscera, added new Liver Function Test Elevation Disposition Table. |
| 2026 | 09/30/2026 | 13 | Medical Policy | In Item 38. Abdomen and Viscera, added new GI Procedures (EGD or Colonoscopy) Disposition Table. |
| 2026 | 09/30/2026 | 14 | Medical Policy | In Item 38. Abdomen and Viscera, added new |
| Splenomegaly Disposition Table. | ||||
| 2026 | 09/30/2026 | 15 | Administrative | In Item 38. Abdomen and Viscera, deleted hernia and splenomegaly and replaced with new disposition tables. |
| 2026 | 09/30/2026 | 16 | Admin | Substances of Dependence/Abuse (Drugs and Alcohol) main page was revised to add DUI DWI Personal Statement, Drug Use Personal Statement, and Substance Use Disorders (DSM); Substance Abuse or Substance Dependence (DSM or CFR) Disposition Table. |
| 2026 | 09/30/2026 | 17 | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), revised DUI/DWI/ Alcohol Incidents Disposition Table to clarify evaluation data and update title to include (18 v.). Row B changed to any lifetime event. AME must upload documents to issue. If concerns for dependence/SUD, see dependence page. |
| 2026 | 09/30/2026 | 18 | Medical Policy | In Substances of Dependence/Abuse, added new DUI/DWI Personal Statement template. |
| 2026 | 09/30/2026 | 19 | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), revised Alcohol Status Report for the AME To include AME attestation of review and uploading records. |
| 2026 | 09/30/2026 | 20 | Medical Policy | In Substances of Dependence/Abuse Drug Use – Past or Present Disposition Table revised to |
| clarify row B evaluation data and add note describing eligibility letter or warning letter. | ||||
| 2026 | 09/30/2026 | 21 | Medical Policy | In Substances of Dependence/Abuse added new Drug Use Personal Statement template. |
| 2026 | 09/30/2026 | 22 | Medical Policy | In Substances of Dependence/Abuse added new Substance Use Disorders (DSM);Substance Abuse or Substance Dependence (DSM or CFR) Disposition Table (e.g. Positive DOT or FAA alcohol or drug test; Failed alcohol or drug test; yes to 18n or 18o; or medical complications associated with drug/alcohol). |
| 2026 | 09/30/2026 | 23 | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), revised FAA Certification Aid – Drug and Alcohol INITIAL to link to DUI/DWI or Drug Use Personal Statement |
| 2026 | 09/30/2026 | 24 | Medical Policy | In Pharmaceuticals, Antihypertensive Medication, added link to Item 46, Neurologic - Headaches - Migraine, CACI and AASI. Removed reserpine. Added (HTN, blood pressure medication) to title. |
| 2026 | 09/30/2026 | 25 | Medical Policy | In Pharmaceuticals, Do Not Issue/Do Not Fly, removed reserpine as no longer available in the US. |
| 2026 | 09/30/2026 | 26 | Medical Policy | In Pharmaceuticals, revised Acceptable Combinations of Diabetes Medications, to clarify within Group A1, adding new type of insulin, 7 day observation time. |
| 2026 | 09/30/2026 | 27 | Medical Policy | In Pharmaceuticals, updated Allergy – Antihistamine & Immunotherapy Medication, added brompheniramine as conditional with no fly 5 days. Removed Unacceptable box, as med no longer available. |
| 2026 | 09/30/2026 | 28 | Medical Policy | In Item 48. General Systemic, revised CACI – Weight Loss Management Worksheet to add orforglipron (Foundayo) as allowed. |
| 2026 | 09/30/2026 | 29 | Medical Policy | Updated PDF to match 08/26/2026 policy change posted on website.In Item 48. General Systemic, revised CACI – Weight Loss Management Worksheet and CACI-Prediabetes Worksheet and Pharmaceuticals, Weight Loss Medication reduced initial observation for GLP (injection or oral) from two weeks to one week. |
| 2026 | 08/26/2026 | 1 | Medical Policy | In General Information, added new Item 26, Subpoena for Medical Records or Testimony: AME Guidance |
| 2026 | 08/26/2026 | 2 | Medical Policy | In General Information, Item 6, Privacy Information, added link to Subpoena for Medical Records or Testimony: AME Guidance |
| 2026 | 08/26/2026 | 3 | Medical Policy | In Item 32. Ophthalmoscopic, added new Retinoschisis Disposition Table. |
| 2026 | 08/26/2026 | 4 | Medical Policy | In Item 31, Eyes, added link to Chorioretinitis Disposition Table. |
| 2026 | 08/26/2026 | 5 | Medical Policy | In Item 31, Eyes, added new Chorioretinitis Status Summary |
| 2026 | 08/26/2026 | 6 | Medical Policy | In Item 42, Upper and Lower Extremities, added new Osteomyelitis Disposition Table. |
| 2026 | 08/26/2026 | 7 | Medical Policy | In Item 31, Eyes, added new Diplopia Disposition Table. |
| 2026 | 08/26/2026 | 8 | Medical Policy | In Item 31, Eyes, added new Amblyopia Disposition Table. |
| 2026 | 08/26/2026 | 9 | Medical Policy | In Item 31, Eyes, added new Amblyopia Status Summary |
| 2026 | 08/26/2026 | 10 | Administrative | In Item 31, Eyes, added link to Amblyopia Disposition Table. |
| 2026 | 08/26/2026 | 11 | Administrative | In Item 42, Upper and Lower Extremities, removed osteomyelitis row. |
| 2026 | 08/26/2026 | 12 | Medical Policy | In Item 38, Abdomen and Viscera, add new Congenital Sucrase Isomaltase Deficiency (CSID) Disposition Table. |
| 2026 | 08/26/2026 | 13 | Medical Policy | In Item 37, Vascular, added new Postural Tachycardia Syndrome (POTS) Disposition Table. |
| 2026 | 08/26/2026 | 14 | Medical Policy | In Item 37, Vascular, added new Buerger Disease or Thromboangiitis Obliterans (TAO) Disposition Table. |
| 2026 | 08/26/2026 | 15 | Medical Policy | In Item 37, Vascular, added new Arteriovenous Malformation (AVM) - Peripheral (lungs, liver, bone) Disposition Table. |
| 2026 | 08/26/2026 | 16 | Medical Policy | In Item 46. Neurologic, Cerebrovascular Disease, revised title Arteriovenous Malformation (AVM) - Neurologic (Brain or Spinal Cord) to differentiate from AVM Peripheral. |
| 2026 | 08/26/2026 | 17 | Medical Policy | On Biologics, Biosimilars, and Non-biologics page, revised to clarify FDAapproved biosimilars are acceptable for same brand |
| named medication. Added bimekizumab (Bimzelx) to acceptable Interleukin Inhibitors. | ||||
| 2026 | 08/26/2026 | 18 | Medical Policy | In Item 46. Neurologic, revised CACI – Migraine and Chronic Headache Worksheet . Reduced eletriptan (Relpax) and frovatriptan (Frova) to 48 hours no fly, added ondansetron (Zofran) with 24 hour no-fly, and reduced to 24 hour no fly time for ubrogepant (Ubrelvy) and Rimegepant (Nurtec). |
| 2026 | 08/26/2026 | 19 | Medical Policy | In Pharmaceuticals, Migraine Medications revised Pharm. Migraine page. Reduced post dose for migraine treatment using CGRP to 24 hours. |
| 2026 | 08/26/2026 | 20 | Medical Policy | Revised AASI for Asthma to removed 3 medication limit. |
| 2026 | 08/26/2026 | 21 | Medical Policy | In Item 35. Lungs and Chest, revised Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Chronic Bronchitis Disposition table to clarify SpO2 is at rest on room air. |
| 2026 | 08/26/2026 | 22 | Medical Policy | In Item 41. G.U., revised Low Testosterone (Low T) hypogonadism Status Summary to hematocrit greater than 54%. |
| 2026 | 08/26/2026 | 23 | Medical Policy | In Item 47. Psychiatric Conditions, AASI for Anxiety, Depression, and Related Conditions clarified clinic visit requirements. |
| 2026 | 08/26/2026 | 24 | Medical Policy | In Pharmaceuticals, updated Osteoporosis Medications to add bazedoxifene (Duavee). |
| 2026 | 08/26/2026 | 25 | Medical Policy | In Item 35. Lungs and Chest, updated Sarcoid Disposition Table row A to clarify bilateral hilar lymphadenopathy alone. |
| 2026 | 08/26/2026 | 26 | Medical Policy | In Substances of Dependence/Abuse, Drug and/or Alcohol Monitoring, revised Drug and Alcohol Monitoring/HIMS FAQs clarified HIMS AME monitor airmen. |
| 2026 | 08/26/2026 | 27 | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, updated FAA CERTIFICATION AID – SSRI INITIAL Certification/Clearance and HIMS AME Checklist - SSRI INITIAL Certification/Clearance And Airman Information - SSRI INITIAL Certification And HIMS AME Checklist - SSRI Recertification/Follow Up Clearance And FAA CERTIFICATION AID – SSRI Recertification/ Follow Up Clearance to remove Chief Pilot report requirement from SSRI program and add note SSRI is now called antidepressant. |
| 2026 | 08/26/2026 | 28 | Medical Policy | In the chart of Acceptable Combinations of Diabetes Medications, updated graph. Insulin is now A1. Updated pharmaceutical considerations and Group Letters. Reduced observation times for some |
| non-insulin and insulin medications/combinations. | ||||
| 2026 | 07/29/2026 | 1 | Medical Policy | New AASI for Anxiety, Depression, and Related Conditions. |
| 2026 | 07/29/2026 | 2 | Medical Policy | New Anxiety, Depression, and Related Conditions PATH Status Summary |
| 2026 | 07/29/2026 | 3 | Medical Policy | In Item 48. General Systemic, added new Acromegaly Disposition Table. |
| 2026 | 07/29/2026 | 4 | Medical Policy | In Item 48. General Systemic, added new Hypoglycemia Disposition Table. |
| 2026 | 07/29/2026 | 5 | Medical Policy | In Item 48. General Systemic, added new Hyperthyroidism Disposition Table. |
| 2026 | 07/29/2026 | 6 | Medical Policy | In Item 48. General Systemic, added new Hyperparathyroidism Disposition Table. |
| 2026 | 07/29/2026 | 7 | Medical Policy | In Item 48. General Systemic, added new Hyperprolactinemia Disposition Table. |
| 2026 | 07/29/2026 | 8 | Medical Policy | In Item 48. General Systemic, added new Adrenal Insufficiency (Addison’s Disease) Disposition Table. |
| 2026 | 07/29/2026 | 9 | Medical Policy | In Item 48. General Systemic, added new Pituitary Adenoma (Microadenoma or Macroadenoma) Disposition Table. |
| 2026 | 07/29/2026 | 10 | Medical Policy | In Item 48. General Systemic, updated name Cushing Syndrome Disposition Table, added link to Pituitary Adenoma page. |
| 2026 | 07/29/2026 | 11 | Medical Policy | In Item 36, Heart, updated Hypertrophic |
| Cardiomyopathy (HCM) Disposition Table to clarify SCD calculator type. | ||||
| 2026 | 07/29/2026 | 12 | Administrative | In Item 48. General Systemic, Endocrine Disorders, removed combined conditions page and replaced with new disposition tables. |
| 2026 | 07/29/2026 | 13 | Administrative | Updated broken links. |
| 2026 | 07/29/2026 | 14 | Administrative | In Item 48. General Systemic, Endocrine Disorders, removed duplicate entry Proteinuria and Glycosuria |
| 2026 | 06/24/2026 | 1 | Medical Policy | In Item 36, Heart, added new Heart Murmur Disposition Table. |
| 2026 | 06/24/2026 | 2 | Medical Policy | In Item 36, Heart, II. Examination Techniques, updated murmur guidance. |
| 2026 | 06/24/2026 | 3 | Medical Policy | In Item 36, Heart, added new Congenital Heart Conditions Disposition Table. |
| 2026 | 06/24/2026 | 4 | Medical Policy | In Item 36, Heart, added new Endocarditis Disposition Table. |
| 2026 | 06/24/2026 | 5 | Medical Policy | In Item 36, Heart, added new Wolff Parkinson White (WPW) and other preexcitation conditions Disposition Table. |
| 2026 | 06/24/2026 | 6 | Medical Policy | In Item 36, Heart, added new Fibromuscular Dysplasia Disposition Table. |
| 2026 | 06/24/2026 | 7 | Medical Policy | In Item 36, Heart, added new Heart Transplant Disposition Table. |
| 2026 | 06/24/2026 | 8 | Medical Policy | In Item 36, Heart, added new Hypertrophic Cardiomyopathy (HCM) Disposition Table. |
| 2026 | 06/24/2026 | 9 | Medical Policy | In Item 36, Heart, II. Examination Techniques, added link to medication guidance. |
| 2026 | 06/24/2026 | 10 | Administrative | In Disease Protocols, removed Heart Transplant. |
| 2026 | 06/24/2026 | 11 | Administrative | In Item 36, Heart, removed other Cardiac Conditions that now have a Disposition table. |
| 2026 | 06/24/2026 | 12 | Administrative | In Item 47, Psychiatric, updated Information for Psychotherapists Treating Pilots and ATCS to clarify email is for licensed providers. |
| 2026 | 05/27/2026 | 1 | Medical Policy | In Item 47, Psychiatric, added new Therapy, Psychotherapy, and Counseling Pilot/ATCS Information Page. |
| 2026 | 05/27/2026 | 2 | Medical Policy | In Item 47, Psychiatric, added new Therapy, Psychotherapy, and Counseling FAQs for Pilot and ATCS |
| 2026 | 05/27/2026 | 3 | Medical Policy | In Item 47, Psychiatric, added new Information for Psychotherapists Treating Pilots and ATCS |
| 2026 | 05/27/2026 | 4 | Medical Policy | In Disease Protocols, Obstructive Sleep Apnea, added new single worksheet OSA Treated Status Summary. |
| 2026 | 05/27/2026 | 5 | Medical Policy | In Disease Protocols, Obstructive Sleep Apnea revised Specification Sheet A to request OSA Treated Status Summary or additional documentation. Changed mailing address to upload by AME. |
| 2026 | 05/27/2026 | 6 | Medical Policy | In Disease Protocols, Obstructive Sleep Apnea revised Specification Sheet B to request OSA Treated Status Summary or previous |
| documentation. Changed mailing address to upload by AME. | ||||
| 2026 | 05/27/2026 | 7 | Medical Policy | In AASI for Sleep Apnea/Obstructive Sleep Apnea (OSA), added can submit the OSA Treated Status Summary or previous documentation. |
| 2026 | 05/27/2026 | 8 | Medical Policy | In Disease Protocols, Obstructive Sleep Apnea, removed OSA Status Summary – Initial and OSA Status Summary – Recertification. |
| 2026 | 05/27/2026 | 9 | Administrative | In Disease Protocols, Obstructive Sleep Apnea, moved disposition table with PMLD and deleted duplicate table. |
| 2026 | 05/27/2026 | 10 | Administrative | In Disease Protocols, Obstructive Sleep Apnea, moved reference materials to end of protocol section and removed duplicate pages. |
| 2026 | 04/29/2026 | 1 | Medical Policy | In Item 31-34, Eye, Ophthalmoscopic examination, restored prior guidance (deleted with page update) bifocal or multifocal contact lenses require one month adaptation and meet vision requirements. |
| 2026 | 04/29/2026 | 2 | Medical Policy | In Item 46. Neurological, revised Carotid or Vertebral Artery Disease Disposition Table to clarify vascular imaging is CTA, MRA or angiogram (not u/s) of head and neck and require current brain MRI. |
| 2026 | 04/29/2026 | 3 | Medical Policy | In Item 38. Abdomen and Viscera, added new Eosinophilic Esophagitis Disposition Table. |
| 2026 | 04/29/2026 | 4 | Medical Policy | In Item 38. Abdomen and Viscera, added new CACI-Eosinophilic Esophagitis. |
| 2026 | 04/29/2026 | 5 | Medical Policy | In Item 48. General Systemic, added new Hormone Replacement Therapy (HRT) - Female Disposition Table. |
| 2026 | 04/29/2026 | 6 | Medical Policy | In Item 48. General Systemic, revised CACI – Weight Loss Management Worksheet removed requirement for annual A1c. |
| 2026 | 04/29/2026 | 7 | Medical Policy | In Item 48. General Systemic, revised Weight Loss Management or Prediabetes Status Report requiring A1C for Prediabetes only. |
| 2026 | 04/29/2026 | 8 | Administrative | In Item 48. General Systemic, revised CACI – Weight Loss Management Worksheet and CACI - Prediabetes Worksheet corrected typographical error: changed 6.4 mg/dL to 6.4%. |
| 2026 | 04/29/2026 | 9 | Medical Policy | In Item 38. Abdomen and Viscera, revised CACI – Colitis Worksheet to Tremfya and Skyrizi with 4 hour post dose. |
| 2026 | 04/29/2026 | 10 | Medical Policy | In Item 43. Spine and Other Musculoskeletal, revised Arthritis Disposition Table row A daily NSAIDS does not need CACI. Updated row B to include items needed for CACI. |
| 2026 | 04/29/2026 | 11 | Medical Policy | In Item 43. Spine, Other Musculoskeletal, revised CACI – Arthritis Worksheet to remove lab for Methotrexate and allow daily NSAIDS plus listed meds. |
| 2026 | 04/29/2026 | 12 | Medical Policy | In Item 48. General Systemic, the Human Immunodeficiency Virus (HIV) disposition table was updated to include Yeztugo (lenacapavir) for PrEP. |
| 2026 | 04/29/2026 | 13 | Medical Policy | In Pharmaceuticals, added new Osteoporosis Medications page. |
| 2026 | 04/29/2026 | 14 | Medical Policy | In Pharmaceuticals, added new Smoking Cessation Medications page |
| 2026 | 04/29/2026 | 15 | Medical Policy | On Biologics, Biosimilars, and Non-biologics page, revised to clarify mechanism. Changed to conditional, removed SI as required. |
| 2026 | 04/29/2026 | 16 | Admin | In Pharmaceuticals, added new Osteoporosis Medications and Smoking Cessation Medications and general information (from current web page) to Pharmaceuticals Page |
| 2026 | 04/29/2026 | 17 | Medical Policy | In Item 41. G. U., updated Low Testosterone (Low T) Hypogonadism Disposition Table. Added link to Status Summary and added Tamoxifen to row B. |
| 2026 | 04/29/2026 | 18 | Medical Policy | In Item 41. G.U., revised CACI - Low Testosterone (Low T) hypogonadism to allow Tamoxifen. Added link to status summary. |
| 2026 | 04/29/2026 | 19 | Medical Policy | In Item 41. G.U., revised Low Testosterone (Low T) hypogonadism Status Summary to allow Tamoxifen. |
| 2026 | 04/29/2026 | 20 | Medical Policy | In Item 38. Abdomen and Viscera Metabolic dysfunction-Associated Liver Disease (MASLD)/Non-Alcoholic Fatty Liver Disease |
| (NAFLD), and Metabolic dysfunction-Associated Steatohepatitis (MASH)/Non-Alcoholic Steatohepatitis (NASH) Disposition Table. corrected typographical error row C: changed ophthalmological to physical exam findings. Clarified Fibrosis score such as FIB-4 or VCTE or Magnetic resonance elastograpy should be included and allowed up to 2.68. | ||||
| 2026 | 04/29/2026 | 21 | Medical Policy | In Item 38. Abdomen and Viscera CACI – MASH/NASH (Liver) Worksheet clarified required only one of the three tests listed. FIB-4 index, increased from 1.3 to 2.68 allowed for CACI. |
| 2026 | 04/29/2026 | 22 | Medical Policy | In Item 36. Heart, clarified Atrial Flutter/Typical Atrial Flutter Disposition Table row B. Holter must be 90 days after the procedure. Does not need to be within 90 days of AME exam. |
| 2026 | 03/25/2026 | 1 | Medical Policy | In AME Physical Examination Information and Disposition Tables, added instructions and new Condition Not Listed Disposition Table. |
| 2026 | 03/25/2026 | 2 | Medical Policy | In Item 38. Abdomen and Viscera added new GERD (gastroesophageal reflux disease or reflux) Disposition Table. |
| 2026 | 03/25/2026 | 3 | Administrative | Item 38. Abdomen and Viscera, revised linked condition index page to add Gastroesophageal Reflux Disease (GERD). |
| 2026 | 03/25/2026 | 4 | Medical Policy | In Item 32. Ophthalmoscopic, added new Retinal Dystrophies (Cone, Rod, or Retinitis Pigmentosa) Disposition Table. |
| 2026 | 03/25/2026 | 5 | Administrative | In Item 32. Ophthalmoscopic table, removed Retinitis Pigmentosa. |
| 2026 | 03/25/2026 | 6 | Medical Policy | In Item 36. Heart, revised Coronary Heart Disease 50% stenosis or higher; intervention (Stent, PTCA, CABG); Myocardial Infarction (MI)/Heart Attack; Acute Coronary Syndrome; or Coronary Artery Disease (CAD) Disposition Table, reduced recovery period after LEFT MAIN stent from 6 to 3 months. |
| 2026 | 03/25/2026 | 7 | Medical Policy | In Disease Protocols, revised Protocol for Coronary Heart Disease – 1st and 2nd Class, to reduce recovery period after Left Main stent from 6 to 3 months and updated title to include ATCS. |
| 2026 | 03/25/2026 | 8 | Medical Policy | In Item 36. Heart, revised Coronary Heart Disease (CHD)/ Coronary Artery Disease (CAD) RECERTIFICATION Status Summary clarifying A1c required for all. |
| 2026 | 03/25/2026 | 9 | Medical Policy | In Item 48. General Systemic, revised CACI - Polycystic Ovarian Syndrome (PCOS) Worksheet. Clarified prolactinoma not CACI eligible. |
| 2026 | 03/25/2026 | 10 | Medical Policy | In Item 36. Heart, revised Syncope Disposition Table. Removed neurogenic as not allowed. |
| 2026 | 03/25/2026 | 11 | Medical Policy | In Item 36. Heart, revised Atrial Fibrillation (AFIB)/A-Flutter Disposition Table row D. Decreased recovery period from 6 to 3 months for LAA. |
| 2026 | 03/25/2026 | 12 | Medical Policy | In Protocols, revised 6-Minute Walk Test (6MWT) – FAA Results Sheet. |
| 2026 | 02/25/2026 | 1 | Medical Policy | In Item 35. Lungs and Chest, added new Alpha-Gal Syndrome Disposition Table |
| 2026 | 02/25/2026 | 2 | Medical Policy | In Item 38. Abdomen and Viscera, revised CACI – Colitis Worksheet to add microscopic colitis, clarified symptoms, and medication classes. |
| 2026 | 02/25/2026 | 3 | Medical Policy | In Item 38. Abdomen and Viscera added new Metabolic dysfunction-Associated Liver Disease (MASLD)/Non-Alcoholic Fatty Liver Disease (NAFLD), and Metabolic dysfunction-Associated Steatohepatitis (MASH)/Non-Alcoholic Steatohepatitis (NASH) Disposition Table. |
| 2026 | 02/25/2026 | 4 | Medical Policy | In Item 38. Abdomen and Viscera, added new CACI – MASH/NASH (Liver) Worksheet. |
| 2026 | 02/25/2026 | 5 | Administrative | On CACI Conditions page added new MASH/NASH (Liver) CACI. |
| 2026 | 02/25/2026 | 6 | Medical Policy | In Item 38. Abdomen and Viscera added new Liver Transplant Disposition Table. |
| 2026 | 02/25/2026 | 7 | Medical Policy | Incorporated Liver transplant Protocol into Disposition Table. |
| 2026 | 02/25/2026 | 8 | Administrative | Removed Liver transplant from Disease Protocols page |
| 2026 | 02/25/2026 | 9 | Medical Policy | In Item 38. Abdomen and Viscera added new |
| Esophageal Varices Disposition Table. | ||||
| 2026 | 02/25/2026 | 10 | Medical Policy | In Item 38. Abdomen and Viscera added new Cirrhosis Disposition Table. |
| 2026 | 02/25/2026 | 11 | Administrative | In Item 38. Abdomen and Viscera revised existing Disposition Table. Removed Cirrhosis (Alcoholic) and (Non-Alcoholic) |
| 2026 | 02/25/2026 | 12 | Administrative | Item 38. Abdomen and Viscera Colon Cancer/Colorectal Cancer simplified title by removing Malignancies. |
| 2026 | 02/25/2026 | 13 | Administrative | Neoplasms table. Removed duplicate entries for Colon/ Rectal Cancer and other Abdominal Malignancies, Acoustic Neuroma |
| 2026 | 02/25/2026 | 14 | Administrative | Item 38. Abdomen and Viscera, created linked condition index page. |
| 2026 | 01/28/2026 | 1 | Medical Policy | In Item 36. Heart, Updated Valvular Disease Table to point to new Mitral Valve Disease Disposition Table. |
| 2026 | 01/28/2026 | 2 | Medical Policy | In Item 36. Heart, added new Mitral Valve Disease Disposition Table |
| 2026 | 01/28/2026 | 3 | Medical Policy | New AASI for Mitral Valve Disease [Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Prolapse (MVP)] |
| 2026 | 01/28/2026 | 4 | Medical Policy | Revised AASI for Mitral or Aortic Insufficiency to AASI Aortic Insufficiency. |
| 2026 | 01/28/2026 | 5 | Administrative | Revised AME Assisted Special Issuance (AASI) change title AASI for Aortic Insufficiency and added |
| AASI for Mitral Valve Disease | ||||
| 2026 | 01/28/2026 | 6 | Administrative | In Item 46. Neurological, Carotid or Vertebral Artery Disease added to list of conditions. |
| 2026 | 01/28/2026 | 7 | Medical Policy | In Item 46. Neurological, added new Carotid or Vertebral Artery Disease Disposition Table. |
| 2026 | 01/28/2026 | 8 | Administrative | On CACI Conditions page added new Carotid/Vertebral Artery Stenosis CACI. |
| 2026 | 01/28/2026 | 9 | Medical Policy | In Item 46. Neurological, added new Carotid/Vertebral Artery Stenosis CACI. |
| 2026 | 01/28/2026 | 10 | Medical Policy | In AASI for Neurofibromatosis Type 1 (NF1), removed requirement for Eye Evaluation unless clinically indicated. |
| 2026 | 01/28/2026 | 11 | Medical Policy | Added Protocol for Cardiac Testing Coronary Artery Calcification (CAC) Scoring; Calcium Score; Coronary Computed Tomography Angiography (CCTA) |
| 2026 | 01/28/2026 | 12 | Medical Policy | In Item 36. Heart, added new Atrial Flutter/Typical Atrial Flutter Disposition Table. |
| 2026 | 01/28/2026 | 13 | Medical Policy | In Item 36. Heart, added new Typical Atrial Flutter Treated with Ablation Status Summary |
| 2026 | 01/28/2026 | 14 | Medical Policy | In Item 36. Heart, revised Atrial Fibrillation Disposition Table row C to clarify use this row for atypical, symptomatic, or untreated atrial flutter. |
| 2026 | 01/28/2026 | 15 | Medical Policy | Revised name of |
| Diabetes or Hyperglycemia on Medications Status Report. Removed word “Oral”. Can be used with any approved diabetic meds other than insulin. Title updated on multiple pages. | ||||
| 2026 | 01/28/2026 | 16 | Administrative | Updated version date to match calendar year. Updated calendar with upcoming publication dates. |
| 2025 | 12/03/2025 | 1. | Medical Policy | Item 47., Psychiatric – Use of Antidepressants, revised time required on stable dose from 6 months to 3 months.Including:• SSRI Decision Path-II• Airman Information - SSRI INITIAL Certification• HIMS AME Checklist - SSRI INITIAL Certification/Clearance• FAA ATCS How-To-Guide SSRI |
| 2025 | 12/03/2025 | 2. | Medical Policy | In Item 46. Neurologic, Head Injury - Concussion, Closed Head Injury (CHI), Open Head Injury, Traumatic Brain Injury (TBI). Revised existing disposition table row D to remove note MRI or MRA/CTA are required. |
| 2025 | 12/03/2025 | 3. | Medical Policy | Revised Protocol for Diabetes Mellitus Type I or Type II Insulin Treated - CGM Option section B. Initial Certificate Consideration Requirements to allow GMI less than 7% and Coefficient of Variance of Less than or equal to 36% with < 33% preferred. |
| 2025 | 12/03/2025 | 4. | Medical Policy | In Pharmaceuticals, Migraine Medications revised Pharm. Migraine page. Updated abortive treatment to 48 hours for CGRP and longer acting triptans. Added ondansetron (Zofran) with 24 hour no fly. |
| 2025 | 12/03/2025 | 5. | Medical Policy | In Pharmaceuticals, Vaccines, revised. Added MMR and Chikungunya Vimkunya (recombinant) as allowed with no down time. Added Ixchiq (liveattenuated) not FDA approved. |
| 2025 | 12/03/2025 | 6. | Administrative | In Item 36. Heart, revised Pacemaker Status Summary. Revised terminology #5 from “Estimated” to “Elective” Replacement Interval (ERI). |
| 2025 | 09/24/2025 | 1. | Medical Policy | In Item 35. Lungs and Chest, added new Pulmonary Fibrosis Disposition Table. |
| 2025 | 09/24/2025 | 2. | Administrative | In Item 35. Lungs and Chest, revised Disease of the Lungs, Pleura, or Mediastinum Disposition Table. Row for Pulmonary Fibrosis removed. |
| 2025 | 09/24/2025 | 3. | Medical Policy | In Item 35. Lungs and Chest, revised Asthma Disposition Table to add row A, AME can issue, row B changed from PFTs to spirometry. |
| 2025 | 09/24/2025 | 4. | Medical Policy | In Item 35. Lungs and Chest, revised CACI – Asthma to require spirometry instead of PFTs and remove FEV1/FVC ratio. |
| 2025 | 09/24/2025 | 5. | Medical Policy | In Item 48. General Systemic, added new Cushing’s Disease or |
| Cushing’s Syndrome Disposition Table. | ||||
| 2025 | 09/24/2025 | 6. | Administrative | In Item 48. General Systemic, revised Endocrine Disorders Disposition Table. Row for Cushing’s Disease or Syndrome removed. |
| 2025 | 09/24/2025 | 7. | Medical Policy | In Item 41. G.U., revised CACI - Low Testosterone (Low T) hypogonadism CACI to allow use with history of cardiovascular disease or prostate cancer. |
| 2025 | 09/24/2025 | 8. | Medical Policy | In Item 41. G. U., updated Low Testosterone (Low T) Hypogonadism Status Summary to remove cardiovascular disease and prostate cancer. |
| 2025 | 09/24/2025 | 9. | Medical Policy | In Special Issuances, revised Low Testosterone (Low T) Hypogonadism AASI. Removed cardiovascular disease and prostate cancer; defer if hematocrit 55 or higher. |
| 2025 | 09/24/2025 | 10. | Medical Policy | In Item 35. Lungs and Chest, added new Sarcoid Disposition Table. |
| 2025 | 09/24/2025 | 11. | Medical Policy | In Item 35. Lungs and Chest, added new Sarcoid Status Summary. |
| 2025 | 09/24/2025 | 12. | Administrative | In Item 35. Lungs and Chest, revised Pleura and Pleural Cavity Disposition Table. Row for Sarcoid removed. |
| 2025 | 09/24/2025 | 13. | Administrative | In Item 40. Skin, removed Sarcoid from Cutaneous Disposition Table. |
| 2025 | 09/24/2025 | 14. | Medical Policy | In Item 46. Neurologic, revised Head Injury or Brain Injury Disposition Table removed EEG as required for row D severe brain injury. |
| 2025 | 09/24/2025 | 15. | Administrative | In Item 46. Neurologic, revised Head Injury or Brain |
| Injury Disposition Table corrected typographical error. (Row D should require items in row C.) | ||||
| 2025 | 09/24/2025 | 16. | Medical Policy | In Item 46. Neurologic, revised Neurofibromatosis Disposition Table and AASI Neurofibromatosis (NF1). Clarified visual fields must have interpretation and can be 30-2 or 24-2 with good reliability. |
| 2025 | 09/24/2025 | 17. | Medical Policy | In Item 31. Eyes, revised Cataract(s) Disposition Table. Clarify if unable to meet 1st/2nd class standards, AME can issue 3rd class if otherwise qualified. |
| 2025 | 09/24/2025 | 18. | Medical Policy | In Item 46. Neurologic, Headaches, revised row B and C column names Migraine (Cluster, Tension, Ocular, Acephalgic, Ophthalmic, or Retinal). |
| 2025 | 09/24/2025 | 19. | Medical Policy | In Item 52. Color Vision, revised the Color Vision Flow Chart for pilot testing. Clarified a returning pilot who previously passed an acceptable test for any class, does not need a new color vision screening to upgrade. |
| 2025 | 08/27/2025 | 1. | Medical Policy | In Item 52. Color Vision, revised the Color Vision Flow Chart for pilot testing. Orientation of the chart has changed. It should be read left to right, starting with the pathways “Returning Pilot” and “First-Time Applicant.” |
| 2025 | 08/27/2025 | 2. | Medical Policy | In Item 52. Color Vision, Color Vision - Frequently Asked Questions (FAQS), added additional questions and answers (items 12-18). |
| 2025 | 08/27/2025 | 3. | Medical Policy | In Item 52. Color Vision, revised Acceptable Tests for Color Vision Screening – Pilots and Acceptable Tests for Color Vision Screening – ATCS to update information on tests:Testing must be done in person.Score parameters for Color Assessment & Diagnosis (CAD test). (Red green (RG): 1.7 if normal Less than 6 if diagnosed as Deutan; Less than 12 if diagnosed as Protan. The RG passing score varies by diagnosis.) Also added note that US or UK keyboard can be used.For Rabin Cone Test - 55 or higher for each color.For Waggoner Computerized Color Vision Test, added note that Adult Diagnostic or FAA Color Vision Test are to be used. |
| 2025 | 08/27/2025 | 4. | Medical Policy | In Item 31. Eyes, added new Quality of Vision Questionnaire. |
| 2025 | 08/27/2025 | 5. | Medical Policy | In Item 31. Eyes, added new Blepharitis and Conjunctivitis Disposition Table. |
| 2025 | 08/27/2025 | 6. | Medical Policy | In Item 31. Eyes, added new Cataract(s) Disposition Table. |
| 2025 | 01/29/2025 | 7. | Medical Policy | In Item 31. Eyes, Procedures, added new |
| Lens Implant Disposition Table. | ||||
| 2025 | 01/29/2025 | 8. | Medical Policy | In Item 31. Eyes, Procedures, added new Eyes - Lens Implant Status Summary. |
| 2025 | 08/27/2025 | 9. | Medical Policy | In Item 31. Eyes, Procedures, added new Cataracts and Intraocular Lenses (IOL) Frequently Asked Questions (FAQS). |
| 2025 | 08/27/2025 | 10. | Medical Policy | In Item 31. Eyes, Procedures, added new Eyes-Refractive Surgery Disposition Table. |
| 2025 | 08/27/2025 | 11. | Medical Policy | In Item 31. Eyes, Procedures, added new Eyes-Refractive Surgery Status Summary. |
| 2025 | 08/27/2025 | 12. | Administrative | In Item 31. Eyes, Procedures, reorganized information hyperlinks on main page. |
| 2025 | 08/27/2025 | 13. | Medical Policy | In Item 31. Eyes, added new Ocular Histoplasmosis Disposition Table. |
| 2025 | 08/27/2025 | 14. | Medical Policy | In Item 32. Ophthalmoscopic, added new Coloboma Disposition Table. |
| 2025 | 08/27/2025 | 15. | Medical Policy | In Item 32. Ophthalmoscopic, added new Optic Neuritis Disposition Table. |
| 2025 | 08/27/2025 | 16. | Administrative | In Item 46. Neurologic, revised Other Neurologic Conditions Disposition Table. Row for Optic Neuritis removed. |
| 2025 | 8/27/2025 | 17. | Administrative | In Item 32. Ophthalmoscopic, revised Disposition Table. Removed Optic Neuritis. |
| 2025 | 08/27/2025 | 18. | Medical Policy | Revised Protocol for Binocular Multifocal and |
| Accommodating Devices to direct readers to updated guidance found in Eyes - Lens Implant Status Summary. | ||||
| 2025 | 8/27/2025 | 19. | Administrative | In Item 31-34. Eyes, Exam Techniques 10. Refractive Procedures. Revised to match new Disposition Table. |
| 2025 | 08/27/2025 | 20. | Medical Policy | In Disease Protocols, Protocol for Coronary Heart Disease – 1st and 2nd Class, clarified item #6. Post-Event Heart Catheterization with Imaging is not required for Limited Second Class or ATCS. |
| 2025 | 08/27/2025 | 21. | Medical Policy | In General Information, AME Equipment and Medical Confidentiality revised to include computerized color vision testers and requirement for EKG/ECG equipment. (A full 12-lead recorded at 25mm/sec at 10mV is required. Anything less will not be accepted.) |
| 2025 | 08/27/2025 | 22. | Medical Policy | In the chart of Acceptable Combinations of Diabetes Medications, added bexagliflozin (Brenzavvy) to SGLT2 Inhibitors. |
| 2025 | 08/27/2025 | 23. | Medical Policy | In the chart of Acceptable Combinations of Diabetes Medications, adding to established treatment, all Group E is 30 days. |
| 2025 | 08/27/2025 | 24. | Medical Policy | Biologics, Biosimilars, and Non-biologics page, added mirikizumab (Omvoh). |
| 2025 | 08/27/2025 | 25. | Medical Policy | In Pharmaceuticals, Cholesterol Medications revised PCSK9 Inhibitors from conditional to |
| acceptable and remove wait time. | ||||
| 2025 | 08/27/2025 | 26. | Medical Policy | In Item 48. General Systemic, revised CACI – Weight Loss Management Worksheet and CACI - Prediabetes Worksheet to add trade names and remove substance use disorder bullet. |
| 2025 | 08/27/2025 | 27. | Medical Policy | In Pharmaceuticals, Weight Loss Medications, revised to add trade names and removed bullet on substance use disorder. Clarified if taking insulin + weight loss medication, seewww.faa.gov/go/ITDM |
| 2025 | 08/27/2025 | 28. | Medical Policy | In Pharmaceuticals – Glaucoma Medications moved Rho Kinase Inhibitors to CACI and added common medication names. |
| 2025 | 08/27/2025 | 29. | Medical Policy | In Pharmaceuticals, revised Antidepressant Medications moving vilazodone (Viibryd) to conditionally acceptable. |
| 2025 | 08/27/2025 | 30. | Administrative | SSRI Decision Path -1 and Path – II, revised graph to link to Antidepressant Medications |
| 2025 | 08/27/2025 | 31. | Medical Policy | In Pharmaceuticals, revised Migraine Medication. Clarified lasmiditan (Reyvow) acceptable for abortive treatment only. Added acceptable combination medications with 24-hour post-dose observation and eptinezumab (Vyepti). |
| 2025 | 08/27/2025 | 32. | Medical Policy | In Item 46. Neurologic, revised CACI – Migraine and Chronic Headache Worksheet removed |
| lasmiditan as not acceptable for preventative. Clarified Triptans monotherapy or with NSAIDS 24 hour no fly. | ||||
| 2025 | 08/27/2025 | 33. | Medical Policy | In Item 43. Spine, Other Musculoskeletal, revised CACI – Arthritis Worksheet to include azathioprine (Imuran) and remove lab requirement. |
| 2025 | 08/27/2025 | 33. | Medical Policy | In Item 40. Skin, revised CACI – Psoriasis Worksheet to include azathioprine (Imuran) and remove lab requirement. |
| 2025 | 08/27/2025 | 35. | Medical Policy | In Item 38. Abdomen and Viscera, revised CACI – Colitis Worksheet to add additional medications and remove lab requirement. |
| 2025 | 08/27/2025 | 36. | Administrative | In Item 40. Skin, revised Psoriasis Disposition Table to remove lab requirement. |
| 2025 | 08/27/2025 | 37. | Medical Policy | In Item 46. Neurologic, revised Multiple Sclerosis guidance to include NMOSD, MOGAD, and CIS. |
| 2025 | 08/27/2025 | 38. | Medical Policy | ITEM 35. Lungs and Chest revised Bronchiectasis disposition table to add expanded guidance. |
| 2025 | 08/27/205 | 39. | Medical Policy | In General Information, added Aeromedical Summary (AMS). |
| 2025 | 01/01/2025 | 1. | Administrative | Updated version date to match calendar year. |
| 2024 | 12/12/2024 | 1. | Medical Policy | Item 52. Color Vision revised to change acceptable testers for color vision screening for pilots to three computerbased tests only. Policy is effective January 1, 2025. |
| 2024 | 12/12/2024 | 2. | Medical Policy | In Item 52. Color Vision, Dispositions, revised to add AME Information - Color Vision Screening Steps. |
| 2024 | 12/12/2024 | 3. | Medical Policy | In Item 52. Color Vision, revised FAA Color Vision Flowchart with new guidance. |
| 2024 | 12/12/2024 | 4. | Medical Policy | In Item 52. Color Vision, added new Color Vision - Frequently Asked Questions (FAQS). |
| 2024 | 12/12/2024 | 5. | Medical Policy | In item 52. Color Vision added new Color Vision Limitation Review. Document is for pilots seeking upgrade to first or second class. |
| 2024 | 12/12/2024 | 6. | Medical Policy | In General Information, AME Equipment and Medical Confidentiality, revised to add new color vision information. |
| 2024 | 12/12/2024 | 7. | Medical Policy | In General Information, Medical Certificate Limitations revised to add limitation #104 “Valid for day visual flight rules (VFR) only.” |
| 2024 | 12/12/2024 | 8. | Administrative | Item 53. Heterophoria revised to remove note regarding substitute testers for color vision. |
| 2024 | 12/12/2024 | 9. | Administrative | In Disease Protocols, Specifications for Psychiatric Evaluations, Specifications for Psychiatric and Psychological Evaluations, and Specifications for Psychiatric and Neuropsychological Evaluations for Substance Abuse/Dependence, revised to remove Psychiatry Branch phone number. Email contact information is still valid. |
| 2024 | 11/27/2024 | 1. | Medical Policy | In Item 40. Skin, revised CACI – Psoriasis Worksheet to include new medication. |
| 2024 | 11/27/2024 | 2. | Medical Policy | In Item 43. Spine, Other |
| Musculoskeletal, revised CACI – Arthritis Worksheet to include new medications. | ||||
| 2024 | 11/27/2024 | 3. | Medical Policy | In Item 38. Abdomen and Viscera, revised CACI – Colitis Worksheet to add new medication. |
| 2024 | 11/27/2024 | 4. | Medical Policy | In Item 46. Neurologic, revised CACI – Migraine and Chronic Headache Worksheet to add new medications. |
| 2024 | 11/27/2024 | 5. | Medical Policy | In Pharmaceuticals, Migraine Medications revised to include new medications. |
| 2024 | 11/27/2024 | 6. | Administrative | In Pharmaceuticals, Biologics, Biosimilars, and Non-Biologics, added note to the bottom of Page 1 to direct readers to Pages 2 and 3 for a table of medications by name. |
| 2024 | 10/30/2024 | 1. | Medical Policy | In Item 48. General Systemic, Pre-Diabetes, revised CACI – Pre-Diabetes Worksheet to add tirzepatide as acceptable. Also added note on observation time: “72-hour observation with each dosage change, either increasing or tapering the medication.” |
| 2024 | 10/30/2024 | 2. | Medical Policy | In General Information, added new page for English Proficiency and Pilot Medical Certification. |
| 2024 | 10/30/2024 | 3. | Medical Policy | In Disease Protocols, Attention-Deficit/Hyperactivity Disorder (ADHD) Fast Track- FAA ADHD Evaluation General Information AND Attention-Deficit/Hyperactivity Disorder (ADHD) Standard Track - FAA Evaluation General Information, revised title to add “for Pilots and ATCS.” References to these documents were also updated in the Attention- |
| Deficit/Hyperactivity Disorder (ADHD) Disposition Table. | ||||
| 2024 | 10/30/2024 | 4. | Medical Policy | In Disease Protocols, Attention Deficit/Hyperactivity Disorder, revised Fast Track – ADHD Summary, to add that anxiety, depression, or related conditions that meet Fast Track criteria are not included in the category covered in item #4 of the Summary. |
| 2024 | 10/30/2024 | 5. | Medical Policy | In Item 48. General Systemic, COVID-19 Infections Disposition Table Row A revised. AMEs do not have to annotate COVID, if resolved. |
| 2024 | 10/30/2024 | 6. | Administrative | In Disease Protocols for Attention Deficit/Hyperactivity Disorders (ADHD), revised to change the name of the FAA Neuropsychologist and Psychologist List to FAA Aviation Neuropsychologist and Psychologist List. |
| 2024 | 10/30/2024 | 7. | Errata | In Item 49. Hearing, corrected abbreviation for decibels. |
| 2024 | 09/25/2024 | 1. | Medical Policy | In Item 41. G. U., added new Low Testosterone (Low T) Hypogonadism Disposition Table. |
| 2024 | 09/25/2024 | 2. | Medical Policy | In Item 41. G. U., added new Low Testosterone (Low T) Hypogonadism Status Summary. |
| 2024 | 09/25/2024 | 3. | Medical Policy | In Item 41. G.U., added new CACI - Low Testosterone (Low T) hypogonadism CACI. |
| 2024 | 09/25/2024 | 4. | Medical Policy | In Special Issuances, added new Low Testosterone (Low T) Hypogonadism |
| AASI. Hyperlink to document was also added on main AASI listing page. | ||||
| 2024 | 09/25/2024 | 5. | Medical Policy | In Pharmaceuticals, added new Biologics, Biosimilars, and Non-biologics guidance page. |
| 2024 | 09/25/2024 | 6. | Medical Policy | In Pharmaceuticals, Vaccines, revised. Postobservation time for listed COVID-19 vaccines reduced to 24 hours. However, If experiencing delayed symptoms such as headache, fatigue, myalgia, or chills: 14 CFR 61.53¹ applies – NO fly, NO safetyrelated duties until symptomfree. Shingles vaccine added to 24 post-dose observation time. |
| 2024 | 09/25/2024 | 7. | Medical Policy | In Item 47. Psychiatric Conditions, revised Anxiety, Depression, and Related Conditions Fast Track for Currently Deferred Cases to clarify that ADHD that does not meet the ADHD Fast Track Requirements is NOT acceptable. |
| 2024 | 09/25/2024 | 8. | Medical Policy | In Item 47. Psychiatric Conditions, revised Anxiety, Depression, and Related Conditions Decision Tool for the AME to clarify that AME must list all diagnoses in Block 60. Also clarified that ADHD that does not meet the ADHD Fast Track Requirements is NOT acceptable. |
| 2024 | 09/25/2024 | 9. | Medical Policy | In Disease Protocols, ADHD Document Checklist revised, Item f. to require submission of “any records for any history |
| of academic/occupational accommodations.” | ||||
| 2024 | 09/25/2024 | 10. | Medical Policy | In Item 47. Psychiatric, Attention-Deficit/Hyperactivity Disorders (ADHD) and/or Use of ADHD Medications, revised Rows A and B to address Anxiety, Depression, and Related Conditions. |
| 2024 | 09/25/2024 | 11. | Medical Policy | In Disease Protocols, Attention-Deficit/Hyperactivity Disorders (ADHD) Fast Track – FAA ADHD Summary, revised item #4 to also include neurocognitive or neurodegenerative disorder diagnosis. Added note that concussion without sequalae are not included in the category. |
| 2024 | 09/25/2024 | 12. | Medical Policy | In Item 43. Spine and Other Musculoskeletal, CACI - Arthritis Worksheet revised. Additional medications added. |
| 2024 | 09/25/2024 | 13. | Medical Policy | In Item 40. Skin, CACI - Psoriasis Worksheet revised, to add the term biologics. |
| 2024 | 09/25/2024 | 14. | Medical Policy | In Item 38. Abdomen and Viscera and Anus Conditions, CACI – Colitis Worksheet revised. Additional medications and post-dose observation times added. |
| 2024 | 09/25/2024 | 15. | Medical Policy | In Pharmaceuticals, revised the Plaquenil Status Report to include checkboxes for screening result. Graphic revised: For annual evaluation, Low Risk category (previously called “long Term”) “Group A only: on meds for 5 or more |
| years,” may consider CACI if all testing shows no abnormality. Status Report must be returned to AME for electronic uploading. | ||||
| 2024 | 09/25/2024 | 16. | Medical Policy | In Item 27. Sinuses, updated Sinus Conditions Disposition Table, Row B to remove “continued use of medication.” |
| 2024 | 09/25/2024 | 17. | Administrative | In Substances or Dependence/Abuse (Drugs and Alcohol), HIMS AME Change Request revised to reorganize order of steps to be taken. |
| 2024 | 09/25/2024 | 18. | Administrative | In General Information, reorganized Pilot Information– Current, Detailed Clinical Progress Note to harmonize with DIWS. |
| 2024 | 08/28/2024 | 1. | Medical Policy | In Item 40. Skin, added new Psoriasis Disposition Table. |
| 2024 | 08/28/2024 | 2. | Medical Policy | In Item 40. Skin, added new CACI – Psoriasis Worksheet. |
| 2024 | 08/28/2024 | 3. | Medical Policy | In Special Issuances, added new AASI – Psoriasis. |
| 2024 | 08/28/2024 | 4. | Medical Policy | In Pharmaceuticals, added new guidance tables for Migraine Medication. |
| 2024 | 08/28/2024 | 5. | Medical Policy | In Item 46. Neurologic, revised CACI – Migraine and Chronic Headache Worksheet. |
| 2024 | 08/28/2024 | 6. | Medical Policy | In Item 35. Lungs and Chest, added new Pectus Excavatum Disposition Table. |
| 2024 | 08/28/2024 | 7. | Medical Policy | In Item 46. Neurologic, revised Head Injury or Brain Injury Disposition Table to add expanded guidance for brain injury 5 or more years ago (Row B1) or brain injury within the past 5 years. (Row B2). |
| 2024 | 08/28/2024 | 8. | Medical Policy | In Item 46. Neurologic, added new Brain Injury Decision Tool for the AME. |
| 2024 | 08/28/2024 | 9. | Medical Policy | In Item 26. Nose, added new Allergies or Anaphylaxis; (Allergic Rhinitis; Seasonal Allergic Rhinitis; Hay fever) Disposition Table. |
| 2024 | 08/28/2024 | 10. | Medical Policy | In Disease Protocols, removed Allergies, Severe. Information is now covered in new Allergies or Anaphylaxis; (Allergic Rhinitis; Seasonal Allergic Rhinitis; Hay fever) Disposition Table. |
| 2024 | 08/28/2024 | 11. | Medical Policy | In Item 27. Sinus, added new Sinus Conditions Dispositions Table. Includes Sinusitis(acute or chronic infection; deviated nasal septum); Sinus Obstruction (nasal cysts; nasal polyps; or sinus tumor) |
| 2024 | 08/28/2024 | 12. | Medical Policy | It Item 28, Mouth and Throat, added new Speech Impediment - Stuttering, or Mechanical Conditions Disposition Table. |
| 2024 | 08/28/2024 | 13. | Medical Policy | In disease protocols, revised OSA Status Summary – Initial to add descriptor “AHI on treatment” to #17 response column. |
| 2024 | 08/28/2024 | 14. | Medical Policy | In Disease Protocols, Obstructive Sleep Apnea, revised OSA Status Summary – Recertification to add descriptor “AHI on treatment” to #10 response column. |
| 2024 | 08/28/2024 | 15. | Medical Policy | In Special Issuances, removed AASI Certificate Issuance Coversheet. This document is no longer |
| needed. Updated the AASI general information page with a note stating the coversheet is no longer required. | ||||
| 2024 | 08/28/2024 | 16. | Medical Policy | In Disease Protocols, revised the Standard Track - FAA ADHD Evaluation General Information sheet to further clarify that separate tests must be ordered for BOTH amphetamines AND methylphenidate. |
| 2024 | 08/28/2024 | 17. | Medical Policy | In Pharmaceuticals, added Over-the-Counter Medications Reference Guide (What Medications Can I Take and Still Be Safe to Fly) to the PDF version of the AME Guide. Document was previously only hyperlinked in the Guide. |
| 2024 | 08/28/2024 | 18. | Administrative | In Item 47. Neurologic, revised main index page to add hyperlinks for “Concussion” and “Traumatic Brain Injury.” |
| 2024 | 08/28/2024 | 19. | Errata | In Item 48. General Systemic, Endocrine Disorders, Hypoparathyroidism Disposition Table, corrected typographical error: changed creatine to creatinine. |
| 2024 | 08/28/2024 | 20. | Errata | In Item 48. General Systemic, HIV Specification Sheet - Initial, corrected typographical error: changed creatine to creatinine. |
| 2024 | 07/31/2024 | N/A | N/A | NO UPDATES PUBLISHED. |
| 2024 | 06/26/2024 | 1. | Medical Policy | In Item 47. Psychiatric Conditions, Anxiety, Depression, and Related Conditions, added FAST TRACK PATHWAY Decision |
| Tool for Current Deferred Cases. | ||||
| 2024 | 06/26/2024 | 2. | Medical Policy | In Item 47. Psychiatric Conditions, Anxiety, Depression, and Related Conditions, added information sheet for Row A conditions. |
| 2024 | 06/26/2024 | 3. | Medical Policy | In Item 47. Psychiatric, revised Anxiety, Depression, and Related Conditions Disposition Table to remove “uncomplicated” from the title. Added Seasonal Affective Disorder to Row B. |
| 2024 | 06/26/2024 | 4. | Medical Policy | In Item 47. Neurologic, revised Head Injury Disposition Table. Renamed Head Injury or Brain Injury. Row A now for head injury only (no brain injury, concussion, or neurological symptoms.) |
| 2024 | 06/26/2024 | 5. | Medical Policy | Item 35. Lungs and Chest , Examination Techniques revised to state breast exam is not required unless indicated by past medical history or symptoms. It may be performed at the discretion of the AME or applicant. Document findings in Item 60. |
| 2024 | 06/26/2024 | 6. | Medical Policy | Item 39. Anus, Examination Techniques revised to state visual or digital exam is not required unless indicated by past medical history or symptoms. It may be performed at the discretion of the AME or applicant. Document findings in Item 60. |
| 2024 | 06/26/2024 | 7. | Medical Policy | Item 41. G-U System, Examination Techniques revised to state that the |
| physical exam does not include pelvic examination and that genital exam is not required unless indicated by past medical history or symptoms. It may be performed at the discretion of the AME or applicant. Document findings in Item 60. | ||||
| 2024 | 06/26/2024 | 8. | Medical Policy | In Pharmaceuticals, Weight Loss Medications and CACI-Weight Loss Management: tirzepatide (GIP + GLP-1 Agonist) added to acceptable category. |
| 2024 | 06/26/2024 | 9. | Medical Policy | Item 32. Ophthalmoscopic revised Lattice Degeneration Disposition Table to add blurry vision to Row A, Evaluation Data. In Row B, added “treated with laser or surgery.” |
| 2024 | 06/26/2024 | 10. | Medical Policy | In Pharmaceuticals, Weight Loss Medications, revised to add tirzepatide (Mounjaro, Zepbound) (GIP + GLP-1 Agonist) to acceptable category. |
| 2024 | 06/26/2024 | 11. | Medical Policy | In Item 47. Psychiatric, revised Anxiety, Depression, and Related Conditions Decision Tool for the AME to remove “uncomplicated” from the title. Clarified AME instructions that “only uncomplicated anxiety, depression, and related will qualify for this pathway.” |
| 2024 | 06/26/2024 | 12. | Medical Policy | In Substances of Dependence/Abuse, DUI/DWI Alcohol Incidents Disposition Table revised to remove alcohol dependency content from Row A. |
| 2024 | 06/26/2024 | 13. | Medical Policy | in General Information, AME Equipment and Medical Confidentiality, revised to state that EKG/ECG equipment must be 12-lead. Anything less will not be accepted. |
| 2024 | 06/26/2024 | 14. | Administrative | In Item 46. Neurologic, grouped together “Other Neurologic Conditions” (Atypical Facial Pain, Immune Related demyelinating disease, Neurosyphilis, Optic Neuritis, Orthostatic Hypotension, Slow Viral Disease [e.g., Creutzfeldt Jacobs Disease], and Wilson’s Disease) in a single disposition table. |
| 2024 | 06/26/2024 | 15. | Administrative | In Item 46. Neurologic, reorganized listing of conditions in alphabetical order (PDF Version of the AME Guide.) |
| 2024 | 06/26/2024 | 16. | Administrative | In Item 47. Psychiatric, revised Post-Traumatic Stress Disorder Disposition Table to remove “uncomplicated” in the title of the hyperlink to the Anxiety, Depression, and Related Conditions Decision Tool for the AME. |
| 2024 | 06/26/2024 | 17. | Administrative | In Item 46. Neurologic, Web version of the AME Guide, created PDF packet with Deep Brain Stimulator (DBS) Disposition Table and DBS Status Summary in a single document. In PDF version of the AME Guide, added hyperlink to AASI on disposition page. |
| 2024 | 06/26/2024 | 18. | Administrative | In Item 46. Neurologic, Web version of the AME Guide, added PDF packet with |
| Neurofibromatosis Disposition Table and AASI Neurofibromatosis (NF1). In PDF version of the AME Guide, added hyperlink to AASI on disposition page. | ||||
| 2024 | 06/26/2024 | 19. | Administrative | In Item 46. Neurologic, Web version of the AME Guide, added PDF packet with Stroke (CVA, TIA) Disposition Table and AASI for Cerebrovascular Disease (CVA, Stroke, TIA). In PDF version of the AME Guide, added hyperlink to AASI on disposition page. |
| 2024 | 06/26/2024 | 20. | Administrative | In Item 46. Neurologic, Web version of the AME Guide, added PDF packet with Headache or Migraine Disposition Table, CACI – Migraine Worksheet, and AASI Migraine. |
| 2024 | 06/26/2024 | 21. | Administrative | In Item 46. Neurologic, Web version of the AME Guide, added PDF packet with Tremor Disposition Table and CACI – Essential Tremor Worksheet. |
| 2024 | 06/26/2024 | 22. | Administrative | In Protocols, Specifications Neurological Evaluations for Potential Neurocognitive Impairment, deleted extraneous information from “Additional helpful Information” section. |
| 2024 | 05/29/2024 | 1. | Medical Policy | In Item 47. Psychiatric, added new Uncomplicated Anxiety, Depression, and Related Conditions Disposition Table. |
| 2024 | 05/29/2024 | 2. | Medical Policy | In Item 47. Psychiatric, added new Uncomplicated Anxiety, Depression, and Related Conditions Decision Tool for the AME. |
| 2024 | 05/29/2024 | 3. | Medical Policy | In Item 47. Psychiatric, revised Post-Traumatic Stress Disorder Disposition Table: Row A – Previous or ongoing psychotherapy is permitted. |
| 2024 | 05/29/2024 | 4. | Medical Policy | In Item 47. Psychiatric, removed Post-Traumatic Stress Disorder Decision Tool from the AME Guide. AMEs should now use the Uncomplicated Anxiety, Depression, and Related Conditions Decision Tool for the AME. |
| 2024 | 05/29/2024 | 5. | Medical Policy | In Item 47. Psychiatric, revised Psychiatric Conditions Disposition Table. Removed bereavement (now listed in new Uncomplicated Anxiety, Depression, and Related Conditions Disposition Table). |
| 2024 | 05/29/2024 | 6. | Medical Policy | In Disease Protocols, added new Coronary Heart Disease (CHD/ Coronary Artery Disease (CAD) Recertification Status Summary. |
| 2024 | 05/29/2024 | 7. | Medical Policy | In Special Issuances, revised AASI - Coronary Heart Disease. Allows Coronary Heart Disease (CHD/Coronary Artery Disease (CAD) Recertification Status Summary from Cardiologist for risk factors verification. Also removed Maximal Graded Exercise Test information as it is no longer required for routine AASI. |
| 2024 | 05/29/2024 | 8. | Medical Policy | In Item 32. Ophthalmoscopic, added new Lattice Degeneration Disposition Table |
| 2024 | 05/29/2024 | 9. | Medical Policy | In Item 38. Abdomen and Viscera, revised Cholelithiasis Disposition Table. |
| 2024 | 05/29/2024 | 10. | Medical Policy | In Protocol for Maximal Graded Exercise Test, removed AASI information from protocol as testing is no longer routinely required for AASI. |
| 2024 | 05/29/2024 | 11. | Medical Policy | In Item 58., ECG, revised to clarify ECG Equipment Requirements. A full 12-lead ECG is required. Anything less than 12-lead will not be accepted. . |
| 2024 | 05/29/2024 | 12. | Medical Policy | Revised Protocol for Graded Exercise Stress Test Requirements. A full 12-lead ECG is required. Anything less than 12-lead will not be accepted. |
| 2024 | 05/29/2024 | 13. | Medical Policy | In Item 36. Heart, revised Pacemaker Status Summary. As of 05/29/2024 - Routine medical certificate for pacemaker will be 12 months up to the month prior to the Estimated Replacement Interval (ERI), which is typically 3-4 months of battery life remaining. |
| 2024 | 05/29/2024 | 14. | Medical Policy | In Item 36. Heart, Mitral Valve Repair Disposition Table (Row B) revised to remove requirement for Exercise Stress Test (EST). |
| 2024 | 05/29/2024 | 15. | Medical Policy | In Disease Protocols, Protocol for Cardiac Valve Replacement - Initial Consideration, revised to remove requirement for cardiologist note regarding why TAVR procedure was |
| chosen (if applicable). Also removed requirement for Maximal Graded Exercise Stress Test (GXT). | ||||
| 2024 | 05/29/2024 | 16. | Medical Policy | In Item 46. Neurologic, revised Brain Tumor (Intracranial Tumor) Disposition Table to remove criteria: “vascular neurologist preferred.” |
| 2024 | 05/29/2024 | 17. | Medical Policy | In Item 36. Heart, Coronary Heart Disease Disposition Table revised to remove option of submitting Fasting Blood Sugar (FBS). Hemoglobin A1c and lipid panel are required. |
| 2024 | 05/29/2024 | 18. | Medical Policy | In Item 36. Heart, Syncope Disposition Table revised to remove option of submitting Fasting Blood Sugar (FBS). Hemoglobin A1c and lipid panel are required. |
| 2024 | 05/29/2024 | 19. | Medical Policy | In Item 36. Heart, Pacemaker Disposition Table revised to remove option of submitting Fasting Blood Sugar (FBS). Hemoglobin A1c and lipid panel are required. |
| 2024 | 05/29/2024 | 20. | Medical Policy | Protocol for Coronary Heart Disease 1st or 2nd Class revised to remove option of submitting Fasting Blood Sugar (FBS). Hemoglobin A1c and lipid panel are required. |
| 2024 | 05/29/2024 | 21. | Medical Policy | Protocol for Coronary Heart Disease - 3rd Class revised to remove option of submitting Fasting Blood Sugar (FBS). Hemoglobin A1c and lipid panel are required. |
| 2024 | 05/29/2024 | 22. | Medical Policy | Protocol for Cardiac Transplant revised to remove |
| option of submitting Fasting Blood Sugar (FBS). Hemoglobin A1c and lipid panel are required. | ||||
| 2024 | 05/29/2024 | 23. | Medical Policy | Protocol for Cardiovascular Evaluation revised to remove option of submitting Fasting Blood Sugar (FBS). Hemoglobin A1c and lipid panel are required. |
| 2024 | 05/29/2024 | 24. | Medical Policy | Protocol for Bundle Branch Block revised to remove option of submitting Fasting Blood Sugar (FBS). Hemoglobin A1c and lipid panel are required. |
| 2024 | 05/29/2024 | 25. | Medical Policy | Protocol for Initial Evaluation of Implanted Pacemaker revised to remove option of submitting Fasting Blood Sugar (FBS). Hemoglobin A1c and lipid panel are required. |
| 2024 | 05/29/2024 | 26. | Medical Policy | In Pharmaceuticals, revised Over the Counter Medications to remove exception for Loperamide for acute conditions. As stated in the Over-the-Counter (OTC) Medications Reference Guide - What Over-the-Counter (OTC) medications can I take and still be safe to fly? guidance, Loperamide should not be used during acute illness as it can cause dizziness. When taken daily for a chronic condition, may require a special issuance. |
| 2024 | 05/29/2024 | 27. | Administrative | Added new Psychiatry Branch email address (9-AVS-Psychiatry-Branch@faa.gov) in Specifications for Psychiatric Evaluations, |
| Specification for Psychiatric and Psychological Evaluations, and Specifications for Psychiatric and Neuropsychological Evaluations. | ||||
| 2024 | 05/29/2024 | 28. | Administrative | In Item 36. Heart, revised Atrial Fibrillation (AFib)/A-Flutter Disposition Table. Renamed hyperlinks for Non-Valvular Atrial Fibrillation (AFib)/A-Flutter Status “Report” to Non-Valvular Atrial Fibrillation (AFib)/A-Flutter Status Report Summary |
| 2024 | 05/29/2024 | 29. | Administrative | In General Information, Medical Certificates – AME Completion, added table of Medical Certificate Limitations by system. |
| 2024 | 05/29/2024 | 30. | Administrative | In the PDF version of the AME Guide, Special Issuances main page listing, added hyperlinks to individual Web pages. |
| 2024 | 04/24/2024 | 1. | Medical Policy | In Pharmaceuticals, Antidepressants, added new table of Antidepressant Medications. |
| 2024 | 04/24/2024 | 2. | Medical Policy | In Pharmaceuticals, Antidepressants, revised to clarify and update section V. Pharmaceutical Considerations. |
| 2024 | 04/24/2024 | 3. | Medical Policy | In Disease Protocols, added new page: Protocol for Antidepressants; includes explanation of the expansion of the Antidepressant Protocol and hyperlinks to pertinent guidance. |
| 2024 | 04/24/2024 | 4. | Medical Policy | In main Disease Protocol listing, added hyperlink called “Antidepressants” and deleted hyperlink titled |
| “Depression treated with SSRI Medications.” | ||||
| 2024 | 04/24/2024 | 5. | Medical Policy | Item 47., Psychiatric – Use of Antidepressants, revised to clarify. Added hyperlink to table of Antidepressant Medications. |
| 2024 | 04/24/2024 | 6. | Medical Policy | Revised CAMI Limited Certificate Petition sheet to clarify that Pilots operating under 14 CFR Part 121 operations are not eligible to accept a lower class with the limitations listed on the sheet. |
| 2024 | 03/27/2024 | 1. | Medical Policy | In Disease Protocols, Cardiovascular Evaluation (CVE), revised to expand guidance. |
| 2024 | 03/27/2024 | 2. | Medical Policy | In Item 36. Heart, added new Coronary Heart Disease Disposition Table. |
| 2024 | 03/27/2024 | 3. | Medical Policy | In Disease Protocols, added new Protocol for Coronary Heart Disease – 1st and 2nd Class. |
| 2024 | 03/27/2024 | 4. | Medical Policy | In Disease Protocols, added new Protocol for Coronary Heart Disease – 3rd Class. |
| 2024 | 03/27/2024 | 5. | Medical Policy | In Special Issuances, AASI for Single Valve Replacement, revised to direct AME to either Protocol for Coronary Heart Disease– 1st and 2nd Class or Protocol for Coronary Heart Disease – 3rd Class, as appropriate. |
| 2024 | 03/27/2024 | 6. | Medical Policy | In Item, 36. Heart, added new Chest Pain/ Angina Disposition Table. |
| 2024 | 03/27/2024 | 7. | Medical Policy | In Item 36. Heart, added a new single Non-Valvular Atrial Fibrillation (A-Fib)/ A-Flutter Status Report. Initial |
| and Recertification status reports were eliminated. | ||||
| 2024 | 03/27/2024 | 8. | Administrative | In Item 36. Heart, Atrial Fibrillation (A-Fib)/A-Flutter, Disposition Table revised to eliminate hyperlinks to Initial and Recertification status summaries reports. Hyperlinks directed to new single Non-Valvular Atrial Fibrillation (A-Fib)/ A-Flutter Status Report. |
| 2024 | 03/27/2024 | 9. | Medical Policy | In Special Issuances, AASI for Atrial Fibrillation, added hyperlink to new Non-Valvular Atrial Fibrillation (A-Fib/ A-Flutter Status Report. Cardiologist report that addresses all items in the status report is also required. |
| 2024 | 03/27/2024 | 10. | Medical Policy | In Item 36. Heart, added expanded Syncope Disposition Table. |
| 2024 | 03/27/2024 | 11. | Medical Policy | In Item 36. Heart, added Syncope Decision Tool for the AME. |
| 2024 | 03/27/2024 | 12. | Medical Policy | In Disease Protocols, Bundle Branch Block (BBB) revised. Hemoglobin A1c (preferred) for Right BBB, 36 or older AND for Left BBB. |
| 2024 | 03/27/2024 | 13. | Medical Policy | In Item, 46., Neurologic, added new Chiari Malformation Disposition Table. |
| 2024 | 03/27/2024 | 14. | Medical Policy | In Item 48. General Systemic, Revised Weight Loss Management (Use of Medication for Obesity or Overweight) Disposition Table, Row B. Current, Detailed Clinical Progress Note OR Weight Loss Management Status Report |
| should be submitted. | ||||
| 2024 | 03/27/2024 | 15. | Medical Policy | In Pharmaceuticals, Weight Loss Medication, revised Conditionally Acceptable Weight Loss Medication section to remove criteria “when 2 more components are used.” Also added hyperlink to Weight Loss Management Status Report. |
| 2024 | 03/27/2024 | 16. | Medical Policy | Coumadin brand name for warfarin has been discontinued in the US and replace by brand name Jantoven. All references to Coumadin were removed from the AME Guide and replaced with warfarin/Jantoven. References in the Archives remain intact to document historical usage. |
| 2024 | 03/27/2024 | 17. | Medical Policy | In Protocol for Neurologic Evaluation, revised. For EEG, provide both interpretive report (on paper) and tracings (on a CD with embedded stand-alone viewing software). |
| 2024 | 03/27/2024 | 18. | Administrative | On main listing for Disease Protocols, added hyperlinks to Protocol for Coronary Heart Disease – 1st and 2nd Class and to Protocol for Coronary Heart Disease – 3rd class. |
| 2024 | 03/27/2024 | 19. | Administrative | In Item 58., ECG, Equipment Requirements, revised to clarify that FAA criteria is the standard voltage of 25mm/sec at 10mV. |
| 2024 | 03/27/2024 | 20. | Administrative | In General Information, Item 19. Protection and Destruction of Forms, revised language to be more concise. |
| 2024 | 03/27/2024 | 21. | Administrative | In Disease Protocols, added copy of CAMI Aerospace Medical Certification Division Limited Certificate Petition. |
| 2024 | 02/28/2024 | 1. | Medical Policy | Clarified CACI- Colitis Worksheet criteria to include Oral budesonide 9 mg or less. |
| 2024 | 02/28/2024 | 2. | Administrative | References to FAA Chief Psychiatrist were removed. Contact changed to Psychiatry Branch Manager. |
| 2024 | 01/31/2024 | 1. | Medical Policy | In Pharmaceuticals, Weight Loss Medications, revised to add tirzepatide (Mounjaro, Zepbound) (GIP + GLP-1 Agonist) to the Conditionally Acceptable category (requires SI). |
| 2024 | 01/31/2024 | 2. | Medical Policy | In Item 29. Ear, expanded disposition table for Middle Ear. Renamed Middle Ear Abnormalities. It includes Otitis Media, Serous Otitis Media, Eardrum Abnormalities, Tympanic Membrane Perforation, Myringotomy, Ear Tubes, PE Tubes, Eustachian Tube Dysfunction (ETD). |
| 2024 | 01/31/2024 | 3. | Medical Policy | In Item 29. Ear, expanded disposition table for Outer Ear. Renamed Outer Ear Abnormalities. It includes Cerumen Impaction, Otitis Externa, and Microtia. |
| 2024 | 01/31/2024 | 4. | Medical Policy | Revised FAA Specifications for Neurologic Evaluation to clarify language and to add caffeine use criterial in social history. |
| 2024 | 01/31/2024 | 5. | Medical Policy | In Item 52. Color Vision, Exam Techniques, testing for pilots and in Item 52. Color Vision, Acceptable Test Instruments for Color Vision |
| Screening of ATCS, clarified passing scores for City Occupational Colour Assessment & Diagnosis (CAD; AVOT-PRO-US). | ||||
| 2024 | 01/31/2024 | 6. | Medical Policy | In Substances of Dependence/abuse, HIMS AME Checklist - Drug and Alcohol Monitoring Recertification Sheet, revised to remove blackedout boxes in Item #2. Gives HIMS AME ability to check “Not Due” option, if appropriate. |
| 2024 | 01/31/2024 | 7. | Administrative | In Items 25-30. Ear, Nose, and Throat (ENT) Examination Techniques revised to add standardized language and added hyperlinks to Middle Ear Abnormalities and Outer Ear Abnormalities. |
| 2024 | 01/01/2024 | 1. | Administrative | Updated version date to match calendar year. |
| 2023 | 11/29/2023 | 1. | Medical Policy | In Item 29. Ears, General – added new sub-category for Hearing Devices. Added disposition table for Cochlear Implant. |
| 2023 | 11/29/2023 | 2. | Medical Policy | In Item 29. Ears, General – added disposition table for Benign Paroxysmal Positional Vertigo (BPPV). |
| 2023 | 11/29/2023 | 3. | Medical Policy | In Item 29. Ears, General – added disposition table for Labyrinthitis (Vestibular Neuritis, Viral Labyrinthitis, Epidemic Vertigo, Acute Vestibulopathy). |
| 2023 | 11/29/2023 | 4. | Medical Policy | In Item 29. Ears, General – added disposition table for Meniere’s Disease. |
| 2023 | 11/29/2023 | 5. | Medical Policy | In Item 29. Ears, General – added disposition table for Perilymph Fistula (PLF). |
| 2023 | 11/29/2023 | 6. | Medical Policy | In Item 29. Ears, General – added disposition table for Persistent Postural Perceptual Dizziness (PPPD or 3PD). |
| 2023 | 11/29/2023 | 7. | Medical Policy | In Item 29. Ears, General – added disposition table for Superior Semicircular Canal Dehiscence Syndrome (SSCDS). |
| 2023 | 11/29/2023 | 8. | Medical Policy | In Substances of Dependence/Abuse, Drug and/or Alcohol Monitoring, revised HIMS AME – Step Down Transition Supplement to indicate that BOTH items A AND B are required in each section. |
| 2023 | 11/29/2023 | 9. | Medical Policy | In Pharmaceuticals, Weight Loss Medication, changed status of tirzepatide-Mounjaro to “Under FAA review.” |
| 2023 | 1/29/2023 | 10. | Administrative | In Item 46. Neurologic, Vertigo and Disequilibrium Disposition Table revised to remove conditions that are now covered in Item 29. Ears, General. |
| 2023 | 10/25/2023 | 1. | Medical Policy | In Substances of Dependence/Abuse, Drug and/or Alcohol Monitoring, added new HIMS AME – Step Down Transition Information. (If the pilot is on a Special Issuance for substance dependence, with or without any other condition, in some instances the HIMS AME may have the option to transition the pilot to another Phase.) |
| 2023 | 10/25/2023 | 2. | Medical Policy | In Substances of Dependence/Abuse, Drug and/or Alcohol Monitoring, added new HIMS AME – |
| Step Down Transition Supplement as a worksheet for HIMS AMEs to determine pilot eligibility for Phase transition. | ||||
| 2023 | 10/25/2023 | 3. | Medical Policy | In Substances of Dependence/Abuse, Drug and/or Alcohol Monitoring – Recertification, revised Airman Information – HIMS Step Down Plan. Added information on HIMS Step Down Transition option and renamed document Pilot Information – HIMS Step Down Plan. |
| 2023 | 10/25/2023 | 4. | Medical Policy | In Substances of Dependence/Abuse, Drug and/or Alcohol Monitoring – Recertification, revised HIMS AME Checklist to include information on Step Down Transition option. |
| 2023 | 10/25/2023 | 5. | Medical Policy | In Substances of Dependence/Abuse, Drug and/or Alcohol Monitoring, revised Drug and Alcohol Monitoring/HIMS FAQs to answer questions about Step Down Transition option. |
| 2023 | 10/25/2023 | 6. | Medical Policy | In Item 38. Abdomen and Viscera and Anus Conditions, revised CACI - Colitis Worksheet. Added to Humira: “4-hour no fly after each dose.” |
| 2023 | 10/25/2023 | 7. | Medical Policy | In Pharmaceuticals, clarified Weight Loss Medication guidance. If starting acceptable medication for weight loss, observation time is two (2) weeks. For each dosage change, the observation time is 72 hours. |
| 2023 | 10/25/2023 | 8. | Medical Policy | In Item 48. General Systemic, revised CACI – |
| Weight Loss Management Worksheet to specify twoweek observation if taking medication for weight loss. | ||||
| 2023 | 10/25/2023 | 9. | Medical Policy | In Item 48. General Systemic, revised CACI - Prediabetes Worksheet to specify two-week observation for medication. |
| 2023 | 10/25/2023 | 10. | Medical Policy | In AASI for Sleep Apnea/Obstructive Sleep Apnea (OSA), removed requirement for signed “Airman Compliance with Treatment Sheet or equivalent. |
| 2023 | 10/25/2023 | 11. | Medical Policy | In Protocols, Obstructive Sleep Apnea (OSA) Reference Materials, changed the title of the “Airman Compliance with Treatment – Obstructive Sleep Apnea” sheet” to “FAA Compliance with Treatment– Obstructive Sleep Apnea” sheet. Sheet can be used by pilots or ATCS. |
| 2023 | 10/25/2023 | 12. | Medical Policy | In Protocols, ADHD, revised ADHD Pathway Chart. Added “Any history diagnosis or any psychiatric treatment ever” as a disqualifier for using the Fast Track. |
| 2023 | 09/27/2023 | 1. | Medical Policy | In Item 48., General Systemic, added Polycystic Ovarian Syndrome (PCOS) Disposition Table. |
| 2023 | 09/27/2023 | 2. | Medical Policy | In Item 48. General Systemic, added CACI - Polycystic Ovarian Syndrome (PCOS) Worksheet. |
| 2023 | 09/27/2023 | 3. | Medical Policy | In Item 48. General Systemic, Added Weight Loss Management (Use of Medication for Obesity or |
| Overweight) Disposition Table. | ||||
| 2023 | 09/27/2023 | 4. | Medical Policy | In Item 48. General Systemic, added CACI – Weight Loss Management Worksheet. |
| 5. | Medical Policy | In Pharmaceuticals, added Weight Loss Medication guidance. | ||
| 2023 | 09/27/2023 | 6. | Medical Policy | In Item 48. General Systemic, added Weight Loss Management or Prediabetes Status Report. |
| 2023 | 09/27/2023 | 7. | Medical Policy | In Special Issuances, added AASI for Prediabetes or Overweight/Obesity Treated with Medication. |
| 2023 | 09/27/2023 | 8. | Medical Policy | In Item 48. General Systemic, added Prediabetes Disposition Table. |
| 2023 | 09/27/2023 | 9. | Medical Policy | In Item 48. General Systemic, revised CACI - Prediabetes Worksheet. Simplified CACI requirements and expanded acceptable medications for consideration. |
| 2023 | 09/27/2023 | 10. | Medical Policy | In Item 48. General Systemic, added Diabetes Mellitus Disposition Table. |
| 2023 | 09/27/2023 | 11. | Medical Policy | In Item 48. General Systemic, added Diabetes Insipidus Disposition Table. |
| 2023 | 09/27/2023 | 12. | Medical Policy | In Pharmaceuticals, COVID-19 MEDICATION, removed medications for which FDA Emergency Use Authorization (EUA) was withdrawn to low efficacy of the medication. |
| 2023 | 09/27/2023 | 13. | Medical Policy | In Item 36. Heart, revised and shortened Non-Valvular Atrial Fibrillation (AFib)/Aflutter Recertification Status Summary. |
| 2023 | 09/27/2023 | 14. | Medical Policy | Item 47. Psychiatric Conditions updated disposition table for Attention-Deficit/Hyperactivity Disorder (ADHD) and/or use of ADHD Medications. Row A: Fast Track virtual evaluation must be face-toface on screen, not audio only. Row B: Standard Track evaluations must be completed by a HIMS Neuropsychologist. |
| 2023 | 09/27/2023 | 15. | Medical Policy | Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), Fast Track – FAA ADHD Summary revised to add attestation that evaluation was done in person or, if virtually, was conducted face-to-face on screen, not audio only. |
| 2023 | 09/27/2023 | 16. | Medical Policy | Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), Fast Track – FAA ADHD - Evaluation Report Requirements revised to add that virtual evaluation must be face-to-face on screen, not audio only. |
| 2023 | 09/27/2023 | 17. | Medical Policy | Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), ADHD Pathway Chart revised to reflect that Standard Track evaluations must be completed by a HIMS Neuropsychologist. |
| 2023 | 09/27/2023 | 18. | Medical Policy | Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), ADHD Document Checklist revised to add virtual evaluation must be face-to-face on screen, not audio only. Also revised to |
| state that Standard Track evaluation must be completed by a HIMS Neuropsychologist. | ||||
| 2023 | 09/27/2023 | 19. | Medical Policy | Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), Standard Track – FAA ADHD Evaluation General Information revised to state that Standard Track evaluation must be completed by a HIMS Neuropsychologist. |
| 2023 | 09/27/2023 | 20. | Medical Policy | Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), Standard Track – FAA ADHD Evaluation Report Requirements revised to state that Standard Track evaluation must be completed by a HIMS Neuropsychologist. |
| 2023 | 09/27/2023 | 21. | Medical Policy | In Item 52. Color Vision, Exam Techniques, testing for pilots, revised Waggoner Computerized Vision Test section by adding information about what is specifically addressed in each section of the test. |
| 2023 | 09/27/2023 | 22. | Medical Policy | In Item 52. Color Vision, Acceptable Test Instruments for Color Vision Screening of ATCS, revised Waggoner Computerized Vision Test section by adding information about what is specifically addressed in each section of the test. |
| 2023 | 09/27/2023 | 23. | Administrative | In Pharmaceuticals, main index page, added listing for Weight Loss Medications. |
| 2023 | 09/27/2023 | 24. | Administrative | In AASI main index page, added listing for Prediabetes or Overweight/Obesity Treated with Medication. |
| 2023 | 09/27/2023 | 25. | Administrative | On AASI Coversheet, added listing for Prediabetes or Overweight/Obesity Treated with Medication. |
| 2023 | 09/27/2023 | 26. | Administrative | On Main CACI index, added links for Polycystic Ovarian Syndrome (PCOS) Worksheet and Weight Loss Management Worksheet. |
| 2023 | 09/27/2023 | 27. | Administrative | In Resources, Frequently Used Pages, added link to Weight Loss Management Disposition Table. |
| 2023 | 08/30/2023 | 1. | Medical Policy | Item 47. Psychiatric Conditions - Psychiatric Conditions added new disposition table for Attention-Deficit/Hyperactivity Disorder (ADHD) and/or use of ADHD Medications. |
| 2023 | 08/30/2023 | 2. | Medical Policy | In Disease Protocols, revised Specifications for ADHD/ADD Home Page. Now called Attention-Deficit/Hyperactivity Disorder (ADHD). Includes links to supporting documents for 2 certification/clearance pathways (Fast Track and Standard Track). |
| 2023 | 08/30/2023 | 3. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), added ADHD Pathway Chart. |
| 2023 | 08/30/2023 | 4. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), added ADHD Document Checklist. |
| 2023 | 08/30/2023 | 5. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), added ADHD |
| Personal Statement Guidelines. | ||||
| 2023 | 08/30/2023 | 6. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), added Fast Track – FAA ADHD Summary. |
| 2023 | 08/30/2023 | 7. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), added Fast Track - FAA ADHD Information for the Psychologist or Neuropsychologist. |
| 2023 | 08/30/2023 | 8. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), added Fast Track – FAA ADHD Evaluation General Information. |
| 2023 | 08/30/2023 | 9. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), added Fast Track – FAA ADHD - Evaluation Report Requirements. |
| 2023 | 08/30/2023 | 10. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), added Standard Track – FAA ADHD Evaluation General Information. |
| 2023 | 08/30/2023 | 11. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), added Standard Track – FAA ADHD Evaluation Report Requirements. |
| 2023 | 08/30/2023 | 12. | Medical Policy | In Specifications for Attention-Deficit/Hyperactivity Disorder (ADHD), revised Reference Information for Psychologists and Neuropsychologists. |
| 2023 | 08/30/2023 | 13. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, revised index on main page to rename links and add two new documents to index. Relabeled documents to match the corresponding letter from the Index. (e.g., A, B, C, etc.). |
| 2023 | 08/30/2023 | 14. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, added new Certification Aid. |
| 2023 | 08/30/2023 | 15. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, added new How to Submit Documents for Initial or Recertification/Renewal. |
| 2023 | 08/30/2023 | 16. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, renamed and revised to clarify information in Pilot Information – Initial Certification. |
| 2023 | 08/30/2023 | 17. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, revised Initial Certificate Consideration Requirements. |
| 2023 | 08/30/2023 | 18. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, revised Information Submission Requirements. |
| 2023 | 08/30/2023 | 19. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, |
| Revised CGM Renewal Requirements page. | ||||
| 2023 | 08/30/2023 | 20. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, added new color view and samples to CGM Data Report Examples. |
| 2023 | 08/30/2023 | 21. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II - Insulin Treated CGM Option, revised and added information to Frequently Asked Questions (FAQs). |
| 2023 | 08/30/2023 | 22. | Administrative | In Protocol for Insulin-Treated Diabetes Mellitus Non-CGM - Third-Class Option, added cover page and index. |
| 2023 | 07/26/2023 | 1. | Medical Policy | In Pharmaceuticals, Diabetes Mellitus – Type II Medication Controlled (Not Insulin), revised the Acceptable Combination of Diabetes Medications. Changed SGLT2 inhibitors (Group F) initial observation time to 30 days; added information for when switching dosing or formulations within the same drug class or device manufacturer; added new GIP/GLP drug class under Group C; and removed restriction of Group F used with Group E. |
| 2023 | 07/26/2023 | 2. | Medical Policy | In Item 36. Heart, revised Atrial Fibrillation Disposition Table to specify that ≥ 24-hour cardiac monitor must be current. |
| 2023 | 07/26/2023 | 3. | Medical Policy | In Disease Protocols, Medication Controlled Metabolic Syndrome |
| (Glucose Intolerance, Impaired Glucose Tolerance, Impaired Fasting Glucose, Insulin Resistance, and Pre-Diabetes revised to condense information, specify medications considered do not include insulin, and direct AMEs to the Acceptable Combinations of Diabetes Medications chart for currently allowed medications and required observation times. | ||||
| 2023 | 07/26/2023 | 4. | Medical Policy | In Item 46. Neurologic, Essential Tremor CACI, revised to add additional question regarding if the applicant relies on medication to be functional: “Does the applicant have a disabling tremor when they do not take the medication or if the medication wears off?” |
| 2023 | 07/18/2023 | 1. | Administrative | Redirected appropriate hyperlinks to the reformatted Item. 38 Abdomen and Viscera, Malignancies (Colon Cancer/ Colorectal Cancer.) |
| 2023 | 06/28/2023 | 1. | Medical Policy | In Pharmaceuticals, expanded Over the Counter Medications section. |
| 2023 | 06/28/2023 | 2. | Medical Policy | In Pharmaceuticals, expanded Do Not Issue (DNI) – Do Not Fly (DNF) section to include DNI-DNF medications tables and general No Fly wait times. |
| 2023 | 06/28/2023 | 3. | Medical Policy | In Pharmaceuticals, Vaccines, removed Johnson & Johnson’s Janssen COVID-19 vaccine as it is no longer available. See |
| June 1, 2023, Review Memorandum - Janssen COVID-19 Vaccine (fda.gov) | ||||
| 2023 | 06/28/2023 | 4. | Medical Policy | In Item 48. General Systemic, Endocrine Disorders, CACI – Hypothyroidism Worksheet revised to clarify that TSH must be less than 10 (uIU/mL or mlU/L) within the last one year to be CACI eligible. TSH of 10 or higher must be deferred. |
| 2023 | 06/28/2023 | 5. | Medical Policy | In General Information, Classes of Medical Certificate, revised to clarify that Balloon Pilots exercising Commercial Pilot Privileges, other than instructional flight, must hold at least a Class II FAA Medical Certificate. |
| 2023 | 06/28/2023 | 6. | Administrative | Added Frequently Used Pages document. Resource identifies and provides quick access to information most often requested. |
| 2023 | 06/28/2023 | 7. | Errata | In Item 35. Lungs and Chest, COPD Status Summary, corrected “primary function” to “pulmonary function” test. |
| 2023 | 06/28/2023 | 8. | Errata | In Item 47. Psychiatric, Use of Antidepressant Medications, SSRI-Decision Path-I and SSRI-Decision Path-II. Clarified Wellbutrin – Extended Release is [XL] not [EX]. |
| 2023 | 05/31/2023 | 1. | Medical Policy | In Item 47. Psychiatric, Use of Antidepressant Medications, revised medications list to include bupropion (Wellbutrin – Extended Release [EX] and Sustained Release [SR]). Also removed language referring to “four” specific |
| SSRIs that may be considered. | ||||
| 2023 | 05/31/2023 | 2. | Medical Policy | In Item 47. Psychiatric, Use of Antidepressant Medications, Updated SSRI-Decision Path-I and SSRI-Decision Path-II to add bupropion (Wellbutrin – Extended Release [EX] and Sustained Release [SR]). |
| 2023 | 05/31/2023 | 3. | Medical Policy | With the approval of bupropion (Wellbutrin – Extended Release [EX] and Sustained Release [SR]), revised language to remove reference to “four” specific SSRIs that may be considered in Pharmaceuticals, Antidepressants |
| 2023 | 05/31/2023 | 4. | Medical Policy | In Item 52. Color Vision, Examination Techniques, added table of acceptable computerized color vision tests with scoring criteria. Approved for pilots, FAA employee 2152 Series ATCS, and contract tower ATCS. |
| 2023 | 05/31/2023 | 5. | Administrative | In Item 52. Color Vision, Dispositions, under “An applicant does not meet the color vision standard if testing reveals” section, added hyperlink to score criteria for approved computerized tests. |
| 2023 | 05/31/2023 | 6. | Medical Policy | In General Information, Equipment Requirements, revised to list three approved computerized color vision tests. |
| 2023 | 05/31/2023 | 7. | Medical Policy | In Item 45. Lymphatics, Leukemia, added new CACI– Chronic Lymphocytic Leukemia (CLL) Small |
| Lymphocytic Lymphoma (SLL) Worksheet. | ||||
| 2023 | 05/31/2023 | 8. | Medical Policy | In Item 45. Lymphatics, Leukemia, added new Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Status Summary. |
| 2023 | 05/31/2023 | 9. | Medical Policy | In Item 45. Lymphatics, Leukemia, added new Chronic Lymphocytic Leukemia (CLL) Small Lymphocytic Lymphoma (SLL) disposition table. |
| 2023 | 05/31/2023 | 10. | Medical Policy | In AME Assisted Special Issuance, revised AASI for Chronic Lymphocytic Leukemia (CLL) to include additional condition. Renamed AASI for Chronic Lymphocytic Leukemia (CLL) Small Lymphocytic Lymphoma (SLL). Added requirement for CLL/SLL Status Summary and current, detailed Clinical Progress Note; revised deferral criteria. |
| 2023 | 05/31/2023 | 11. | Medical Policy | In Item 35. Lungs and Chest, added new Chronic Obstructive Pulmonary Disease (COPD) Status Summary. |
| 2023 | 05/31/2023 | 12. | Medical Policy | In Item 35. Lungs and Chest, revised, expanded, and renamed Chronic Obstructive Pulmonary Disease (COPD) disposition table. Now called Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Chronic Bronchitis. |
| 2023 | 05/31/2023 | 13. | Medical Policy | In AME Assisted Special Issuance, revised AASI for Chronic Obstructive |
| Pulmonary Disease (COPD) to update deferral criteria. | ||||
| 2023 | 05/31/2023 | 14. | Medical Policy | In Item 48. General Systemic, Endocrine Disorders, revised and expanded disposition table Hypoparathyroidism. |
| 2023 | 05/31/2023 | 15. | Medical Policy | In Item 37. Vascular, revised and expanded disposition table for Raynaud’s Syndrome (Primary Raynaud’s/ Raynaud’s Disease or Secondary Raynaud’s/ Raynaud’s Phenomenon). |
| 2023 | 05/31/2023 | 16. | Medical Policy | In Item 40. Skin, Cutaneous, added hyperlink to Item 37. Vascular for Raynaud’s Syndrome (Primary Raynaud’s/ Raynaud’s Disease or Secondary Raynaud’s/Raynaud’s Phenomenon). |
| 2023 | 05/31/2023 | 17. | Medical Policy | In General Information, Classes of Medical Certificate, revised to add new requirement: Effective May 22, 2023, Balloon Pilots exercising Commercial Pilot Privileges, other than instructional flight, must hold a Class II FAA Medical Certificate. |
| 2023 | 05/31/2023 | 18. | Medical Policy | In General Information, Who May Be Certified, revised to clarify: “The AME may issue any class of medical certificate without regard to age to any applicant who meets the appropriate medical standards.” Added hyperlink to pilot certificate minimum age requirements, defined in 14 CFR part 6. |
| 2023 | 05/31/2023 | 19. | Administrative | In General Information, Operations Not Requiring a Medical Certificate, reorganized content for clarity. |
| 2023 | 05/31/2023 | 20. | Medical Policy | In Applicant History, Item 6., Date of Birth, revised to clarify that it is not mandatory that applicants provide a Social Security Number. Added hyperlink for instructions regarding applicants who do not wish to use their SSN. |
| 2023 | 05/31/2023 | 21. | Medical Policy | In Item 48. General Systemic, Neoplasms, G-U Systems Cancer, revised Row B. Prostate Cancer to add “active surveillance/watchful waiting.” |
| 2023 | 05/31/2023 | 22. | Medical Policy | In Item 46. Neurologic – Neurologic Conditions, Epilepsy, revised to clarify that EEG recordings on CD should have proprietary opening software that is compatible with Windows 10. |
| 2023 | 05/31/2023 | 23. | Administrative | In Special Issuances, AASI Coversheet, added information regarding Continue Authorization Letter: If the AME issued an AASI correctly, AAM will no longer send a “continue authorization” letter, in accordance with the last paragraph of the authorization letter. |
| 2023 | 04/26/2023 | 1. | Medical Policy | In Item 48. General Systemic, Blood and Bloodforming Tissue Disease, added disposition table for Acute Lymphocytic Leukemia (ALL). |
| 2023 | 04/26/2023 | 2. | Medical Policy | CACI – Hypothyroidism Worksheet revised to remove “on current regimen and no changes recommended” from treating physician review requirement, if condition is stable. |
| 2023 | 04/26/2023 | 3. | Medical Policy | In Item 46. Neurologic – Stroke/CVA/TIA, clarified note regarding if the cause of stroke is known and corrected. |
| 2023 | 04/26/2023 | 4. | Medical Policy | In Item 46. Neurologic – Demyelinating Disease, changed “Allergic Encephalomyelitis” to “Immune-related Demyelinating Disease” to match current clinical terminology. |
| 2023 | 04/26/2023 | 5. | Administrative | In Item 46. Neurologic Conditions, Epilepsy (Seizure Disorder), added Rolandic seizures (and others) to disposition table with current clinical terminology of SeLECTS. No policy change. Footnote containing Rolandic seizure information omitted with disposition table update. |
| 2023 | 03/29/2023 | 1. | Medical Policy | In Item 43. Spine and Other Musculoskeletal, revised disposition table entry for “Active Diseases of Bones and Joints.” If due to a specific condition or due to arthritis, AMEs should review those corresponding pages. |
| 2023 | 03/29/2023 | 2. | Administrative | In Item 43. Spine and other Musculoskeletal, Collagen Disease, updated terminology from periarteritis nodosa to current clinical term of polyarteritis nodosa. |
| 2023 | 03/29/2023 | 3. | Administrative | Revised Non-Valvular Atrial Fibrillation (AFib) A-Flutter Status Report, both initial and recertification, to include lines for pilot’s name, birthdate, etc., on second page. |
| 2023 | 03/29/2023 | 4. | Administrative | In Student Pilot Rule Change information page, changed information link for foreign student pilots (non-resident) to Flight Training Security Program (FTSP). |
| 2023 | 02/22/2023 | 1. | Administrative | Added additional hyperlinks for related material to four neurologic pages: Alzheimer's Disease or Mild Cognitive Impairment (MCI) or Dementia; Parkinson’s Disease and Parkinsonism (Secondary); Tourette Syndrome or Tic Disorder; and Deep Brain Simulator. |
| 2023 | 01/25/2023 | 1. | Medical Policy | In Item 48. General Systemic, Endocrine Disorders, revised CACI - Hypothyroidism Worksheet. TSH of 9.9 (uIU/mL or mlU/L) or less in the past one year can be considered for CACI, if other criteria are met. |
| 2023 | 01/25/2023 | 2. | Medical Policy | In Item 48. General Systemic, Endocrine Disorders, added new disposition table for Hypothyroid or Hypothyroidism |
| 2023 | 01/25/2023 | 3. | Medical Policy | In AME Assisted Special Issuances, added AASI for Cerebrovascular Disease (CVA/Stroke/TIA). |
| 2023 | 01/25/2023 | 4. | Medical Policy | In AME Assisted Special Issuances, added AASI for Neurofibromatosis – Type 1. |
| 2023 | 01/25/2023 | 5. | Medical Policy | In AME Assisted Special Issuances, updated Certificate Issuance sheet to include Cerebrovascular Disease (CVA/Stroke/TIA) and Neurofibromatosis – Type 1. |
| 2023 | 01/25/2023 | 6. | Medical Policy | In Item 46. Neurologic, Cerebrovascular Disease, added expanded disposition table guidance for Stroke/CVA/TIA. |
| 2023 | 01/25/2023 | 7. | Medical Policy | In Item 46. Neurologic, Cerebrovascular Disease, expanded disposition table guidance for Brain Bleed - (Intracranial Hemorrhage, Cerebral Hemorrhage, Ruptured Aneurysm, Subarachnoid Hemorrhage, Subdural/Epidural Hemorrhage). |
| 2023 | 01/25/2023 | 8. | Medical Policy | In Item 46. Neurologic, Cerebrovascular Disease, added expanded disposition table guidance for Brain Aneurysm - (Intracranial Aneurysm/Cerebral Aneurysm) Not Ruptured. |
| 2023 | 01/25/2023 | 9. | Medical Policy | In Item 46. Neurologic, Cerebrovascular Disease, added expanded disposition table guidance for Arteriovenous Malformation (AVM). |
| 2023 | 01/25/2023 | 10. | Medical Policy | In Item 46. Neurologic, Cerebrovascular Disease, added expanded disposition table guidance for Brain Tumor (Intracranial Tumor). |
| 2023 | 01/25/2023 | 11. | Medical Policy | In Item 46. Neurologic, Cerebrovascular Disease, added expanded disposition table guidance for Pseudotumor Cerebri. |
| 2023 | 01/25/2023 | 12. | Medical Policy | In Item 46. Neurologic, Demyelinating Disease, revised existing disposition table to remove reference to Guillain Barre Syndrome, Multiple Sclerosis, and Myasthenia Gravis. |
| 2023 | 01/25/2023 | 13. | Medical Policy | In Item 46. Neurologic, Demyelinating Disease, expanded guidance and added new disposition table for Guillain Barre Syndrome. |
| 2023 | 01/25/2023 | 14. | Medical Policy | In Item 46. Neurologic, Demyelinating Disease, expanded guidance and added new disposition table for Multiple Sclerosis. |
| 2023 | 01/25/2023 | 15. | Medical Policy | In Item 46. Neurologic, Demyelinating Disease, expanded guidance and added new disposition table for Myasthenia Gravis. |
| 2023 | 01/25/2023 | 16. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, revised existing disposition table to remove references to Alzheimer’s Disease, Dystonia, Huntington’s Disease, Parkinson’s Disease, and Tourette Syndrome. |
| 2023 | 01/25/2023 | 17. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, added new disposition table for Alzheimer's Disease or Mild Cognitive Impairment (MCI) or Dementia. |
| 2023 | 01/25/2023 | 18. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, |
| and Degenerative Diseases of the Nervous System, added new disposition table for Amyotrophic Lateral Sclerosis (ALS) aka Lou Gehrig's Disease and other Motor Neuron Diseases. | ||||
| 2023 | 01/25/2023 | 19. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, added new disposition table for Deep Brain Stimulator (DBS). |
| 2023 | 01/25/2023 | 20. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, added new Deep Brain Stimulator (DBS) Status Summary |
| 2023 | 01/25/2023 | 21. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, added new disposition table for Dystonia (Including Torticollis). |
| 2023 | 01/25/2023 | 22. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, added new disposition table for Huntington’s Disease. |
| 2023 | 01/25/2023 | 23. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, added new disposition table for Parkinson’s Disease and Parkinsonism (Secondary). |
| 2023 | 01/25/2023 | 24. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, added new disposition table for Tremor. |
| 2023 | 01/25/2023 | 25. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, added new CACI – Essential Tremor Worksheet. |
| 2023 | 01/25/2023 | 26. | Medical Policy | In Item 46. Neurologic, Extrapyramidal, Hereditary, and Degenerative Diseases of the Nervous System, added new disposition table for Tourette Syndrome or Tic Disorder. |
| 2023 | 01/25/2023 | 27. | Medical Policy | In Item 46. Neurologic, Headaches, revised existing disposition table to remove references to Migraine Headaches and Post-Traumatic Headaches. |
| 2023 | 01/25/2023 | 28. | Medical Policy | In Item 46. Neurologic, Headaches, added new disposition table for Headache or Migraine (Cluster, Tension, Ocular, Acephalgic, Ophthalmic, or Retinal). Table also includes guidance on post-traumatic headaches. |
| 2023 | 01/25/2023 | 29. | Medical Policy | In Item 46. Neurologic, Hydrocephalus and Shunts, expanded disposition table guidance; renamed Hydrocephalus (With or Without Shunt). |
| 2023 | 01/25/2023 | 30. | Medical Policy | In Item 46. Neurologic, Infections of the Nervous System, revised existing |
| disposition table to remove references to Brain Abscess, Encephalitis, and Meningitis. | ||||
| 2023 | 01/25/2023 | 31. | Medical Policy | In Item 46. Neurologic, Infections of the Nervous System, added new disposition table for Brain Abscess. |
| 2023 | 01/25/2023 | 32. | Medical Policy | In Item 46. Neurologic, Infections of the Nervous System, added new disposition table for Encephalitis. |
| 2023 | 01/25/2023 | 33. | Medical Policy | In Item 46. Neurologic, Infections of the Nervous System, added new disposition table for Meningitis. |
| 2023 | 01/25/2023 | 34. | Medical Policy | In Item 46. Neurologic, Neurologic Conditions, removed existing disposition table. Conditions expanded to individual disposition tables. |
| 2023 | 01/25/2023 | 35. | Medical Policy | In Item 46. Neurologic, Neurologic Conditions, added new disposition table for Central Sleep Apnea. |
| 2023 | 01/25/2023 | 36. | Medical Policy | In Item 46. Neurologic, Neurologic Conditions, added new disposition table for Epilepsy (Seizure Disorder). |
| 2023 | 01/25/2023 | 37. | Medical Policy | In Item 46. Neurologic, Neurologic Conditions, added new disposition table for Cognitive or Mental Impairment or Dysfunction, Cognitive Disorder. |
| 2023 | 01/25/2023 | 38. | Medical Policy | In Item 46. Neurologic, Neurologic Conditions, added new disposition table for Seizure. |
| 2023 | 01/25/2023 | 39. | Medical Policy | In Item 46. Neurologic, Neurologic Conditions, added new disposition table |
| for Transient Global Amnesia (TGA). | ||||
| 2023 | 01/25/2023 | 40 | Medical Policy | In Item 46. Neurologic, Neurologic Conditions, added new disposition table for Unexplained Loss of Consciousness (ULOC) (Unexplained Disturbance of Consciousness or Transient LOC Without Satisfactory Medical Explanation). |
| 2023 | 01/25/2023 | 41. | Medical Policy | In Item 46. Neurologic, Other Conditions, removed existing disposition table. Conditions expanded to individual disposition tables. |
| 2023 | 01/25/2023 | 42. | Medical Policy | In Item 46. Neurologic, Other Conditions, added new disposition table for Bell’s Palsy (Facial Nerve Palsy, Cranial Nerve Palsy). |
| 2023 | 01/25/2023 | 43. | Medical Policy | In Item 46. Neurologic, Other Conditions, added new disposition table for Narcolepsy and Idiopathic Hypersomnia. |
| 2023 | 01/25/2023 | 44. | Medical Policy | In Item 46. Neurologic, Other Conditions, added new disposition table for Neuralgia (Trigeminal Neuralgia, Post Herpetic Neuralgia). |
| 2023 | 01/25/2023 | 45. | Medical Policy | In Item 46. Neurologic, Presence of Any NeurologicaL Condition or Disease That Potentially May Incapacitate an Individual, expanded disposition table guidance; renamed Head Injury - Concussion, Closed Head Injury (CHI), Open Head Injury, Traumatic Brain Injury (TBI). |
| 2023 | 01/25/2023 | 46. | Medical Policy | In Item 46. Neurologic, Spasticity, Weakness, or |
| Paralysis of the Extremities, removed existing disposition table to expand guidance on specific conditions. | ||||
| 2023 | 01/25/2023 | 47. | Medical Policy | In Item 46. Neurologic, Spasticity, Weakness, or Paralysis of the Extremities, added new disposition table for Paraplegia. |
| 2023 | 01/25/2023 | 48. | Medical Policy | In Item 46. Neurologic, Spasticity, Weakness, or Paralysis of the Extremities, added new disposition table for Polio (Poliomyelitis). |
| 2023 | 01/25/2023 | 49. | Medical Policy | In Item 35. Lungs and Chest, Sleep Apnea, revised existing disposition table to remove reference to periodic limb movement. Added new disposition table for Restless Leg Syndrome. |
| 2023 | 01/25/2023 | 50. | Medical Policy | In Item 42. Upper and Lower Extremities, revised existing disposition table to remove reference to neuropathy; revised entries for neuralgia and for tremors. |
| 2023 | 01/25/2023 | 51. | Medical Policy | In Item 42. Upper and Lower Extremities and in Item 46. Neurologic, Other Conditions, added new disposition table for Neuropathy. |
| 2023 | 01/25/2023 | 52. | Medical Policy | In Item 43. Spine, Other Musculoskeletal, revised existing disposition table to remove Cerebral Palsy. Condition expanded to individual disposition table. |
| 2023 | 01/25/2023 | 53. | Medical Policy | In Item 43. Spine, Musculoskeletal and in Item 46. Neurologic, Other Conditions, added new disposition table for Cerebral Palsy. |
| 2023 | 01/01/2023 | 1. | Administrative | Updated version date to match calendar year. |
| 2022 | 12/28/2022 | 1. | Medical Policy | In Protocols, added SSRI Recertification – Neuropsychological Report Changes and FAQs announcing policy change for airman and ATCS SSRI Recertification/Follow-up. Neuropsychological evaluation and follow-up CogScreen-AE are no longer needed, except when clinically indicated or specified on the Authorization/Special Consideration Letter. This policy does NOT affect INITIAL evaluations. |
| 2022 | 12/28/2022 | 2. | Medical Policy | Revised Airman SSRI Follow-up Path for the HIMS AME to reflect policy change for SSRI renewals. Neuropsychological evaluation and routine CogScreen AE are no longer needed for SSRI renewals, except when clinically indicated or specified on the Authorization/Special Consideration Letter. This policy does NOT affect INITIAL evaluations. |
| 2022 | 12/28/2022 | 3. | Medical Policy | Revised FAA ATCS SSRI Follow-up Path for the HIMS AME to reflect policy change for SSRI renewals. Neuropsychological evaluation and routine CogScreen AE are no longer needed for SSRI renewals, except when clinically indicated or specified on the Authorization/Special Consideration Letter. This |
| policy does NOT affect INITIAL evaluations. | ||||
| 2022 | 12/28/2022 | 4. | Medical Policy | Revised HIMS AME Checklist SSRI Recertification/Follow-up Clearance to reflect policy change for SSRI renewals. Neuropsychological evaluation and routine CogScreen AE are no longer needed for SSRI renewals, except when clinically indicated or specified on the Authorization/Special Consideration Letter. This policy does NOT affect INITIAL evaluations. |
| 2022 | 12/28/2022 | 5. | Medical Policy Revised | Revised FAA Certification Aid – SSRI Recertification/Follow-up Clearance to reflect policy change for SSRI renewals. Neuropsychological evaluation and routine CogScreen AE are no longer needed for SSRI renewals, except when clinically indicated or specified on the Authorization/Special Consideration Letter. This policy does NOT affect INITIAL evaluations. |
| 2022 | 12/28/2022 | 6. | Medical Policy | Revised Item 50. Distance Vision and Item 51. Near and Intermediate Vision to add single, simplified visual acuity limitation, replacing previous visual acuity limitations. For any class of medical certificate, when corrective lenses are required to meet any part or combination of visual acuity standards, the AME must add the following limitation to the medical certificate: “Must |
| Use Corrective Lens(es) to meet vision standards at all required distances.” NOTE: This change does NOT impact Item 52. Color Vision. | ||||
| 2022 | 12/28/2022 | 7. | Administrative | In the AME Guide PDF version, reorganized and reformatted Synopsis of Medical Standards page. |
| 2022 | 11/30/2022 | 1. | Errata | Corrected typographical error in the Acceptable Combinations of Diabetes Medication Chart (DDP4 changed to DPP4). |
| 2022 | 10/26/2022 | 1. | Medical Policy | In Item 48., General Systemic, Covid-19 Infections, revised disposition table to add long Covid and further clarify consideration criteria. |
| 2022 | 10/26/2022 | 2. | Medical Policy | In Pharmaceuticals, Vaccines, revised to add Novavax Covid-19 vaccine as allowed (with 48-hour post-dose observation). |
| 2022 | 10/26/2022 | 3. | Medical Policy | In Pharmaceuticals, Covid-19 Medication, added link to Covid-19 Vaccines. |
| 2022 | 10/26/2022 | 4. | Medical Policy | In Pharmaceuticals, Allergy Medications, revised tables to identify mode of use. |
| 2022 | 10/26/2022 | 5. | Medical Policy | In Item 31-34, Eye, Ophthalmoscopic examination, removed requirement that contact lenses must be removed several hours before cornea exam. |
| 2022 | 10/26/2022 | 6. | Medical Policy | In Item 36. Heart, Arrhythmias, revised 1st Degree AV Block into two categories: PR interval of less than 300 ms and PR interval of 300 ms or more. |
| 2022 | 10/26/2022 | 7. | Medical Policy | In Item 58. ECG Normal Variants List, revise 1st Degree AV Block criteria to “less than 300 ms (0.30 sec).” |
| 2022 | 10/26/2022 | 8. | Medical Policy | In Item 48. General Systemic, Diabetes, Prediabetes, Metabolic Syndrome, and/or Insulin Resistance, restored link to Diabetes Mellitus Insulintreated non CGM, Third Class. |
| 2022 | 09/28/2022 | 1. | Medical Policy | In Substances of Dependence/ Abuse, Drug and Alcohol Monitoring and HIMS, added new policy on the processing of formal HIMS cases. Effective immediately. |
| 2022 | 09/28/2022 | 2. | Medical Policy | Revised CACI – Colitis Worksheet to include additional medications to determination criteria. |
| 2022 | 08/31/2022 | 1. | Medical Policy | In Item 46. Neurologic, Cerebrovascular Disease Entries for Transient Ischemic Attack (TIA) and Completed Stroke (ischemic or hemorrhagic) updated to specify that a two-year recovery period must elapse before evaluations should be submitted to the FAA for review. |
| 2022 | 08/31/2022 | 2. | Medical Policy | In Pharmaceuticals, Acceptable Combination of Diabetes Medication Chart updated to add Group F to the table titled “When adding a new medication to an established treatment regimen.” |
| 2022 | 07/27/2022 | 1. | Medical Policy | In Item 47. Psychiatric Conditions, revised Situational Depression |
| (Adjustment Disorder with Depressed Mood or Minor Depression) Disposition Table. | ||||
| 2022 | 07/27/2022 | 2. | Medical Policy | In Item 47. Psychiatric Conditions, added new Situational Depression (Adjustment Disorder with Depressed Mood or Minor Depression) Decision Tool for the AME. |
| 2022 | 07/27/2022 | 3. | Medical Policy | In Disease Protocols, Protocol for Insulin-Treated Diabetes Mellitus Non CGM - Third-Class Option, renamed and clarified that option is for third class ONLY not using a CGM device. |
| 2022 | 07/27/2022 | 4. | Medical Policy | Revised CACI – Pre Diabetes Worksheet to clarify Condition is PRE-DIABETES, stable on current regimen, and no changes recommended. Also, diet-controlled diabetes, diabetes treated with medication (including insulin), or diabetes insipidus DO NOT qualify. |
| 2022 | 07/27/2022 | 5. | Medical Policy | In Disease Protocols, Cardiac Valve Replacement, revised to clarify that first and second-class applicant “may be” reviewed by the Federal Air Surgeon Cardiology Panel, etc.(dependent on the number of valves replaced). |
| 2022 | 07/27/2022 | 6. | Medical Policy | In Item 36. Heart, Other Cardiac Conditions, added as must be deferred: Hypertrophic Cardiomyopathy (HCM) [formerly called hypertrophic obstructive cardiomyopathy (HOCM); idiopathic |
| hypertrophic sub-aortic stenosis (IHSS)] and Noncompaction cardiomyopathy. | ||||
| 2022 | 07/27/2022 | 7. | Medical Policy | In Disease Protocols, reorganized Specifications for Neurologic Evaluation sheet to reinforce that pilots should take the sheet to their neurologist. |
| 2022 | 07/27/2022 | 8. | Medical Policy | In Applicant History, Items 4. Social Security, clarified what to do if pilot does not wish to give Social Security number for exam. |
| 2022 | 06/29/2022 | 1. | Medical Policy | In Disease Protocols, revised Diabetes Mellitus Type II - Medication Controlled. Renamed Protocol for Diabetes Mellitus Treated with Any Medication Other Than Insulin, the revision outlines criteria for initial authorization, subsequent exams, and general considerations. |
| 2022 | 06/29/2022 | 2. | Medical Policy | In Item 26. Nose, Anosmia Disposition Table, Item B revised to include that etiology must be included, if found. |
| 2022 | 06/29/2022 | 3. | Administrative | Throughout the entire Guide, removed and replaced the word “form” if the document referenced is not an official, numbered OMB Form. |
| 2022 | 05/25/2022 | 1. | Medical Policy | In Pharmaceuticals, added guidance for Controlled Substances and CBD Products. |
| 2022 | 05/25/2022 | 2. | Medical Policy | In Item 47. Psychiatric, added new Situational Depression - Adjustment Disorder with Depressed Mood or Minor Depression Disposition Table. |
| 2022 | 05/25/2022 | 3. | Medical Policy | In Item 47, Psychiatric Conditions Disposition Table, removed entries for “Adjustment Disorder” and “Minor Depression.” The categories are addressed in the new Situational Depression - Adjustment Disorder with Depressed Mood or Minor Depression Disposition Table. |
| 2022 | 05/25/2022 | 4. | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, added note to Airman Information – SSRI Initial Certification and HIMS AME Checklist – SSRI Initial Certification/Clearance. (“While exam is under review, pilots should continue to Continue to submit the Chief Pilot or Air Traffic Manager reports EVERY 3 months AND the HIMS AME evaluations and treating psychiatrist reports EVERY 6 months.”) |
| 2022 | 05/25/2022 | 5. | Medical Policy | In Pharmaceuticals, renamed Hydroxychloroquine (HCQ)/Chloroquine (CQ) Status Report [Plaquenil/Aralen] to Plaquenil Status Report to match common usage name for medication. |
| 2022 | 05/25/2022 | 6. | Medical Policy | In General Systemic, Human Immunodeficiency Virus (HIV) Disposition Table, added Apretude (cabotegravir) as an FDAapproved medication used for PrEP. |
| 2022 | 04/27/2022 | 1. | Medical Policy | In Pharmaceuticals, added COVID-19 Medication page. |
| 2022 | 04/27/2022 | 2. | Medical Policy | In Item 48. General Systemic, updated COVID-19 Infections Disposition Table to include links to COVID-19 Medications guidance. |
| 2022 | 04/27/2022 | 3. | Medical Policy | In Pharmaceuticals, renamed Glaucoma Medications to Glaucoma and Ocular Hypertension Medications. Revised to include chart of CACI acceptable, conditionally acceptable, and unacceptable glaucoma medications. |
| 2022 | 04/27/2022 | 4. | Medical Policy | In Pharmaceuticals, added new Eye Medication page. |
| 2022 | 04/27/2022 | 5. | Medical Policy | In Item 38. Abdomen, Viscera, and Anus Conditions, added disposition table for Barrett’s Esophagus. |
| 2022 | 04/27/2022 | 6. | Medical Policy | In Item 36. Heart, added disposition table for Premature Atrial Contraction. |
| 2022 | 04/27/2022 | 7. | Medical Policy | Item 62. Has Been Issued, deferral instructions clarified and visual reference updated. |
| 2022 | 04/27/2022 | 8. | Medical Policy | Pharmaceuticals section revised to include links to guidance on Do No Issue/Do Not Fly and Over-the-counter (OTC) Medications. |
| 2022 | 04/27/2022 | 9. | Medical Policy | Revised all CACI condition worksheets to remove usage of “current status report” term. |
| 2022 | 04/27/2022 | 10. | Administrative | New shortcut URLS for HIMS:https://www.faa.gov/go/hims and for Medications:https://www.faa.gov/go/meds . |
| 2022 | 04/27/2022 | 11. | Administrative | Letter of Denial Issued by AME revised to add “AME Name” and “Date Signed” lines. |
| 2022 | 04/27/2022 | 12. | Administrative | In PDF version of the Guide, title of Items 25-48 revised to include disposition tables: “AME Physical Examination Information and Disposition Tables.” |
| 2022 | 04/27/2022 | 13. | Administrative | In Specifications for Neuropsychological Evaluations for Potential Neurocognitive Impairment (in PDF version of the AME Guide only), added actual URL addresses for Web links contained in the document. |
| 2022 | 04/13/2022 | 1. | Administrative | Revised all CACI condition worksheets to add “current, detailed Clinical Progress Note” language and link to introductory paragraph. |
| 2022 | 03/30/2022 | 1. | Medical Policy | In Item 25-30. Nose, and Throat, revised to remove anosmia note. Added link to the Anosmia Disposition Table. |
| 2022 | 03/30/2022 | 1. | Medical Policy | In Item 25-30. Nose, and Throat, revised to remove anosmia note. Added link to the Anosmia Disposition Table. |
| 2022 | 03/30/2022 | 2. | Medical Policy | In Item 52. Color Vision, revised to add Farnsworth D-15 as UNACCEPTABLE. |
| 2022 | 03/30/2022 | 3. | Medical Policy | In Pharmaceuticals, Cholesterol Medication, expanded chart to add additional acceptable medications: iovastatin (Altoprev), rosuvastatin (Crestor), gemfibrozil (Lopid), cholestyramine (Prevalite; Questran), |
| colesevelam (Welchol), and niacin (Niaspan). | ||||
| 2022 | 03/30/2022 | 4. | Medical Policy | In General Information, added Item #23. Pilot Information – Detailed Current Clinical Progress Note. Item explains what must be included in the current detailed Clinical Progress Note. The information was also added under the Resources section in the Web version of the AME Guide. |
| 2022 | 03/30/2022 | 5. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II – Insulin Treated - CGM Option, removed requirement to send finger stick blood glucose data. Deleted “Blood Glucose Monitoring Sheet” and “Finger Stick Blood Glucose Information” worksheets. |
| 2022 | 03/30/2022 | 6. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II – Insulin Treated - CGM Option, Initial Certification – Airman Information, added requirement that CGM data be sent in 30-day increment. Changed and expanded ranges to report. |
| 2022 | 03/30/2022 | 7. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II – Insulin Treated - CGM Option, Initial Certification Consideration Requirements, revised to remove requirement for FSBS data; remove optional information for flight hours; add monthly reporting requirement; expand CGM |
| levels to report; and add chart of target range values. | ||||
| 2022 | 03/30/2022 | 8. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II – Insulin Treated - CGM Option, Renewal Certificate Requirements, revised to clarify what information is required within each timeframe. |
| 2022 | 03/30/2022 | 9. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II – Insulin Treated - CGM Option, Insulin Treated Diabetes Information Submission Requirements, revised to clarify what is due when; removed FSBS readings and flight time; and changed A1C to annual reporting. |
| 2022 | 03/30/2022 | 10. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II – Insulin Treated - CGM Option, Overlay Report and Alert Sample, revised to add samples from CGM devices that currently meet FAA requirements. |
| 2022 | 03/30/2022 | 11. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I or Type II – Insulin Treated - CGM Option, Frequently Asked Questions (FAQs), revised #9 to indicate that while the FAA does not recommend specific brands of CGM devices, a section was added to include devices that currently meet FAA requirements. |
| 2022 | 03/30/2022 | 12. | Administrative | Added shortcut link for Bundle Branch Block (BBB) at www.faa.gov/go/bbb. |
| 2022 | 02/23/2022 | 1. | Medical Policy | In Item 26. Nose, added new Anosmia Disposition Table. |
| 2022 | 02/23/2022 | 2. | Medical Policy | In Item 48. General Systemic, Covid-19 Infections Disposition Table |
| 2022 | 02/23/2022 | 3. | Medical Policy | In Pharmaceuticals, added new section for Cholesterol Medications. |
| 2022 | 02/23/2022 | 4. | Medical Policy | Revised all CACI Worksheets to add language that a detailed Clinical Progress Note (within 90 days of the exam) is required from the treating physician. |
| 2022 | 02/23/2022 | 5. | Medical Policy | In Item 36. Heart, Mitral Valve Repair Disposition Table, added note for pilots: “Take the CACI worksheet to your cardiologist so they can fully address the FAA requirements.” |
| 2022 | 02/23/2022 | 6. | Medical Policy | Revised CACI – Mitral Valve Repair Worksheet to clarify and add: “Aortic regurgitation/insufficiency (any severity)” as disqualifying criteria. |
| 2022 | 02/23/2022 | 7. | Medical Policy | In Item 35. Lungs and Chest, Chronic Obstructive Pulmonary Disease, revised evaluation data to state detailed Clinical Progress Note and FEV1, FVC, and FEV1/FVC are required. |
| 2022 | 02/23/2022 | 8. | Medical Policy | In Item 46. Neurologic, Cerebrovascular Disease, revised note at end of page which previously referenced benign supratentorial tumors. |
| 2022 | 02/23/2022 | 9. | Administrative | In Disease Protocols, Protocol for Attention Deficit Disorder/ Hyperactivity Disorder, updated FAA HIMS Neuropsychologist List. |
| 2022 | 02/23/2022 | 1. | Administrative | Changed coversheet to 2022 and added monthly update schedule for the calendar year. |
| 2021 | 11/24/2021 | 1. | Medical Policy | Revised all CACI Worksheets to add an option to indicate if the airman “Has current OR previous SI/AASI but now CACI qualified.” |
| 2021 | 11/24/2021 | 2. | Administrative | On the home page of both the PDF and HTML versions of the AME Guide, added an “AME Alert” box for important notifications. |
| 2021 | 10/27/2021 | 1. | Medical Policy | In CACI – Arthritis Worksheet, revised to change no-fly time for adalimumab (Humira) from 24 hours to 4 hours. |
| 2021 | 10/27/2021 | 2. | Medical Policy | In Item 48. General Systemic, Primary Hemochromatosis Disposition Table, revised to add myeloproliferative disorders as a co-morbid condition. |
| 2021 | 10/27/2021 | 3. | Medical Policy | In Item 48. General Systemic, CACI – Primary Hemochromatosis Worksheet, revised to add myeloproliferative disorders as a co-morbid condition. |
| 2021 | 10/27/2021 | 4. | Medical Policy | In Item 48. General Systemic, COVID-19 Disposition Table, revised to add cognitive symptoms to “ongoing residual signs and symptoms.” Also added neuropsychology to the examples of “specialty consultations performed.” |
| 2021 | 10/27/2021 | 5. | Medical Policy | In Item 52. Color Vision, added instructive note: “If the airman fails acceptable color vision tests, then obtains an LOE or SODA - check fail and add airman has LOE. If they pass any acceptable color vision test- mark pass.” |
| 2021 | 10/27/2021 | 6. | Administrative | To improve ability to search in PDF Guide document, changed title of AASI for Colon Cancer to AASI for Colon Cancer/ Colorectal Cancer. Title change also made on Malignancies - Colon Cancer Disposition Table and CACI worksheet. |
| 2021 | 10/27/2021 | 7. | Administrative | In AASI for Thrombocytopenia, revised to add “or” to list of defer criteria. |
| 2021 | 10/14/2021 | 1. | Medical Policy | In Item 47. Psychiatric, added new Post-Traumatic Stress Disorder (PTSD) Disposition Table. |
| 2021 | 10/14/2021 | 2. | Medical Policy | In Item 47. Psychiatric, added new Post-Traumatic Stress Disorder (PTSD) Decision Tool for the AME. |
| 2021 | 09/29/2021 | 1. | Medical Policy | In Protocols, Obstructive Sleep Apnea, added OSA Status Summary – Initial. |
| 2021 | 09/29/2021 | 2. | Medical Policy | In Protocols, Obstructive Sleep Apnea, added OSA Status Summary – Recertification. |
| 2021 | 09/29/2021 | 3. | Medical Policy | In Protocols, Obstructive Sleep Apnea, added guidance for OSA Treated with PAP and Use of Two Machines (or more). |
| 2021 | 09/29/2021 | 4. | Medical Policy | In Pharmaceuticals, revised Hydroxychloroquine (HCQ)/Chloroquine (CQ) Status Report to clarify groups and to add “color vision loss” to question #8 on the report. |
| 2021 | 09/29/2021 | 5. | Medical Policy | In AASI, revised title of Deep Venous Thrombosis, Pulmonary Embolism, and/or Hypercoagulopathies to “Venous Thromboembolism (VTE) – Deep Venous |
| Thrombosis (DVT), Pulmonary Embolism (PE), and/or Hypercoagulopathies.” Change was also made on AASI main listings and on AASI Coversheet. | ||||
| 2021 | 09/29/2021 | 6. | Medical Policy | In HIMS AME Information – HIMS Step Down Plan, revised chart to show parameters of Maintenance Phase-4 is 8+ years. |
| 2021 | 09/29/2021 | 7. | Medical Policy | In Pharmaceuticals, Vaccines, added tradename Comirnaty to FDA-approved Pfizer-BioNTech COVID-19 vaccine. |
| 2021 | 09/29/2021 | 8. | Administrative | In General Information, added AMCS Technical Support information for help with transmitting exams, resetting passwords, etc. |
| 2021 | 09/29/2021 | 9. | Administrative | In Item 36. Heart, Arrhythmias, added link for Implanted Pacemaker Disposition Table. |
| 2021 | 09/29/2021 | 10. | Medical Policy | In Item 47. Psychiatric Conditions Disposition Table, added a placeholder for Post-Traumatic Stress Disorder. Policy due to be finalized and posted mid-October 2021. |
| 2021 | 08/25/2021 | 1. | Medical Policy | In Item 48. General Systemic, added Primary Hemochromatosis Disposition Table. |
| 2021 | 08/25/2021 | 2. | Medical Policy | In Item 48. General Systemic, added CACI – Primary Hemochromatosis Worksheet. |
| 2021 | 08/25/2021 | 3. | Medical Policy | In Protocols, added 6-Minute Walk Test (6MWT) – FAA Results Sheet. |
| 2021 | 08/25/2021 | 4. | Medical Policy | In Item 48. General Systemic, added link to |
| 6MWT in COVID-19 Disposition Table. | ||||
| 2021 | 08/25/2021 | 5. | Medical Policy | In Item 35. Lungs and Chest, added link to 6MWT in Chronic Obstructive Pulmonary Disease (COPD) Disposition Table. |
| 2021 | 08/25/2021 | 6. | Medical Policy | In Disease Protocols, added Specifications for Neurologic Evaluation. |
| 2021 | 08/25/2021 | 7. | Medical Policy | In Disease Protocols, revised Protocol for Implanted Pacemaker. (Evaluation of Pacemaker Dependency is no longer required for any class.) |
| 2021 | 08/25/2021 | 8. | Medical Policy | In Disease Protocols, revised Pacemaker Status Summary sheet. |
| 2021 | 08/25/2021 | 9. | Medical Policy | In Item 36. Heart, added Pacemaker Disposition Table. |
| 2021 | 08/25/2021 | 10. | Medical Policy | In Pharmaceuticals, Therapeutic Medications, added Hydroxychloroquine (HCQ)/ Chloroquine (CQ) Status Report [Plaquenil/Aralen]. |
| 2021 | 08/25/2021 | 11. | Medical Policy | Revised Arthritis – CACI Worksheet to include links to Hydroxychloroquine (HCQ)/Chloroquine (CQ) Status Report (Plaquenil/Aralen). |
| 2021 | 08/25/2021 | 12. | Medical Policy | In Special Issuances, AASI for All Classes, changed Cardiac – Single Valve Replacement to “Cardiac – Single Valve Replacement or Repair.” |
| 2021 | 08/25/2021 | 13. | Medical Policy | On Special Issuance Coversheet, changed Cardiac – Single Valve Replacement to “Cardiac – Single Valve Replacement or Repair.” |
| 2021 | 08/25/2021 | 14. | Medical Policy | In Protocols Graded Exercise Stress Test Requirements, revised note to state “Single Valve Replacement or Repair.” |
| 2021 | 08/25/2021 | 15. | Administrative | Revised shading in blocks for HIMS AME Checklist – SSRI Initial Certification-Clearance. |
| 2021 | 08/25/2021 | 16. | Administrative | Changed mailing address (from Washington DC to Oklahoma City) on Airman Information – SSRI Initial Certification sheet and HIMS AME Checklist – SSRI Initial Certification-Clearance. |
| 2021 | 07/28/2021 | 1. | Medical Policy | In Pharmaceuticals, Allergy – Antihistamines & Immunotherapy Medications, revised to include prohibition of antihistamine eye drops immediately before or during flight or safety-related duties. Also added list of acceptable Second Generation Histamine-H1 receptor antagonist eye drops. |
| 2021 | 07/28/2021 | 2. | Medical Policy | In Pharmaceuticals, Therapeutic Medications, revised Vaccines page. No post-dose observation time is required for Bacillus Calmette-Guérin [intradermal] (BCG) vaccine. |
| 2021 | 07/28/2021 | 3. | Medical Policy | In Item 38. Abdomen and Viscera and Anus Conditions, revised CACI - Colitis Worksheet to add additional acceptable medications and applicable no-fly times. |
| 2021 | 07/28/2021 | 4. | Medical Policy | In Item 35. Lungs and Chest, revised CACI – Asthma Worksheet to add that Monoclonal antibodies are NOT acceptable for CACI. |
| 2021 | 07/28/2021 | 5. | Medical Policy | In Item 43. Spine and Other Musculoskeletal, revised CACI - Arthritis Worksheet to identify additional acceptable medications (biologics) and applicable no- fly times. No labs needed for NSAIDS or steroids only. |
| 2021 | 07/28/2021 | 6. | Medical Policy | In Item 43. Spine and Other Musculoskeletal, revised Arthritis Disposition Table. |
| 2021 | 06/30/2021 | 1. | Medical Policy | In Item 36. Heart, Atrial Fibrillation, revised disposition table to include recovery periods for atrial fibrillation treated with ablation (3 months) or cardioversion (1 month). |
| 2021 | 06/30/2021 | 2. | Medical Policy | In Disease Protocols, Human Immunodeficiency Virus (HIV), revised HIV Specification Sheet to clarify instructions and include directions for authorized professionals to use secure FAA Neuropsychology Testing Specification Site. |
| 2021 | 06/30/2021 | 3. | Medical Policy | In Disease Protocols, Human Immunodeficiency Virus (HIV), revised Under 2 Year Surveillance HIV Specification Sheet to clarify instructions and include directions for authorized professionals to use secure FAA Neuropsychology Testing Specification Site. |
| 2021 | 06/30/2021 | 4. | Medical Policy | In Disease Protocols, Human Immunodeficiency Virus (HIV), revised After 2 Years Surveillance HIV Specification Sheet to clarify instructions and include directions for authorized professionals to use secure |
| FAA Neuropsychology Testing Specification Site. | ||||
| 2021 | 05/26/2021 | 1. | Medical Policy | In Pharmaceuticals, Therapeutic Medications, added new Vaccines page. |
| 2021 | 05/26/2021 | 2. | Medical Policy | In Examination Techniques, Item 36. Heart, revised and expanded Atrial Fibrillation disposition table. |
| 2021 | 04/28/2021 | 1. | Medical Policy | Revised Protocol for Insulin-Treated Diabetes Mellitus - Type I & Type II Non CGM - Third-Class Option to include link to and preference for Initial Comprehensive Report. |
| 2021 | 04/28/2021 | 2. | Medical Policy | In Disease Protocols, changed name of Graded Exercise Stress Test Requirements (Bundle Branch Block) to Protocol for Bundle Branch Block (BBB). Page content revised and reorganized. |
| 2021 | 04/28/2021 | 3. | Medical Policy | In Item 36. Heart, Arrhythmias, revised disposition table entry for Bundle Branch Block. |
| 2021 | 03/31/2021 | 1. | Medical Policy | In Item 48. General Systemic, added disposition table for guidance on COVID-19 Infections. |
| 2021 | 03/31/2021 | 2. | Medical Policy | In General Information, Equipment Requirements, added equipment checklist and signature document: AME Equipment and Confidentiality. |
| 2021 | 03/31/2021 | 3. | Medical Policy | In Substances of Dependence/Abuse, revised HIMS-Trained AME Checklist - Drug and Alcohol Monitoring - Initial Certification to clarify that checklist must be submitted. Also clarified First and |
| second class HIMS cases should be sent via Huddle electronic submission. All others should be mailed to AMCD. | ||||
| 2021 | 03/31/2021 | 4. | Medical Policy | In Synopsis of Medical Standards, revised Audiology entry to clarify intensity parameters for audiometric speech discrimination test. |
| 2021 | 02/24/2021 | 1. | Medical Policy | In Protocols, Implanted Pacemaker, revised guidance and changed title to Initial Evaluation for Implanted Pacemaker. |
| 2021 | 02/24/2021 | 2. | Medical Policy | In Protocols, Initial Evaluation for Implanted Pacemaker, added Pacemaker Status Summary Sheet. |
| 2021 | 02/24/2021 | 3. | Medical Policy | In Pharmaceuticals, merged Allergy pages to create Allergy- Antihistamine & Immunotherapy Medication page with tables for acceptable, conditionally acceptable, and unacceptable medications. |
| 2021 | 02/24/2021 | 4. | Medical Policy | In Item 36. Heart, Atrial Fibrillation (Afib)/A-Flutter), updated disposition table to include specific sleep study criteria. |
| 2021 | 02/24/2021 | 5. | Medical Policy | In Disease Protocols, revised Cardiac Valve Replacement, Follow up Certification section: TAVR or other SINGLE valve replacement may be eligible for AASI Cardiac – Single Valve Replacement. |
| 2021 | 02/24/2021 | 6. | Medical Policy | In Pharmaceuticals, Do Not Issue/Do Not Fly, revised information on FDA approval. |
| 2021 | 02/24/2021 | 7. | Medical Policy | In Reference Materials for Obstructive Apnea, Frequently Asked Questions, added information on the four types of sleep studies. |
| 2021 | 02/24/2021 | 8. | Administrative | Added Conditions AMEs Can Issue (CACI) and Special Issuance (SI) to the Glossary/Acronyms. |
| 2021 | 01/27/2021 | 1. | Medical Policy | In Specifications for Psychiatric and Psychological Evaluations, added link for information on Selecting MMPI-2 vs MMPI-3. |
| 2021 | 01/27/2021 | 2. | Medical Policy | In Pharmaceuticals, Do Not Issue/ Do Not Fly, Diabetic Medications, removed prohibitions on SGLT2 inhibitors. Added pramlintide (Symlin) as not allowed. |
| 2021 | 01/27/2021 | 3. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type II - Medication Controlled, revised and reformatted Acceptable Combinations of Diabetes Medication guidance and chart to include SGLT2 inhibitors. |
| 2021 | 01/27/2021 | 4. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), General Information for All AMEs, reorganized guidance with new Drug and Alcohol Event– FAA Certification Aid – Required Information. |
| 2021 | 01/27/2021 | 5. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), Drug/Alcohol Monitoring Programs and HIMS section, added guidance for HIMS AME – Huddle Electronic Case Submission and FAQs. |
| 2021 | 01/27/2021 | 6. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), Drug/Alcohol Monitoring Programs and HIMS section, revised HIMS-Trained AME Checklist – Drug and Alcohol Monitoring– Initial Certification to align with Huddle naming conventions and submissions order. |
| 2021 | 01/27/2021 | 7. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), Drug/Alcohol Monitoring Programs and HIMS section, revised and renamed FAA Certification Aid - HIMS Drug and Alcohol– INITIAL. |
| 2021 | 01/27/2021 | 8. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), Recertification, added Introductory page in PDF Version and blurb in HTML version. |
| 2021 | 01/27/2021 | 9. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), Recertification- added HIMS AME Information – HIMS Step Down Plan. |
| 2021 | 01/27/2021 | 10. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), Recertification- added Airman Information – HIMS Step Down Plan. |
| 2021 | 01/27/2021 | 11. | Medical Policy | In Item 36. Heart, revised Coronary Heart Disease Disposition Table to include all classes considered. |
| 2021 | 01/27/2021 | 12. | Medical Policy | In Item 36 Heart, Valvular Disease Disposition Table, revised row for Single Valve Replacement to indicate all classes may be considered for initial special issuance. |
| 2021 | 01/27/2021 | 13. | Medical Policy | In Protocol for Cardiac Valve Replacement, revised note in Follow-up Certification Section to indicate all classes may be eligible for an AASI Cardiac Valve Replacement. |
| 2021 | 01/27/2021 | 14. | Medical Policy | In Special Issuance, removed page for third class AASI. All previously listed cardiac condition categories are now considered for all classes. Revised AASI All Classes listings to include Coronary Heart Disease and Cardiac-Single Valve Replacement. |
| 2021 | 01/27/2021 | 15. | Medical Policy | Revised AASI Certificate Issuance Sheet to mirror changes made in Special Issuance section for cardiac conditions. |
| 2021 | 01/27/2021 | 16. | Medical Policy | In Special Issuances, revised AASI for Single Valve Replacement. All classes eligible for consideration. |
| 2021 | 01/27/2021 | 17. | Medical Policy | In Special Issuances, revised AASI for Coronary Heart Disease. All classes eligible for consideration. |
| 2021 | 01/27/2021 | 18. | Medical Policy | In Disease Protocols, revised Graded Exercise Stress Test Requirements (Maximal). |
| 2021 | 01/27/2021 | 19. | Administrative | In Special Issuances, expanded title of Sleep Apnea to Sleep Apnea/Obstructive Sleep Apnea (OSA) on cover page and on the individual AASI page. |
| 2021 | 01/01/2021 | 1. | Administrative | Changed coversheet to 2021 and added monthly update schedule for the calendar year. |
| 2020 | 12/30/2020 | 1. | Administrative | In Disease Protocols, added word “Protocol” to Coronary |
| Heart Disease ( ) listing to improve search function. | ||||
| 2020 | 12/30/2020 | 2. | Administrative | In Pharmaceuticals, Do Not Issue/ Do Not Fly, added note and hyperlinks: “For airmen seeking more information, see Medications and Flying and What Over The Counter Medications Can I Take and Still Be Safe to Fly?” |
| 2020 | 11/25/2020 | 1. | Medical Policy | In Diabetes Mellitus - Type II, Medication Controlled (Not Insulin), in Acceptable combination of Diabetes Medication Chart, revised observation times when initiating new diabetes therapy using monotherapy or new combination medications. |
| 2020 | 11/25/2020 | 2. | Administrative | In General Information, added link to Aerospace Medical Disposition Tables. |
| 2020 | 10/28/2020 | 1. | Medical Policy | In Disease Protocols, Coronary Heart Disease and Thromboembolic Disease were revised to group blood clotting disorders. |
| 2020 | 09/30/2020 | 1. | Medical Policy | In Diabetes Mellitus Type I or Type II Insulin Treated - CGM Option, revised required glucose parameters time–in-range to 80-180 mg/dL. |
| 2020 | 09/30/2020 | 2. | Medical Policy | In Diabetes Mellitus Type I or Type II Insulin Treated - CGM Option, revised Airman Information sheet. |
| 2020 | 09/30/2020 | 3. | Medical Policy | In Diabetes Mellitus Type I or Type II Insulin Treated - CGM Option, revised Initial Certificate Consideration Requirements, (Changes made to Item #1 Initial Comprehensive Report, Item |
| #3 FSBS Glucose Monitoring Diary, Item #4 Continuous Glucose Monitoring CGM Data, and Item #7 Cardiac Evaluation.) | ||||
| 2020 | 09/30/2020 | 4. | Medical Policy | In Diabetes Mellitus Type I or Type II Insulin Treated - CGM Option, revised Blood Glucose Worksheet for CGM Use. |
| 2020 | 09/30/2020 | 5. | Medical Policy | In Diabetes Mellitus Type I or Type II Insulin Treated - CGM Option, revised Frequently Asked Questions to address change in glucose parameters. |
| 2020 | 08/26/2020 | 1. | Medical Policy | In Exam Techniques, Item 36. Heart, added new Non-Valvular Atrial Fibrillation (AFib)/A-Flutter Disposition Table. This replaces the old “Atrial Fibrillation” table. |
| 2020 | 08/26/2020 | 2. | Medical Policy | In Exam Techniques, Item 36. Heart, added new Non-Valvular Atrial Fibrillation (AFib)/A-Flutter INITIAL Status Report. |
| 2020 | 08/26/2020 | 3. | Medical Policy | In Exam Techniques, Item 36. Heart, added new Non-Valvular Atrial Fibrillation (AFib)/A-Flutter RECERTIFICATION Status Report. |
| 2020 | 08/26/2020 | 4. | Medical Policy | In Special Issuances, AASI for Atrial Fibrillation revised to match updated guidance. |
| 2020 | 08/26/2020 | 5. | Medical Policy | In Pharmaceuticals, Anticoagulants, added guidance for Non-Valvular Atrial Fibrillation (AFib)/A-Flutter Emboli Mitigation. |
| 2020 | 08/26/2020 | 6. | Medical Policy | In Item 36. Heart, Arrhythmias Disposition Table, updated Radio Frequency Ablation section to include note: *If performed |
| for atrial fibrillation AFib/A-Flutter, see that section first. | ||||
| 2020 | 08/26/2020 | 7. | Medical Policy | In CACI Conditions, updated CACI - Mitral Valve Worksheet to remove notation regarding atrial fibrillation treated with ablation. |
| 2020 | 07/29/2020 | 1. | Medical Policy | In Examination Techniques, Item 41. G-U Systems, added a Polycystic Kidney Disease (PKD) disposition table. Nephritis disposition table was revised to remove reference to PKD. |
| 2020 | 07/29/2020 | 2. | Medical Policy | In General Information, added guidance on Medical Certificates Requested for any Situation or Job Other than a Pilot or Air Traffic Controller. |
| 2020 | 07/29/2020 | 3. | Medical Policy | In Pharmaceuticals, Sleep Aids, revised wait time for Sonata (zaleplon) from 6 to 12 hours. |
| 2020 | 07/29/2020 | 4. | Medical Policy | In protocol for Diabetes Mellitus Type I or type II Insulin Treated - CGM Option, revised multiple pages to state that eye evaluation must be done by a board-certified ophthalmologist (M.D. or D.O.) and eye evaluation by an optometrist (O.D.) is NOT acceptable. |
| 2020 | 07/29/2020 | 5. | Medical Policy | In Pharmaceuticals, Acceptable Combinations of Diabetes Medications, revised to add observation wait times and additional notes to combinations chart. |
| 2020 | 07/29/2020 | 6. | Administrative | Updated FAA Neuropsychologist List. |
| 2020 | 06/24/2020 | 1. | Medical Policy | In Item 38. Abdomen and Viscera, added Pancreatitis Disposition table. |
| 2020 | 06/24/2020 | 2. | Medical Policy | In 18.v. Medical History v. History of Arrest(s), Conviction(s) and/or Administrative Action(s), revised to clarify language. |
| 2020 | 06/24/2020 | 3. | Medical Policy | In Item 48, General Systemic, Gender Dysphoria, Revised Gender Dysphoria Mental Health Status Report to clarify issue/defer criteria. |
| 2020 | 02/26/2020 | 1. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I and Type II – Insulin Treated – Continuous Glucose Monitoring (CGM) Option (ITDM CGM Option Protocol) for all classe, revised multiple sections to clarify that only airmen with flight hours are required to “Note on an Excel spreadsheet any flights, glucose levels during flight, and any actions needed to correct glucose.” Sections changed: Airman Information; |
| 2020 | 02/26/2020 | 2. | Medical Policy | In Disease Protocols, Diabetes Mellitus Type I and Type II – Insulin Treated – Continuous Glucose Monitoring (CGM) Option (ITDM CGM Option Protocol) for all classes, revised Blood Glucose Worksheet. Added language to include any recalls to the “CGM device/insulin pump or parts.” |
| 2020 | 01/29/2020 | 1. | Medical Policy | In Disease Protocols - Attention Deficit/Hyperactivity |
| Disorder, sections for Testing Requirements, Report Requirements, and Reference Information for the Neuropsychologists, revised to remove description of specific neuropsychological testing and to provide a link directing authorized users to the FAA Neuropsychological Testing Specifications site. | ||||
| 2020 | 01/29/2020 | 2. | Medical Policy | In Disease Protocols - Human Immunodeficiency Virus (HIV), Human Immunodeficiency Virus (HIV) Specification Sheet, revised to remove description of specific neuropsychological testing and to provide a link directing authorized users to the FAA Neuropsychological Testing Specifications site. |
| 2020 | 01/29/2020 | 3. | Medical Policy | In Item 47. Psychiatric Conditions - Use of Antidepressant Medications, Specifications for Neuropsychological Evaluations for Treatment with SSRI Medications, revised to remove description of specific neuropsychological testing and to provide a link directing authorized users to the FAA Neuropsychological Testing Specifications site. |
| 2020 | 01/29/2020 | 4. | Medical Policy | In Disease Protocols - Specifications for Psychiatric and Neuropsychological Evaluations for Substance Abuse/Dependence, revised to remove description of specific neuropsychological testing and to provide a link |
| directing authorized users to the FAA Neuropsychological Testing Specifications site. | ||||
| 2020 | 01/29/2020 | 5. | Medical Policy | In Disease Protocols - Neurocognitive Impairment, Specifications for Neuropsychological Evaluations for Potential Neurocognitive Impairment, revised to remove description of specific neuropsychological testing and to provide a link directing authorized users to the FAA Neuropsychological Testing Specifications site. |
| 2020 | 01/29/2020 | 6. | Medical Policy | In Disease Protocols - Psychiatric and Psychological Evaluations, Specification for Psychiatric and Psychological Evaluations, revised to remove description of specific neuropsychological testing and to provide a link directing authorized users to the FAA Neuropsychological Testing Specifications site. |
| 2020 | 01/02/2020 | 1. | Administrative | Changed coversheet to 2020 and added monthly update schedule for the calendar year. |
| 2019 | 11/07/2019 | 1. | Medical Policy | In Disease Protocols, added new protocol for Diabetes Mellitus Type I and Type II – Insulin Treated – Continuous Glucose Monitoring (CGM) Option (ITDM CGM Option Protocol) for all classes. Includes Initial Certificate Consideration Requirements and Renewal Certificate Requirements. |
| 2019 | 11/07/2019 | 2. | Medical Policy | In Disease Protocols, added Airman Information Sheet to the ITDM CGM Protocol. |
| 2019 | 11/07/2019 | 3. | Medical Policy | In Disease Protocols, added Insulin Treated Diabetes Information Submission Requirements Worksheet to the ITDM CGM Option Protocol. |
| 2019 | 11/07/2019 | 4. | Medical Policy | In Disease Protocols, added Blood Glucose Worksheet for Continuous Glucose Monitoring (CGM) Use to the ITDM CGM Option Protocol. |
| 2019 | 11/07/2019 | 5. | Medical Policy | In Disease Protocols, added Overlay Report and Alert Sample sheets to the ITDM CGM Protocol. |
| 2019 | 11/07/2019 | 6. | Medical Policy | In Disease Protocols, added ITDM Frequently Asked Questions (FAQs) section to the ITDM CGM Option Protocol. |
| 2019 | 11/07/2019 | 7. | Medical Policy | In Disease Protocols, changed the name for the former Diabetes Mellitus Type I and Type II – Insulin Treated Protocol to include “NON CGM Option – Third Class” in the title. |
| 2019 | 11/07/2019 | 8. | Medical Policy | Revised Pharmaceuticals (Therapeutic Medications) Diabetes Mellitus - Insulin Treated to include link to ITDM CGM Option Protocol. |
| 2019 | 11/07/2019 | 9. | Medical Policy | In Exam Techniques, Item 48. General Systemic - Diabetes, Pre-Diabetes, Metabolic Syndrome, and/or Insulin Resistance revised Disposition Table to include link to ITDM CGM Option Protocol. |
| 2019 | 10/30/2019 | 1. | Medical Policy | In Item 48. General Systemic, the Human Immunodeficiency Virus (HIV) disposition table was updated to include Descovy |
| (emtricitabine and tenofovir alafenamide). | ||||
| 2019 | 10/30/2019 | 2. | Administrative | Updated AASI Certificate Issuance Coversheet to match guidance. Removed block for “Metabolic Syndrome, Glucose Intolerance, Impaired Glucose Tolerance, Impaired Fasting Glucose, Insulin Resistance, and Pre-Diabetes.” |
| 2019 | 10/21/2019 | 1. | Administrative | Change links for the HIMS-Trained AME Data Sheet to a online portal athttps://www.himsdatasheet.c om |
| 2019 | 10/21/2019 | 2. | Medical Policy | Revised HIMS-Trained AME Checklist – Drug and Alcohol Monitoring Initial Certification to clarify when HIMS Data Sheet is required. |
| 2019 | 09/25/2019 | 1. | Medical Policy | In Item 48. General Systemic, added Disposition Table for Thrombocytopenia. |
| 2019 | 09/25/2019 | 2. | Medical Policy | In Item 48. General Systemic, added CACI Worksheet for Chronic Immune Thrombocytopenia (C-ITP). |
| 2019 | 09/25/2019 | 3. | Medical Policy | In AME Assisted Special Issuances, All Classes, added AASI for Thrombocytopenia. |
| 2019 | 09/25/2019 | 4. | Medical Policy | Updated the AASI Certificate Issuance Sheet to include Thrombocytopenia. |
| 2019 | 09/25/2019 | 5. | Administrative | In Item 48. General Systemic, Gender Dysphoria, updated the FAA Gender Dysphoria Mental Health Status Report to remove use of the word “form.” |
| 2019 | 08/28/2019 | 1. | Medical Policy | In Disease Protocols, updated and reorganized |
| Protocol for Cardiac Valve Replacement. | ||||
| 2019 | 08/28/2019 | 2. | Administrative | Updated address (Room 8W-100) for Medical Certification Appeals – AAM-240 on pages for Airman Information – SSRI Initial Certification, HIMS AME Checklist – SSRI Initial Certification, and HIMS-Trained AME Checklist – Drug and Alcohol Monitoring– Initial Certification. |
| 2019 | 07/31/2019 | 1. | Medical Policy | In Disease Protocols, Cardiac Valve Replacement, updated to show TAVR procedure may be considered. |
| 2019 | 07/09/2019 | 1. | Administrative | In Item Exam Techniques, Item 48. General Systemic, Gender Dysphoria, updated link to World Professional Association for Transgender Health. (Note: Link must be opened in Google Chrome.) |
| 2019 | 06/26/2019 | 1. | Medical Policy | In Pharmaceuticals, updated chart of Acceptable Combinations of Diabetes Medications. Added lixisenatide (Adlyxin) to GLP-1 mimetics. |
| 2019 | 06/26/2019 | 2. | Administrative | Standardized references to Visual Acuity Standards. |
| 2019 | 05/29/2019 | 1. | Medical Policy | In Examination Techniques, Items 50 - 54., added Visual Acuity Standards table. |
| 2019 | 05/29/2019 | 2. | Medical Policy | In Examination Techniques, Item 51.a Near Vision and Item 51.b. Intermediate Vision, updated Visual Acuity Standards table. |
| 2019 | 05/29/2019 | 3. | Medical Policy | In Protocol for Binocular Multifocal and Accommodating Devices, added a new Visual Acuity Standard table. |
| 2019 | 04/24/2019 | 1. | Medical Policy | In Substances of Dependence/Abuse, added a hyperlink to a revised HIMS-Trained AME DATA Sheet. |
| 2019 | 04/24/2019 | 2. | Medical Policy | In Substances of Dependence/Abuse, added a hyperlink to an Instruction Page on how to complete the new HIMS-Trained AME DATA Sheet. |
| 2019 | 03/27/2019 | 1. | Medical Policy | Revised Chronic Kidney Disease (CKD) Disposition Table to clarify guidance regarding airmen with single kidney (with eGFR 34-44; eGFR 44 or less). |
| 2019 | 03/27/2019 | 2. | Medical Policy | Revised CACI Chronic Kidney Disease (CKD) Worksheet to clarify that two functioning kidneys, among other criteria, are required for CACI consideration. |
| 2019 | 03/27/2019 | 3. | Medical Policy | AASI Atrial Fibrillation and AASI Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), and/ or Hypercoagulopathies revised to add Savaysa to the list of “other types” of anticoagulants (NOAC/DOAC). |
| 2019 | 02/27/2019 | 1. | Medical Policy | In Pharmaceutical Medications, Do Not Issue/Do Not Fly, added Xigduo, Invokamet, and Qtern as NOT allowed. |
| 2019 | 02/27/2019 | 2. | Medical Policy | In Acceptable Combinations of Diabetes Medications, In Group C, added semaglutide (Ozempic) under GLP-1 mimetics. Also, in Group E, added gliclazide (Diamicron)- International under Sulfonylureas (SFU). |
| 2019 | 01/30/2019 | 1. | Administrative | Changed coversheet to 2019 and added monthly schedule |
| of when updates will take place. | ||||
| 2018 | 12/13/2018 | 1. | Medical Policy | Revised language on “Who may perform a neuropsychological examination” and added link to FAA Neuropsychologist List to the following specification sheets: Specifications for Neuropsychological Evaluations for ADHDAirman Information – ADHDSpecifications for Neuropsychological Evaluations for Treatment with SSRI MedicationsSpecifications for Neuropsychological Evaluations for Potential Neurocognitive ImpairmentSpecifications for Psychiatric and Psychological EvaluationsSpecifications for Psychiatric and Neuropsychological evaluations for Substance Abuse/Dependence. |
| 2018 | 11/28/2018 | 1. | Medical Policy | In Item 48. General Systemic, Blood and Blood-Forming Tissue Disease, revised the disposition table to provide guidance for Chronic Lymphocytic Leukemia. |
| 2018 | 11/28/2018 | 2. | Administrative | In Disease Protocols, Attention Deficit/Hyperactivity Disorder, |
| Airman Information – ADHD/ADD Evaluation, changed title of the “Aeromedical Neuropsychologist List” to “HIMS Neuropsychologist List.” | ||||
| 2018 | 11/28/2018 | 3. | Errata | In Item 47. Psychiatric Conditions - Use of Antidepressant Medications, HIMS AME Checklist - SSRI Recertification/Follow Up Clearance, corrected PO Box in the mailing address. |
| 2018 | 10/31/2018 | 1. | Medical Policy | In AASI for Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), and/ or Hypercoagulopathies, guidance added for use of NOAC/DOACs. |
| 2018 | 10/31/2018 | 2. | Medical Policy | In ASSI for Atrial Fibrillation, guidance added for use of NOAC/DOACs. |
| 2018 | 10/31/2018 | 3. | Medical Policy | In Pharmaceuticals – Anticoagulants, guidance added for use of NOAC/DOACs. |
| 2018 | 10/31/2018 | 4. | Medical Policy | In Protocol for Thromboembolic Disease, guidance added for use of NOAC/DOACs. |
| 2018 | 09/26/2018 | 1. | Medical Policy | In Disease Protocols, Specifications for Neuropsychological Evaluations for ADHD/ADD – add language to Airman Information and Testing Requirements to clarify that if the airman has stopped taking ADHD/ADD medication(s), they must be off the medication(s) for 90 days before testing and evaluation. |
| 2018 | 08/29/2018 | 1. | Administrative | Throughout the AME Guide - revised instructions to airmen on how to request copies of their medical records. Requests should now be made by submitting FAA Form 8065-2. |
| 2018 | 07/25/2018 | 1. | Medical Policy | In Item 47. Psychiatric Conditions - Use of Antidepressant Medications, Recertification/Follow-up Clearance, added a new page, HIMS AME Change Request. |
| 2018 | 07/25/2018 | 2. | Administrative | In Specifications for Neuropsychological Evaluations for ADHD/ADD, updated the Aeromedical Neuropsychologist List. |
| 2018 | 06/27/2018 | 1. | Medical Policy | In Specifications for Psychiatric and Psychological Evaluations, updated testing information. For cases in which the clinical history or presentation indicates a possible personality disorder, the Millon Clinical Multiaxial Inventory, 4th Edition (MCMI-IV) should be used (updated from MCMI-III). |
| 2018 | 06/27/2018 | 2. | Administrative | In General Information, added link to new FAA Form 8065-2 06/18 – Request for Airman Information. |
| 2018 | 06/27/2018 | 3. | Administrative | References to the Security and Investigations Division AMC-700 were updated to show organization’s new name, AXE-700. |
| 2018 | 05/30/2018 | 1. | Medical Policy | In Item 29. Ears, added new Acoustic Neuroma Disposition Table. |
| 2018 | 04/25/2018 | 1. | Medical Policy | In AASI, changed the title of Renal Carcinoma to Renal Cancer. Also Changed title |
| of Testicular Carcinoma to Testicular Cancer. Titles were also changed on the main AASI listing page. | ||||
| 2018 | 04/25/2018 | 2. | Medical Policy | In the PDF version of the Guide, revised Specifications for Neuropsychological Evaluation for ADHD/ADD, Reference Information for Neuropsychologists to match the Web version. (Item f.) |
| 2018 | 04/25/2018 | 3. | Medical Policy | In Specifications for Neuropsychological Evaluation for ADHD/ADD – Testing Requirements, clarified that Tower of London (TOL), Drexler Edition (TOL-DX) is the version to be used. |
| 2018 | 04/25/2018 | 4. | Medical Policy | In Specifications for Neuropsychological Evaluation for ADHD/ADD – Airman Information, revised guidance to state that urine drug screening for ADHD must include testing for amphetamine and methylphenidate. |
| 2018 | 03/28/2018 | 1. | Medical Policy | In Substance of Dependence/Abuse, FAA Certification Aid – Drug and Alcohol Initial, removed requirement for a “blue ribbon” copy of the airman’s FAA medical file. |
| 2018 | 03/28/2018 | 2. | Medical Policy | In Disease Protocols – Attention Deficit/Hyperactivity Disorder, Report Requirements, removed requirement for a “blue ribbon” copy of the airman’s FAA medical file. |
| 2018 | 02/28/2018 | 1. | Medical Policy | In Disease Protocols - Attention Deficit/Hyperactivity |
| Disorder, revised section to include links to new information pages. | ||||
| 2018 | 02/28/2018 | 2. | Medical Policy | In Disease Protocols - Attention Deficit/Hyperactivity Disorder, added Airman Information for ADHD/ADD page. |
| 2018 | 02/28/2018 | 3. | Medical Policy | In Disease Protocols - Attention Deficit/Hyperactivity Disorder, Airman Information for ADHD/ADD page, added link to Aeromedical Neuropsychologist List |
| 2018 | 02/28/2018 | 4. | Medical Policy | In Disease Protocols - Attention Deficit/Hyperactivity Disorder, added Neuropsychologist ADHD/ADD Information - Testing Requirements. |
| 2018 | 02/28/2018 | 5. | Medical Policy | In Disease Protocols - Attention Deficit/Hyperactivity Disorder, added Neuropsychologist ADHD/ADD Information – Report Requirements. |
| 2018 | 02/28/2018 | 6. | Medical Policy | In Disease Protocols - Attention Deficit/Hyperactivity Disorder, added Neuropsychologist ADHD/ADD Information – Reference Information for the Neuropsychologist. |
| 2018 | 02/28/2018 | 7. | Medical Policy | In Applicant History – II Prior to Exam, removed guidance that applicant needs to bring summary sheet to the exam |
| 2018 | 02/28/2018 | 8. | Administrative | In Item 47. Psychiatric Conditions – Use of Antidepressant Medications, added a link at the top of the |
| page directing ATCS on SSRI to see the FAA ATCS How to Guide. | ||||
| 2018 | 01/31/2018 | 1. | Administrative | On the AME Guide Cover Page, added monthly schedule of when updates will take place in 2018. |
| 2017 | 12/27/2017 | 1. | Administrative | In Security Notification/Reporting Events, reworded link information. |
| 2017 | 12/27/2017 | 2. | Administrative | In Pharmaceuticals, Sedatives - Convictions or Administrative Actions: revised wording in the PDF version to match Web version of the AME Guide. |
| 2017 | 11/29/2017 | 1. | Medical Policy | Revised CACI – Renal Cancer Worksheet to address chemotherapy and surgery. |
| 2017 | 10/25/2017 | 1. | Medical Policy | Item 36. Heart - Revised guidance for Other Cardiac Conditions, including that anticoagulants may be allowed, if the condition is allowed. |
| 2017 | 10/25/2017 | 2. | Medical Policy | In Item 47. Psychiatric – Use of Antidepressant Medications: added box at the top of the page to direct airmen to information for SSRI initial certification. |
| 2017 | 10/25/2017 | 3. | Medical Policy | HIMS AME Checklist – SSRI Initial Certification/Clearance: clarified that the checklist and ALL supporting information must be submitted. |
| 2017 | 09/27/2017 | 1. | Medical Policy | In Item 48., General Systemic, added new Breast Cancer Disposition Table and CACI - Breast Cancer Worksheet. Breast Cancer added to the main CACI Conditions index. |
| 2017 | 09/27/2017 | 2. | Medical Policy | Substances of Dependence/Abuse (Drugs and Alcohol) main page was revised to add index of new documents. |
| 2017 | 09/27/2017 | 3. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), added new General Information for All AMEs section. |
| 2017 | 09/27/2017 | 4. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), added new DUI/DWI/ Alcohol Incidents Disposition Table. |
| 2017 | 09/27/2017 | 5. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), added new Alcohol Status Report for the AME. |
| 2017 | 09/27/2017 | 6. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), added new Drug Use – Past or Present Disposition Table. |
| 2017 | 09/27/2017 | 7. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), added new FAA Certification Aid – Drug and Alcohol INITIAL. |
| 2017 | 09/27/2017 | 8. | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), added Security Notification/Reporting Events information. |
| 2017 | 09/27/2017 | 9 | Medical Policy | In Substances of Dependence/Abuse (Drugs and Alcohol), added new Substances of Dependence/Abuse FAQs. |
| 2017 | 09/27/2017 | 10. | Medical Policy | In Substance of Dependences of Abuse (Drugs and Alcohol), added new section FAA Drug and/or Alcohol Monitoring Programs and the HIMS |
| Program with information for initial certification criteria. | ||||
| 2017 | 09/27/2017 | 11. | Medical Policy | In FAA Drug and/or Alcohol Monitoring Programs and the HIMS Program, added new HIMS-Trained AME Checklist – Drug and Alcohol INITIAL. |
| 2017 | 09/27/2017 | 12. | Medical Policy | In FAA Drug and/or Alcohol Monitoring Programs and the HIMS Program, added new HIMS-Trained AME Data Sheet. |
| 2017 | 09/27/2017 | 13. | Medical Policy | In FAA Drug and/or Alcohol Monitoring Programs and the HIMS Program, added links to FAA Certification Aid – Drug and Alcohol INITIAL and to Specifications for Neuropsychological Evaluations for Substance Abuse/Dependence. |
| 2017 | 09/27/2017 | 14. | Medical Policy | Moved HIMS-Trained AME Checklist Drug and Alcohol Monitoring Recertification and FAA Certification Aid – Drug and Alcohol Monitoring Recertification sheets into the section for FAA Drug and/or Alcohol Monitoring Programs and the HIMS Program. |
| 2017 | 09/27/2017 | 15. | Medical Policy | In FAA Drug and/or Alcohol Monitoring Programs and the HIMS Program section, added new Monitoring Programs and HIMS FAQs. |
| 2017 | 09/27/2017 | 16. | Medical Policy | In Item 47. Psychiatric, revised language in disposition table notes which referenced substances of abuse. |
| 2017 | 09/27/2017 | 17. | Medical Policy | Moved language from Substances of Dependence/Abuse into Pharmaceuticals to clarify |
| reasons why there is no list of “acceptable” medications. | ||||
| 2017 | 09/27/2017 | 18. | Medical Policy | In Applicant History, revised Items 18. n., 18. o, and 18. v to reflect changes in Substances of Dependence/Abuse section. |
| 2017 | 08/30/2017 | 1. | Medical Policy | In Pharmaceuticals, Erectile Dysfunction and Benign Prostatic Hyperplasia Medications, added daily Cialis (tadalafil) use as allowed with limitations. Decreased required wait time after last dose of PRN Cialis from 36 to 24 hours. |
| 2017 | 08/30/2017 | 2. | Administrative | Throughout the AME Guide, updated mailing address for the Aerospace Medical Certification Division to PO Box 25082.(Previous address with PO Box 26080 or PO Box 26200 are no longer to be used.) |
| 2017 | 08/30/2017 | 3. | Administrative | In Substances of Dependence/Abuse (Drugs and Alcohol), HIMS AME Checklist – Drug and Alcohol Monitoring Recertification Worksheet, updated checkboxes for item #2 on the worksheet. |
| 2017 | 07/26/2017 | 1. | Medical Policy | In Disease Protocols, Disease Protocols - Diabetes Mellitus Type I and Type II - Insulin Treated, added Diabetes on Insulin Re-Certification Status Report. |
| 2017 | 07/26/2017 | 2. | Medical Policy | In Student Pilot Rule Change FAQs, clarified Item E. Paper 8500-8 forms are no longer valid; any remaining paper 8500-8 forms must be destroyed by the AME. |
| 2017 | 07/26/2017 | 3. | Medical Policy | In General Information, 12. Medical Certificates – AME Completion Requirements, clarified instructions to the AME regarding the completion, signing, distribution, etc., of an airman medical certificate. |
| 2017 | 07/26/2017 | 4. | Administrative | In General information, 13. Validity of Medical Certificates, removed redundant note regarding typing or hand-writing medical certificates. |
| 2017 | 06/28/2017 | 1. | Administrative | In Item 55. Blood Pressure, added a link to Hypertension FAQs. |
| 2017 | 06/28/2017 | 2. | Medical Policy | In the chart of Acceptable Combinations of Diabetes Medications, added albiglutide (Tanzeum) to GLP1 – mimetics, Group C (not allowed with Meglitinides). |
| 2017 | 06/28/2017 | 3. | Medical Policy | In Item 50. Distant Vision and Item 51. Near and Immediate Vision, revised to remove requirement to test both corrected and uncorrected visual acuity. Added “Note: If correction is required to meet standards, only the corrected visual acuity needs to be tested and recorded.” |
| 2017 | 06/28/2017 | 4. | Administrative | Reformatted Table of Contents to include all vision testing items and sections titled “AME Physical Exam Information” and “AME Office-Required Ancillary Testing.” |
| 2017 | 05/31/2017 | 1. | Medical Policy | In Pharmaceuticals, updated the Do Not Issue – Do Not Fly list to provide examples |
| within classes of medications. | ||||
| 2017 | 04/26/2017 | 1. | Medical Policy | In Disease Protocols - Coronary Heart Disease (CHD), Disease Protocols - Valve Replacement, and Disease Protocols – Cardiac Transplant, revised language to remove reference to mandatory wait time for third class, per Public Law 114-190, Sec. 2307. Note: 49 USC 44703 note. Medical Certification of Certain Small Aircraft Pilots. |
| 2017 | 04/26/2017 | 2. | Medical Policy | Revised language In Pharmaceuticals – Glaucoma Medications, Item 31. Eye, and CACI – Glaucoma Worksheet. Applicants using miotic or mydriatic eye drops or taking an oral medication for glaucoma may be considered for Special Issuance certification following their demonstration of adequate control. These medications do not qualify for the CACI program. |
| 2017 | 04/07/2017 | 1. | Administrative | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, revised Airman Information – SSRI INITIAL Certification sheet to clarify information regarding submitting package to the FAA. |
| 2017 | 04/07/2017 | 2. | Administrative | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, revised HIMS AME Checklist– SSRI Recertification/Follow Up Clearance to correct the address. |
| 2017 | 03/29/2017 | 1. | Administrative | In the Protocol for History of Diabetes Mellitus Type II Medication-Controlled (Non-Insulin), added a note to the Diabetes or Hyperglycemia on Oral Medications Status Report:“Note: Acceptable Combinations of Diabetes Medications and copies of this form for future follow-ups can be found atwww.faa.gov/go/diabetic.” |
| 2017 | 03/29/2017 | 2. | Medical Policy | Item 47. Psychiatric Conditions, Use of Antidepressant Medications revised to include information regarding FAA ATCS and added hyperlinks to new documents. |
| 2017 | 03/29/2017 | 3. | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, revised SSRI Decision Path-I flow chart to include FAA ATCS. |
| 2017 | 03/29/2017 | 4. | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, revised SSRI Decision Path-II flow chart to include FAA ATCS. Renamed it SSRI Decision Path-II – INITIAL Certification/ Clearance. |
| 2017 | 03/29/2017 | 5. | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, deleted Airman Information and HIMS AME Checklist - SSRI Initial Certification sheet. Replaced it with Airman Information – SSRI INITIAL Certification sheet. |
| 2017 | 03/29/2017 | 6. | Medical Policy | In Item 47. Psychiatric Conditions, Use of |
| Antidepressant Medications, added FAA ATCS How To Guide - SSRI. | ||||
| 2017 | 03/29/2017 | 7. | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, Revised HIMS AME Checklist – SRRI Initial Certification sheet to include FAA ATCS. Sheet renamed HIMS AME Checklist – SSRI INITIAL Certification/Clearance. |
| 2017 | 03/29/2017 | 8. | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, revised FAA Certification Aid– SSRI Initial Certification to include information regarding FAA ATCS. Sheet renamed FAA Certification Aid – SSRI INITIAL Certification/Clearance. |
| 2017 | 03/29/2017 | 9. | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, added flow chart FAA ATCS SSRI Follow Up Path for the HIMS AME. |
| 2017 | 03/29/2017 | 10. | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, revised HIMS AME Checklist– SSRI Recertification to include information regarding FAA ATCS. Renamed HIMS AME Checklist – SSRI Recertification/Follow Up Clearance. |
| 2017 | 03/29/2017 | 11. | Medical Policy | In Item 47. Psychiatric Conditions, Use of Antidepressant Medications, revised FAA Certification Aid– SSRI Recertification. Renamed FAA Certification Aid – SSRI |
| Recertification/Follow Up Clearance. | ||||
| 2017 | 03/29/2017 | 12. | Medical Policy | In Disease Protocols, revised Specifications for Neuropsychological Evaluations for Treatment with SSRI Medications to include information regarding FAA ATCS. |
| 2017 | 02/22/2017 | 1. | Medical Policy | In Item 38. Abdomen and Viscera, added new CACI – Colon Cancer Worksheet. |
| 2017 | 02/22/2017 | 2. | Medical Policy | In Item 38. Abdomen and Viscera, updated Malignancies Disposition Table with information on colon cancer. |
| 2017 | 02/22/2017 | 3. | Medical Policy | On main CACI page, added listing for colon cancer. |
| 2017 | 02/22/2017 | 4. | Medical Policy | In Pharmaceuticals, Allergies– Immunotherapy, updated information for sublingual immunotherapy (SLIT). |
| 2017 | 02/22/2017 | 5. | Medical Policy | In Item 26. Nose, added note on desensitization treatment (injection or SLIT). |
| 2017 | 02/22/2017 | 6. | Medical Policy | In Item 35. Lungs and Chest- Allergies, expanded information on hay fever requiring antihistamines and added note on desensitization treatment (injection or SLIT). |
| 2017 | 01/25/2017 | 1. | Medical Policy | In Item 48. General Systemic, added guidance on blood donation. |
| 2016 | 12/28/2016 | 1. | Medical Policy | Revised General Information, Authority of Aviation Medical Examiners to further clarify that an AME may not perform selfexaminations for issuance of a medical certificate or issue to themselves or an immediate family member. Status reports must be done |
| by the treating provider. Reports done by the airman will NOT be accepted, even if that airman is a physician. | ||||
| 2016 | 11/30/2016 | 1. | Medical Policy | Reworded and restructured Item 58. ECG to further clarify when an ECG is required, what is a current ECG, equipment requirements, AME review and interpretation, transmitting, and FAA support information. |
| 2016 | 11/30/2016 | 2. | Medical Policy | In Substances of Dependence/Abuse, in the FAA CERTIFICATION AID – Drug and Alcohol Monitoring Recertification sheet, revise page 2 to remove “AA Meeting” as a valid example in the “Group, Aftercare or Counselor” category. |
| 2016 | 11/30/2016 | 3. | Medical Policy | Revised Item 47. Psychiatric Conditions – Use of Antidepressant Medications - “4.) The applicant DOES NOT have symptoms or history of.” Also reorganized listing of informational hyperlinks associated with the “Initial Certification” and “Recertification” categories. |
| 2016 | 11/30/2016 | 4. | Administrative | On the main Disease Protocol page, update the link for Depression Treated with SSRI Medications so it directs the user to Item 47. Psychiatric Conditions - Use of Antidepressant Medications. |
| 2016 | 10/26/2016 | 1. | Medical Policy | Revised Item 47. Psychiatric to add Airman Information and HIMS AME Checklist – SSRI INITIAL Certification guidance. |
| 2016 | 10/26/2016 | 2. | Medical Policy | Revised Item 47. Psychiatric to add FAA Certification Aid– SSRI Initial Certification guidance. |
| 2016 | 10/26/2016 | 3. | Medical Policy | In Item 47. Psychiatric, revised SSRI Decision Path II – (HIMS AME) flow chart. Renamed and added verbiage to reflect update in SSRI INITIAL Certification policy. |
| 2016 | 10/26/2016 | 4. | Medical Policy | In Disease Protocols – Depression Treated with SSRI Medications, reorganized Specifications for Neuropsychological Evaluations for Treatment with SSRI Medications. Moved notes from the bottom to the top of the page. |
| 2016 | 09/28/2016 | 1. | Medical Policy | In General Information, Who May Be Certified, and in Student Pilot Rule Change, revise information on language requirements. Remove references to ICAO language proficiency requirements and any related AME actions. |
| 2016 | 08/31/2016 | 1. | Medical Policy | Revised HIMS AME Checklist - Drug and Alcohol Monitoring Recertification to add “N/A” column to item 2. |
| 2016 | 08/31/2016 | 2. | Errata | In Item 62. Has Been Issued, added hyperlink for Letter of Denial. |
| 2016 | 07/27/2016 | 1. | Medical Policy | Revised CACI – Renal Cancer Worksheet to specify that if it has been 5 or more years since the airman had any treatment for renal cancer, with no history of metastatic disease and no reoccurrence, CACI is not |
| required and examiner must notate in Box 60. | ||||
| 2016 | 06/29/2016 | 1. | Medical Policy | In Item 46. Neurologic, added new FAA Airman Seizure Questionnaire. |
| 2016 | 06/29/2016 | 2. | Medical Policy | In Item 47. Psychiatric, changed the title of the SSRI Specification Sheet to SSRI Specification Sheet – for Initial Consideration. Appropriate hyperlinks were also renamed in the Web version of the AME Guide. |
| 2016 | 06/29/2016 | 3. | Medical Policy | In Item 47. Psychiatric, changed title of Depression Treated with SSRI Medications to Specifications for Neuropsychological Evaluations for Treatment with SSRI Medications. Appropriate hyperlinks were also renamed in the Web version of the AME Guide. |
| 2016 | 05/25/2016 | 1. | Medical Policy | In Item 47. Psychiatric, added new SSRI Follow Up Path for the HIMS AME. Chart has new title and content. This replaces the previously titled “SSRI Follow Up Path.” |
| 2016 | 05/25/2016 | 2. | Medical Policy | In Item 47. Psychiatric, added HIMS AME Checklist– SSRI Recertification. |
| 2016 | 05/25/2016 | 3. | Medical Policy | In Item 47. Psychiatric, added FAA Certification AID– SSRI Recertification. |
| 2016 | 05/25/2016 | 4. | Medical Policy | In Substances of Dependence/Abuse, added HIMS AME Checklist – Drug and Alcohol Monitoring Recertification. |
| 2016 | 05/25/2016 | 5. | Medical Policy | In Substances of Dependence/Abuse, added FAA Certification AID – Drug |
| and Alcohol Monitoring Recertification. | ||||
| 2016 | 05/25/2016 | 6. | Errata | Removed duplicated punctuation on CACI - Pre Diabetes Mellitus Worksheet. |
| 2016 | 04/27/2016 | 1. | Medical Policy | References to ATCS removed from the AME Guide with the exception of use in General Information – Classes of Medical Certificate and in Item 52. Color Vision – ATCS testing criteria. |
| 2016 | 04/27/2016 | 2. | Medical Policy | In 41. GU- Kidney Stone(s) - (Nephrolithiasis, Renal Calculi) or Renal Colic - All Classes, revised disposition table to clarify criteria. |
| 2016 | 04/27/2016 | 3. | Medical Policy | In the Acceptable Combinations of Diabetes Medications Chart, added dulaglutide (Trulicity) to the GLP-1 section. |
| 2016 | 04/27/2016 | 4. | Medical Policy | Revised title of CACI – Kidney Stones Worksheet to CACI – Retained Kidney Stone(s) Worksheet. |
| 2016 | 04/27/2016 | 5. | Errata | In the Glossary, clarified entries for PAC, PET, and PVC. |
| 2016 | 03/30/2016 | 1. | Medical Policy | As of April 1, 2016 (per Final Rule [81 FR 1292]), AMEs will no longer be able to issue the combined FAA Medical Certificate and Student Pilot Certificate. Student Pilots will have a separate Student Pilot Certificate and a separate FAA Medical Certificate. As such, all AME instructions regarding the issuance of a combined certificate have been removed from the AME Guide. In addition, a section |
| explaining the policy change has been added. See Student Pilot Rule Change. | ||||
| 2016 | 03/30/2016 | 2. | Administrative | In Application Process for Medical Certification, Applicant History, II. Prior to the Examination, revise to change any “MedX” references to MedXpress. |
| 2016 | 03/30/2016 | 3. | Administrative | In Item 31. Eyes, General – revise language in disposition table for Amblyopia. |
| 2016 | 03/30/2016 | 4. | Administrative | In Item 42. Upper and Lower Extremities, Item 49. Hearing, and Disease Protocol for Musculoskeletal, revise language to clarify process. |
| 2016 | 03/30/2016 | 5. | Administrative | In Glossary, revise entries for AMCS and AME to clarify definition. |
| 2016 | 02/24/2016 | 1. | Medical Policy | In Item 36. Heart, Valvular Disease Disposition Table, reorganize and add entry for Mitral Valve Repair. |
| 2016 | 02/24/2016 | 2. | Medical Policy | In Item 36. Heart, add Mitral Valve Repair Disposition Table. |
| 2016 | 02/24/2016 | 3. | Medical Policy | In Item 36. Heart, add CACI– Mitral Valve Repair Worksheet. |
| 2016 | 02/24/2016 | 4. | Medical Policy | Add entry for CACI – Mitral Valve Repair Worksheet to main CACI section page |
| 2016 | 02/24/2016 | 5. | Medical Policy | In the PDF version of The Guide, Item 26. Nose, revise information on severe allergic rhinitis and hay fever requiring antihistamines so information is consistent with the Web version. |
| 2016 | 02/24/2016 | 6. | Errata | In Special Issuances, AASI for Mitral or Aortic Insufficiency, correct typographical error. |
| 2016 | 01/27/2016 | 1. | Medical Policy | In Item, 41., G-U System, Gender Identity Disorder, rename to Gender Dysphoria, update information, and relocate entry to Item 48, General Systemic, Gender Dysphoria. |
| 2016 | 01/27/2016 | 2. | Medical Policy | In Item 48., General Systemic, Gender Dysphoria, add Gender Dysphoria Mental Health Status Report form. |
| 2016 | 01/27/2016 | 3. | Medical Policy | In Item 41, G-U System, Pregnancy, remove and relocate entry to Item 48., General Systemic, Pregnancy. |
| 2016 | 01/27/2016 | 4. | Medical Policy | In Pharmaceuticals, Contraceptive and Hormone Replacement Therapy, III Aeromedical Considerations, change reference from Item 41., Gender Identity Disorder to Item 48., General Systemic, Gender Dysphoria. |
| 2016 | 01/27/2016 | 5. | Errata | In Synopsis of Medical Standards, correct typographical error. |
| 2016 | 01/01/2016 | 1. | Administrative | Changed cover page to reflect current calendar year. |
| 2015 | 11/25/2015 | 1. | Medical Policy | In Item 41. G-U Systems, General Disorders, add Chronic Kidney Disease Dispostion Table. |
| 2015 | 11/25/2015 | 2. | Medical Policy | In Item 41. G-U Systems, General Disorders, add CACI – Chronic Kidney Disease Worksheet. |
| 2015 | 11/25/2015 | 3. | Administrative | On main CACI Certification Worksheets page, add entry for Chronic Kidney Disease. |
| 2015 | 11/25/2015 | 4. | Medical Policy | In Special Issuances, add AASI for Chronic Kidney Disease. |
| 2015 | 11/25/2015 | 5. | Administrative | On main AASI page, add entry for Chronic Kidney Disease. |
| 2015 | 11/25/2015 | 6. | Medical Policy | In AME Assisted Special Issuances (AASI), revise AASI Coversheet to include box for Chronic Kidney Disease. |
| 2015 | 11/06/2015 | 1. | Errata | In Item 48. General Systemic– CACI – Pre Diabetes Worksheet, corrected typographical errror in Accebtable Certification Criteria: Oral glucose test, if performed, should be less than 200 mg/dl at 2 hours. |
| 2015 | 10/28/2015 | 1. | Medical Policy | In Item 36. Heart, revise Hypertension Dispositions Table to clarify certification requirements. |
| 2015 | 10/28/2015 | 2. | Medical Policy | In Item 36. Heart, revise CACI – Hypertension Worksheet to provide example of clonidine as a centrally acting antihypertensive(s), which is not acceptable. |
| 2015 | 10/28/2015 | 3. | Medical Policy | In Item 36. Heart, add Hypertension – Frequently Asked Questions ( FAQs). |
| 2015 | 10/28/2015 | 4. | Medical Policy | In Pharmaceuticals (Therapeutic Medications) - Antihypertensives, revise to include table with examples of medications that are acceptable and not acceptable for treatment of hypertension. |
| 2015 | 10/28/2015 | 5. | Medical Policy | In AME Assisted Special Issuances (AASI), add AASI for Hypertension. |
| 2015 | 10/28/2015 | 6. | Medical Policy | In AME Assisted Special Issuances (AASI), revised AASI Coversheet to include box for Hypertension. |
| 2015 | 10/28/2015 | 7. | Medical Policy | In Item 55. Blood Pressure, Decision Considerations, revise to include more information on AME options if airman’s blood pressure is higher than 155/95 during the exam. |
| 2015 | 09/30/2015 | 1. | Medical Policy | In Item 41. G-U Systems, add Kidney Stone(s) Dispositions Table. |
| 2015 | 09/30/2015 | 2. | Medical Policy | In Item 41. G-U Systems, add CACI – Kidney Stone(s) Worksheet. |
| 2015 | 09/30/2015 | 3. | Medical Policy | In Item 41. G-U Systems, Neoplastic Disorders, Dispositions Table, revise information for Renal Cancer. |
| 2015 | 09/30/2015 | 4. | Medical Policy | In Item 41. G-U Systems, Neoplastic Disorder, revise the CACI – Renal Cancer Worksheet to include “disease recurrence and stage 4 disease” as part of criteria AME must review. |
| 2015 | 09/30/2015 | 5. | Medical Policy | In Item 41. G-U Systems, Urinary System, revise Disposition Table to include information on Hematuria, Proteinuria, and Glycosuria. Removed information on renal calculi, which is now captured in Kidney Stone (s) Disposition Table. |
| 2015 | 09/30/2015 | 6. | Administrative | In Item 41. G-U Systems, revised the list of conditions to appear in the following order: -General Disorders -Gender Identity Disorders -Inflammatory Conditions -Kidney Stone(s) -Neoplastic Disorders Bladder Cancer Prostate Cancer Renal Cancer |
| Testicular Cancer Other G-U Cancers/Neoplastic Disorders -Nephritis -Pregnancy -Urinary System | ||||
| 2015 | 08/26/2015 | 1. | Medical Policy | In Item 41. G-U Systems, Neoplastic Disorders, Dispositions Table, revise information for Prostate Cancer. |
| 2015 | 08/26/2015 | 2. | Medical Policy | In Item 41. G-U System, Neoplastic Disorders, add CACI – Prostate Cancer Worksheet. |
| 2015 | 08/26/2015 | 3. | Medical Policy | In Item 42. G-U System, Neoplastic Disorders, add Prostate Conditions Dispositions Table to include information on BPH and elevated PSA. |
| 2015 | 08/26/2015 | 4. | Medical Policy | On CACI Conditions main page, revise guidance to clarify that if all the CACI criteria are met and the applicant is otherwise qualified, the AME may issue on the first exam or the first time the condition is reported to the AME without contacting AMCD/RFS. AMEs should document the appropriate notes in Block 60 and keep the supporting documents in their files; they do not need to be submitted to the FAA at this time. |
| 2015 | 08/26/2015 | 5. | Administrative | In Special Issuance, AASI for Melanoma and in Item 40. Skin, Disposition Table for Skin Cancer – All Classes, revised to clarify expression of Breslow level. (Removed < > signs.) EX: “Melanoma less than 0.75 mm in depth |
| or Melanoma in Situ” and "Melanoma equal to 0.75 mm or greater in depth.” | ||||
| 2015 | 08/26/2015 | 6. | Administrative | Item 41. G-U System – Neoplastic Disorders, Disposition Table – Testicular Cancer – All Classes and in Disposition Table – Bladder Cancer – All Classes, revise to clarify - “Non metastatic and treatment completed 5 or more years ago.” |
| 2015 | 08/26/2015 | 7 | Administrative | In CACI – Bladder Cancer Worksheet and CACI – Testicular Cancer Worksheet, revise information in notes to clarify: “If it has been 5 or more years since…” |
| 2015 | 07/29/2015 | 1. | Medical Policy | In Item 41. G-U System, Neoplastic Disorders, Dispositions Table, revise information for Bladder Cancer. |
| 2015 | 07/29/2015 | 2. | Medical Policy | In Item 41. G-U System, Neoplastic Disorders, add CACI – Bladder Cancer Worksheet. |
| 2015 | 07/29/2015 | 3. | Medical Policy | In Item 48. General Systemic- Endocrine Disorders, revised CACI – Hypothyroidism Worksheet. Changed normal TSH requirement from 90 days to one year. |
| 2015 | 07/29/2015 | 4. | Medical Policy | In Item 38. Abdomen and Viscera, Dispositions Table, revise to include criteria for liver transplant recipient, donor, and liver transplant in combination with kidney, heart, or other organ. |
| 2015 | 07/29/2015 | 5. | Medical Policy | In Protocols, add protocol for Liver Transplant – (Recipient). |
| 2015 | 06/24/2015 | 1. | Medical Policy | In Item 41. G-U System, Neoplastic Disorders, Dispositions Table, revise information for Testicular Cancer. |
| 2015 | 06/24/2015 | 2. | Medical Policy | In Item 41. G-U System, Neoplastic Disorders, add CACI – Testicular Cancer Worksheet. |
| 2015 | 06/24/2015 | 3. | Medical Policy | In Pharmaceuticals (Therapeutic Medications), add guidance for use of Erectile Dysfunction and/or Benign Prostatic Hyperplasia Medications, including table of wait times. |
| 2015 | 06/24/2015 | 4. | Medical Policy | In CACI – Hypertension Worksheet, revise to change medication wait time from 2 weeks to 7 days. |
| 2015 | 06/24/2015 | 5. | Medical Policy | In PDF version of the Guide, create a page listing all CACI worksheets. In both PDF and Web versions of the Guide, include instructions for the Examiner to review the disposition table first to verify that a CACI is required. |
| 2015 | 06/17/2015 | 1. | Administrative | In Protocols, Diabetes Mellitus Type I and Type II – Insulin Treated, clarify diabetes requirements by class. |
| 2015 | 06/17/2015 | 2. | Administrative | In Pharmaceuticals, Diabetes Mellitus Type I and Type II – Insulin Treated, remove redundant language. Retain links to applicable Diabetes information elsewhere in the AME Guide. |
| 2015 | 05/27/2015 | 1. | Medical Policy | In Item 48. General Systemic, Dispositions Table for Human Immunodeficiency Virus (HIV), add issuance criteria |
| for HIV negative airmen taking long-term prevention or Pre-Exposure Prophylaxis (PrEP). Also added link to the information in Protocol for Human Immunodeficiency Virus (HIV). | ||||
| 2015 | 05/27/2015 | 2. | Medical Policy | Protocols, Diabetes Mellitus Type II – Medication Controlled, added PDF form Diabetes or Hyperglycemic on Oral Medications Status Report. Links to the form also added in Pharmaceuticals, Diabetes Mellitus Type II – Medication Controlled (Not Insulin) and in Special Issuances AME Assisted - All Classes - Diabetes Mellitus - Type II, Medication Controlled (Not Insulin). |
| 2015 | 04/29/2015 | 1. | Medical Policy | In Item 40. Skin, replace dispositions table for Malignant Melanoma with an expanded table named “Skin Cancers – All classes.” |
| 2015 | 04/29/2015 | 2. | Administrative | In all CACI worksheets, revise note in Block 60 language to read: CACI qualified (condition). Not CACI qualified (condition). Issued per valid SI/AASI. (Submit supporting documents.) NOT CACI qualified (condition). I have deferred. |
| 2015 | 04/29/2015 | 3. | Medical Policy | In Disease Protocols, Obstructive Sleep Apnea, Reference Materials, revise Specification Sheet B to include bullet: “In communities where a Level II HST is unavailable, the FAA |
| will accept a level III HST. If the HST is positive for OSA, no further testing is necessary and treatment in accordance with the AASI must be followed. However, if the HST is equivocal, a higher level test such as an in-lab sleep study will be needed unless a sleep medicine specialist determines no further study is necessary and documents the rationale.” | ||||
| 2015 | 04/29/2015 | 4. | Medical Policy | In Disease Protocols, Protocol for History of Diabetes Mellitus Type II Medication – Controlled (Non Insulin), Protocol for Metabolic Syndrome, and CACI – Pre Diabetes, revise to add 14 day wait period for use of Metformin only. (Any other single diabetes medication requires a 60-day wait period.) |
| 2015 | 04/29/2015 | 5. | Medical Policy | In Item 43. Spine and other Musculoskeletal, add a disposition table for Gout and Pseudogout. |
| 2015 | 04/21/2015 | 1. | Medical Policy | In Disease Protocols, Protocol for Diabetes Mellitus, Type I and Type II – Insulin Treated, revise to remove reference to class of certification. |
| 2015 | 04/21/2015 | 2. | Medical Policy | In Pharmaceuticals (Therapeutic Medications) Diabetes Mellitus – Insulin Treated, revise language under III. Aeromedical Decision Considerations. Remove reference to class of certification. |
| 2015 | 04/16/2015 | 1. | Medical Policy | In Disease Protocols, Protocol for History Diabetes |
| Mellitus Type II Medication-Controlled (Non-Insulin) and in Protocol for Medication Controlled Metabolic Syndrome, remove: “An applicant who uses insulin for the treatment of his or her metabolic syndrome may only be considered for an Authorization for a third-class airman medical certificate.” | ||||
| 2015 | 04/16/2015 | 2. | Administrative | To bring the PDF version of the Guide up-to-date with the online version: In Item 36. Heart, C. Medication, NOT ACCEPTABLE - Remove "A combination of betaadrenergic blocking agents used with insulin, meglitinides, or sulfonylureas.” |
| 2015 | 04/03/2015 | 1. | Medical Policy | In Disease Protocols, Obstructive Sleep Apnea, Reference Materials, Frequently Asked Questions (FAQs), add new FAQ: “What if the doctor or insurance provider is only willing to do a level III Home Sleep Test (HST).” |
| 2015 | 03/19/2015 | 1. | Medical Policy | In Disease Protocols, Obstructive Sleep Apnea, add new section within the Reference Materials for Frequently Asked Questions (FAQs). |
| 2015 | 03/19/2015 | 2. | Administrative | In Disease Protocols, Obstructive Sleep Apnea, add a link for the FAA OSA screening video. |
| 2015 | 03/10/2015 | 1. | Administrative | In Disease Protocols, Obstructive Sleep Apnea, create additional hyperlinks within the material. |
| 2015 | 03/02/2015 | 1. | Medical Policy | In Disease Protocols, revise guidance to introduce |
| “Protocol for Obstructive Sleep Apnea (OSA).” | ||||
| 2015 | 03/02/2015 | 2. | Medical Policy | In Disease Protocols, add new section, “Reference Materials for Obstructive Sleep Apnea (OSA),” to the end of the Protocols. |
| 2015 | 03/02/2015 | 3. | Medical Policy | In AME Assisted – All Classes - Sleep Apnea, revise guidance on certification criteria. Change title to “AME Assisted – All Classes – Obstructive Sleep Apnea (OSA).” |
| 2015 | 03/02/2015 | 4. | Medical Policy | In Item. 35, Lungs and Chest, Revise guidance in Decisions Considerations Table regarding Obstructive Sleep Apnea. |
| 2015 | 03/02/2015 | 5. | Medical Policy | In Item. 25-30, Ear, Nose and Throat, add link to Protocol for Obstructive Sleep Apnea. |
| 2015 | 03/02/2015 | 6. | Medical Policy | In Item. 28, Mouth and Throat Decision Considerations Table, add link to Protocol for Obstructive Sleep Apnea. |
| 2015 | 03/02/2015 | 7. | Administrative | In Protocols, revise table of contents page to show entry for Obstructive Sleep Apnea (OSA). In the PDF version of the AME Guide, add note to indicate location of the “Obstructive Sleep Apnea (OSA) – Reference Materials.” |
| 2015 | 02/11/2015 | 1. | Administrative | In Item. 52, Color vision, revise format to emphasize existing policy – “Color vision tests approved for airmen ARE NOT all acceptable for air traffic controllers.” |
| 2015 | 02/11/2015 | 2. | Medical Policy | In Protocol for History of Human Immunodeficiency Virus (HIV) Related |
| Conditions, revise language and insert links to specification sheets to clarify criteria for Special Issuance and follow-up. | ||||
| 2015 | 01/05/2015 | 1. | Administrative | Revise cover page to reflect the current calendar year. |
| 2014 | 12/09/2014 | 1. | Medical Policy | In Pharmaceuticals, Antihypertensives, revise to state that the combination use of beta-blockers and insulin, meglitinides, or sulfonylurea is now allowed. |
| 2014 | 12/09/2014 | 1. | Medical Policy | In Pharmaceuticals, Do Not Issue – Do Not Fly, remove “Concurrent use of a betablocker plus a sulfonylurea or insulin or a meglitinide” from the Do Not Issue listing. |
| 2014 | 12/02/2014 | 1. | Administrative | Review Guide and remove any erroneous references to Titmus II Vision Testers (TII, TIIs). Tester was previously removed (09/27/13) as acceptable for airmen. |
| 2014 | 11/24/2014 | 1. | Administrative | In Disease Protocols, review and adjust table of contents order. |
| 2014 | 10/22/2014 | 1. | Medical Policy | In Pharmaceuticals, Diabetes Mellitus Type II – Medication Controlled (Not Insulin), revise chart of Acceptable Combinations of Diabetes Medications to include alogliptin (Nesina) and trade names for metformin (Glucophage, Fortament, Glutetza, Riomet.) |
| 2014 | 10/20/2014 | 1. | Medical Policy | In Pharmaceuticals, Diabetes Mellitus – Insulin Treated and in Diabetes Mellitus – Diabetes Mellitus Type II – Medication Controlled (Not Insulin), revise Pharmaceutical |
| Considerations regarding chart of Acceptable Combinations of Diabetes Medications. | ||||
| 2014 | 10/20/2014 | 2. | Medical Policy | In Pharmaceuticals, revise chart of Acceptable Combinations of Diabetes Medications. |
| 2014 | 10/20/2014 | 3. | Medical Policy | In AASI, Diabetes Mellitus – Type II Medication Controlled (Not Insulin), revise guidance regarding deferral criteria. |
| 2014 | 09/10/2014 | 1. | Medical Policy | In General Information, Equipment Requirements and in Item. 52, Color Vision, revise to indicate that the OPTEC 2000 vision tester (Models 2000 PM, 2000 PAME, 2000 PI) MUST contain the 2000-010 FAR color perception PIP plate to be approved. |
| 2014 | 08/06/2014 | 1. | Medical Policy | In General Information, Classes of Medical Certificates and also in Validity of Medical Certificates, revise to include language regarding digital signatures of authorized FAA physicians on certificates. |
| 2014 | 07/25/2014 | 1. | Medical Policy | In General Information, Classes of Medical Certificates and also in Validity of Medical Certificates, revise to include language regarding necessity for original AME or FAA physician signature on certificates. |
| 2014 | 07/23/2014 | 1. | Medical Policy | In AASI, Diabetes Mellitus, Medication Controlled (Not Insulin), revise to include that applicant must be deferred if taking more than 3 Diabetes medications or is using a |
| combination prohibited in the Acceptable Combinations of Diabetes Medical Chart. | ||||
| 2014 | 05/16/2014 | 1. | Administrative | In Pharmaceuticals (Therapeutic Medications), Malaria, reorder category content. |
| 2014 | 05/16/2014 | 2. | Medical Policy | In Pharmaceuticals, (Therapeutic Medicatins), Sleep Aids, revise to include warning on eszopiclone. |
| 2014 | 05/16/2014 | 3. | Medical Policy | In Item 46. Neurologic, In the dispositions table, change “Dystonia musculorum deformans" to "Dystonia - primary or secondary.” |
| 2014 | 05/12/14 | 1. | Medical Policy | In Acceptable Combinations of Diabetes Medications Chart, revise to add alogliptin (Nesina). |
| 2014 | 05/06/2014 | 1. | Medical Policy | In Decision Considerations, Disease Protocols - Graded Exercise Stress Test Requirements, revise to remove hyperventilation requirement from testing. |
| 2014 | 04/22/2014 | 1. | Administrative | In Pharmaceuticals (Therapeutic Medications) revise chart of Acceptable Combinations of Diabetes Medications to include link to Pre-Diabetes CACI worksheet. |
| 2014 | 04/17/2014 | 1. | Medical Policy | In Pharmaceuticals (Therapeutic Medications) revise to include chart of Acceptable Combinations of Diabetes Medications. |
| 2014 | 04/17/2014 | 2. | Administrative | In Applicant History, Item 3., (Last Name; First Name; Middle Name.), revise to clarify instructions if applicant has no middle name. |
| 2014 | 03/28/2014 | 1. | Administrative | In Disease Protocols, add acronyms to Protocol for |
| Cardiovascular Evaluation (CVE) and Protocol for Evaluation of Coronary Heart Disease (CHD). | ||||
| 2014 | 03/20/2014 | 1. | Medical Policy | In CACI Certification Worksheets, add worksheet for Colitis. Revise Colitis Dispositions Table and Colitis Special Issuance criteria to reflect the change. |
| 2014 | 03/18/2014 | 1. | Medical Policy | In Disease Protocols, Cardiovascular Evaluation, revise to clarify criteria. |
| 2014 | 03/18/2014 | 2. | Medical Policy | In Disease Protocols, Coronary Heart Disease, revise to clarify criteria. |
| 2014 | 03/18/2014 | 3. | Medical Policy | In Disease Protocols, Graded Exercise Stress Test Requirements, revise to clarify criteria. |
| 2014 | 03/14/2014 | 1. | Medical Policy | In Exam Techniques, III. Aerospace Medical Disposition, revise to clarify the definition of Conditions AMEs Can Issue (CACI). |
| 2014 | 03/10/2014 | 1. | Medical Policy | In Item 47. Psychiatric, Use of Antidepressant Medications, revise policy to change the required time applicant must be on a stable dose of the SSRI from 12 months to 6 months. |
| 2014 | 02/05/2014 | 1. | Medical Policy | In Pharmaceuticals (Therapeutic Medications) – Anticoagulants and in Disease Protocols – Thromboembolic Disease, revise to policy include required wait time after initial start of warfarin (Coumadin) treatment. |
| 2014 | 01/16/2014 | 1. | Medical Policy | In Equipment Requirements and Item 52. Color Vision, remove APT-5 Color Vision Tester. |
| 2014 | 01/16/2014 | 2. | Medical Policy | In Pharmaceuticals (Therapeutic Medications), add new “Do Not Issue-Do Not Fly” section. |
| 2014 | 01/01/2014 | 1. | Administrative | Revise cover page to reflect the current calendar year. |
| 2013 | 12/23/2013 | 1. | Administrative | In Pharmaceutical (Therapeutic Medications), Sleep Aids, add link to FDA study. |
| 2013 | 12/12/2013 | 1. | Medical Policy | In Pharmaceutical (Therapeutic Medications), Acne Medications, revise policy to include language on use of topical acne medications, such as Retin A, and oral antibiotics, such as tretracycline. |
| 2013 | 12/06/2013 | 1. | Administrative | In AASI, change title of Deep Venous Thrombosis/Pulmonary Embolism - Warfarin (Coumadin) Therapy to “Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), and/ or Hypercoagulopathies”. Title of block on the Certificate Issuance sheet also changed. |
| 2013 | 11/06/2013 | 1. | Medical Policy | In Item 46. Neurologic, revise the Cerebrovascular Disease dispositions table to expand on criteria for Transient Ischemic Attack, Completed Stroke (ischemic or hemorrhagic), and Subdural, Epidural, or Subarachnoid Hemorrhage. |
| 2013 | 09/27/2013 | 1. | Medical Policy | In General Information, Equipment Requirements – Color Vision Test Apparatus, remove Titmus II Vision Tester (Model Nos. TII and TIIS) from the list of approved testers. |
| 2013 | 09/27/2013 | 2. | Medical Policy | In Disease Protocols, revise Hypertension Worksheet to clarify criteria whereby AME can assess current status. |
| 2013 | 09/17/2013 | 1. | Medical Policy | In Disease Protocols, add new test (Gordon Diagnostic System [GDS]) to evaluation sheets for Attention Deficit/Hyperactivity Disorder; Depression Treated with SSRI Medications; Neurocognitive Impairment; and Psychiatric and Neuropsychological Evaluations for Substance Abuse/Dependence. |
| 2013 | 09/17/2013 | 2. | Medical Policy | In Disease Protocols listing, rename “Substances of Dependence/Abuse (Drugs and Alcohol)” to “Psychiatric– Substances of Dependence/Abuse (Drugs and Alcohol.” |
| 2013 | 09/17/2013 | 3. | Administrative | Add updated link for the International Standards on Personnel Licensing. |
| 2013 | 08/16/2013 | 1. | Medical Policy | In Pharmaceuticals, Malaria Medications, update policy information regarding the use of mefloquine. |
| 2013 | 08/16/2013 | 2. | Medical Policy | In Special Issuances, update policy for prednisone usage for treatment of Asthma, Arthritis, Colitis, and/ or Chronic Obstructive Pulmonary Disease. |
| 2013 | 08/16/2013 | 3. | Medical Policy | In Special Issuances, revise introductory language to clarify requirements for deferral. (Specifically, “if the applicant does not meet the issue criteria in the Aerospace Medicine Dispositions Tables or the Certification Worksheets.”) |
| 2013 | 08/14/2013 | 1, | Medical Policy | In Item 41. G-U System – Neoplastic Disorders, revise dispositions table language from “Any other G-U Neoplastic Disorder” to “All G-U cancers when treatment was completed less than 5 years ago or for which there is a history of metastatic disease.” Also, direct Examiners to reference the specific cancers in this category for requirements and dispositions. |
| 2013 | 07/30/2013 | 1. | Medical Policy | In Pharmaceuticals, add information page on Sleep Aids, including wait times. |
| 2013 | 07/30/2013 | 2. | Errata | In Examination Techniques, Item 36. Heart – Syncope, correct typographical error: bilatcarotid Ultrasound to bilateral carotid Ultrasound. |
| 2013 | 06/19/2013 | 1. | Medical Policy | In Item 41. G-U System – Neoplastic Disorders, revise dispositions table to include criteria for “All G-U Cancers when treatment was completed more than 5 years ago and there is no history of metastatic disease.” |
| 2013 | 06/13/2013 | 1. | Medical Policy | Revise language in all Certification Worksheets: (Arthritis, Asthma, Renal Cancer, Glaucoma, Hepatitis C, Hypertension, Hypothyroidism, Migraine – Chronic Headaches, and Pre Diabetes) to add “Applicants for first- or second- class must provide this information annually; applicants for thirdclass must provide the information with each required exam.” |
| 2013 | 06/13/2013 | 2. | Medical Policy | In Item 35. Lungs and Chest, revise Asthma Worksheet to |
| include “FEV1, FVC, and FEV1/FVC are all equal to or greater than 80% predicted before bronchodilators” and Pulmonary Function Test “is not required if the only treatment is PRN use on one or two days a week of a short-acting beta agonist (e.g. albuterol).” | ||||
| 2013 | 06/13/2013 | 3. | Administrative | In Item 43. Spine and Other Musculoskeletal, revise Arthritis Worksheet to include link to steroid conversion calculator. |
| 2013 | 06/13/2013 | 4. | Medical Policy and Administrative | In Item 41. G-U System – Neoplastic Disorders, revise Renal Cancer Worksheet to state “ECOG performance status or equivalent is 0.” Also, include link to ECOG Performance Status definitions. |
| 2013 | 06/13/2013 | 5. | Medical Policy | In Item 48. General Systemic –Pre-Diabetes, Diabetes, Metabolic Syndrome, and/or Insulin Resistance, revise dispositions table to include Polycystic Ovary Syndrome. |
| 2013 | 06/13/2013 | 6. | Medical Policy | In Item 48. General Systemic- Pre-Diabetes, Diabetes, Metabolic Syndrome, and/or Insulin Resistance, revise Pre-Diabetes Worksheet to include Polycystic Ovary Syndrome. |
| 2013 | 06/11/2013 | 1. | Medical Policy | In Dispositions Table, Item 46. Neurologic, revise language to reflect that “Any loss of consciousness, alteration of consciousness, or amnesia, regardless of duration” requires FAA Decision. |
| 2013 | 06/04/2013 | 1. | Medical Policy | In Dispositions Table, Item 38. Abdomen and Viscera, |
| Hepatitis C, revise to show that if disease is resolved without sequela and need for medications, the AME can issue. | ||||
| 2013 | 05/15/2013 | 1. | Medical Policy | In Dispositions Table, Item 43. Arthritis – add row for certification criteria for Osteoarthritis and variants on PRN NSAIDS only. |
| 2013 | 05/15/2013 | 2. | Medical Policy | In Dispositions Table, Item 55. Blood Pressure, Hypertension Worksheet, revise to state “treating physician or AME finds…etc.” |
| 2013 | 05/08/2013 | 1. | Administrative | In Archives and Modifications, change title to “Archives and Updates.” |
| 2013 | 05/08/2013 | 2. | Administrative | In AME Assisted Special Issuances (AASI), revise language on the introductory page and all 25 AASI pages from "If this is a first time issuance of an Authorization for the above disease/condition…” to “If this is a first-time application for an AASI for the above disease/condition …” |
| 2013 | 04/09/2013 | 1. | Medical Policy | In Examination Techniques, Item 35. Lungs and Chest, revise dispositions table for Asthma. Introduce Asthma Worksheet with certification criteria under which the AME can regular issue. |
| 2013 | 04/09/2013 | 2. | Medical Policy | In Examination Techniques, Item 43. Spine and Other Musculoskeletal, revise dispositions table for Arthritis. Introduce Arthritis Worksheet with certification criteria under which the AME can regular issue. |
| 2013 | 04/09/2013 | 3. | Medical Policy | In Examination Techniques, Item 41. G-U System – Neoplastic Disorders, revise dispositions table for Prostatic, Renal, and Testicular Carcinomas. Introduce Renal Cancer Worksheet with certification criteria under which the AME can regular issue. |
| 2013 | 04/09/2013 | 4. | Medical Policy | In Examination Techniques, Items 31 - 34. Eye, revise Examination techniques and dispositions table for Glaucoma. Introduce Glaucoma Worksheet with certification criteria under which the AME can regular issue. |
| 2013 | 04/09/2013 | 5. | Medical Policy | In Examination Techniques, Items 38. Abdomen and Viscera, revise dispositions table for Hepatitis C - Chronic. Introduce Hepatitis C – Chronic Worksheet with certification criteria under which the AME can regular issue. |
| 2013 | 04/09/2013 | 6. | Medical Policy | In Examination Techniques, Items 55. Blood Pressure, revise dispositions table for Hypertension. Introduce Hypertension Worksheet with certification criteria under which the AME can regular issue. |
| 2013 | 04/09/2013 | 7. | Medical Policy | In Disease Protocols, delete Hypertension Protocol. |
| 2013 | 04/09/2013 | 8. | Medical Policy | In Examination Techniques, Items 48. General Systemic– Endocrine Disorders, revise dispositions table for Hypothyroidism. Introduce Hypothyroidism Worksheet with certification criteria |
| under which the AME can regular issue. | ||||
| 2013 | 04/09/2013 | 9. | Medical Policy | In Examination Techniques, Items 46. Neurologic – Headaches, revise dispositions table for Migraine and Chronic Headache. Introduce Migraine and Chronic Headache Worksheet with certification criteria under which the AME can regular issue. |
| 2013 | 04/09/2013 | 10. | Medical Policy | In Examination Techniques, Items 48. General Systemic– Diabetes, Metabolic Syndrome, and/or Insulin Resistance, revise dispositions table to add Pre-Diabetes. Introduce Pre-Diabetes Worksheet with certification criteria under which the AME can regular issue. |
| 2013 | 04/09/2013 | 11. | Medical Policy | In Disease Protocols, delete protocol for Medication Controlled Metabolic Syndrome (Glucose Intolerance, Impaired Glucose Tolerance, Impaired Fasting Glucose, Insulin Resistance, and Pre-Diabetes) |
| 2013 | 04/09/2013 | 12. | Medical Policy | In Disease Protocols, revise Diet Controlled Diabetes Mellitus and Metabolic Syndrome. Change title to Diabetes Mellitus – Diet Controlled. |
| 2013 | 04/09/2013 | 13. | Medical Policy | In Disease Protocols, revise title of Medication Controlled Diabetes Mellitus - Type II. Change name to Diabetes Mellitus Type II – Medication Controlled (Non Insulin). Also, in Pharmaceuticals |
| section, revise name of protocol link to reflect title change. | ||||
| 2013 | 04/09/2013 | 14. | Medical Policy | In Disease Protocols, revise title of Insulin Treated Diabetes Mellitus - Type I or Type II. Change title to Diabetes Mellitus Type I or Type II – Insulin Treated. Also, in Pharmaceuticals section, revise name of protocol link to reflect title change. |
| 2013 | 04/09/2013 | 15. | Medical Policy | In Pharmaceuticals, Antihypertensives, change name of protocol link from Hypertension Protocol to Hypertension Worksheet. |
| 2013 | 04/09/2013 | 16. | Medical Policy | In AME Assisted Special Issuance (AASI), delete AASI for Metabolic Syndrome, Glucose Intolerance, Impaired Glucose Tolerance, Impaired Fasting Glucose, Insulin Resistance, and Pre-Diabetes. |
| 2013 | 03/05/13 | 1. | Medical Policy | In Disease Protocols, add Specifications for Neuropsychological Evaluations for ADHD/ADD. |
| 2013 | 03/05/13 | 2. | Medical Policy | In Disease Protocols, add Specifications for Neuropsychological Evaluations for Treatment with SSRI Medications. |
| 2013 | 03/05/13 | 3. | Medical Policy | In Disease Protocols, add Specifications for Neuropsychological Evaluations for Potential Neurocognitive Impairment. |
| 2013 | 03/05/13 | 4. | Medical Policy | In Disease Protocols, add Specifications for Psychiatric Evaluations. |
| 2013 | 03/05/13 | 5. | Medical Policy | In Disease Protocols, add Specifications for Psychiatric |
| and Psychological Evaluations. | ||||
| 2013 | 03/05/13 | 6. | Medical Policy | In Disease Protocols, add Specifications for Psychiatric and Neuropsychiatric Evaluations for Substance Abuse/Dependence. |
| 2013 | 03/05/13 | 7. | Medical Policy | In Item 47. Psychiatric Conditions, revise table to include reference to new Psychiatric Specification Sheets. |
| 2013 | 03/05/13 | 8. | Medical Policy | In Item 47. Psychiatric Conditions, revise SSRI Specifications Sheet to remove Federal Register link and include link to Specifications for Neuropsychological Evaluations for Treatment with SSRI Medications. |
| 2013 | 02/15/13 | 1. | Medical Policy | In Item 47. Psychiatric Conditions, revise Table of Medical Dispositions to include additional evaluation guidance. |
| 2013 | 02/15/13 | 2. | Medical Policy | In Item 52. Color Vision, revise to state that use of computer applications, downloaded versions, or printed versions of color vision tests are prohibited for evaluation. |
| 2013 | 02/15/13 | 3. | Medical Policy | In Disease Protocols, Disease Protocols - Human Immunodeficiency Virus (HIV), revise to include statement on status report requirements after the first two years of SI/SC. |
| 2013 | 01/03/12 | 1. | Administrative | Revise cover page to reflect the current calendar year. |
| 2012 | 12/14/12 | 1. | Medical Policy | In Item 47. Psychiatric Conditions, revise SSRI Specifications Sheet to change “neurocognitive |
| testing” to “CogScreen-AE testing.” | ||||
| 2012 | 12/06/12 | 1. | Medical Policy | In Item 47. Psychiatric Conditions, revise SSRI Decision Path I chart to change application wait time from 90 days to 60 days. Also, revise SSRI Follow Up Path chart to change “neurocognitive testing” to “CogScreen-AE testing.” |
| 2012 | 10/24/12 | 1. | Medical Policy | In Disease Protocols – Coronary Heart Disease, remove reference to FAA Form 8500-20 Medical Exemption Petition. Form 8500-20 is cancelled. |
| 2012 | 10/01/12 | 1. | Administrative | Revise language throughout the AME Guide to reflect procedural changes as dictated by MedXPress, the mandatory electronic application system for airmen. (Effective October 1, 2012) |
| 2012 | 10/01/12 | 2. | Medical Policy | In Special Issuances, Atrial Fibrillation, revise to specify INR requirement for airmen being treated with warfarin (Coumadin). |
| 2012 | 08/09/12 | 1. | Errata | In Examination Techniques, Item 52. Color Vision; revise title of chart for Acceptable Test Instruments for Color Vision Screening of ATCS (FAA Employee 2151 Series and Contract) to “Acceptable Test Instruments for Color Vision Screening of ATCS (FAA Employee 2151 Series and Contract Tower ATCSs.)” |
| 2012 | 07/20/12 | 1. | Medical Policy | In accordance with the direct final rule (14 CFR Part 67 [Docket No. FAA-2012-0056; Amdt. No 67-21] ),“Removal |
| of the Requirement for Individuals Granted the Special Issuance of a Medical Certificate To Carry Their Letter of Authorization While Exercising Pilot Privileges,” references to the requirement to carry an LOA were removed from the General Information and Special Issuances sections of the Guide. | ||||
| 2012 | 07/03/12 | 1. | Medical Policy | In Item 41. G-U System, remove information on “Contraceptives and Hormone Replacement Therapy.” Move this information to a new page (of the same title) within the Pharmaceuticals section. |
| 2012 | 06/07/12 | 1. | Medical Policy | In Item 41. G-U System, revise guidance on Gender Identity Disorder to specify requirements for current status report, psychiatric and/or psychological evaluations, and surgery follow-up reports. |
| 2012 | 05/25/12 | 1. | Medical Policy | In Item 52. Color Vision, add chart for criteria and acceptable tests for Air Traffic Controllers (FAA employee 2152 series and Contract Tower ATCS). |
| 2012 | 04/19/12 | 1. | Medical Policy | In Pharmaceuticals, Antihypertensive, specify clonidine is not acceptable by FAA. |
| 2012 | 01/31/12 | 1. | Medical Policy | In Decision Considerations. Aerospace Medical Dispositions, Item 45. Lymphatics, revise title from ‘Hodgkin’s Disease – Lymphoma” to “Lymphoma and Hodgkin’s Disease.” |
| 2012 | 01/26/12 | 1. | Medical Policy | In Examination Techniques. Item 48. Hypothyroidism, add note that AMES may call FAA for verbal clearance if airman presents current lab reports. |
| 2012 | 01/26/12 | 2. | Medical Policy | In Pharmaceuticals, Allergy – Desensitization Injections, Change the title and references to Allergy – Immunotherapy. Add note stating that sublingual immunotherapy (SLIT) is not acceptable. |
| 2012 | 01/26/12 | 3. | Medical Policy | In Examination Techniques, Item 36. Heart, remove requirement for reporting serum potassium values if the airman is taking diuretics. |
| 2012 | 01/26/12 | 4. | Medical Policy | In Protocol for Evaluation of Hypertension, remove requirement for reporting serum potassium if the airman is taking diuretics. |
| 2012 | 01/26/12 | 5. | Medical Policy | In Item 36. Heart – Dispositions Table, Coronary Artery Disease, revise table to clarify evaluation data required for third class. |
| 2012 | 01/03/12 | 1. | Administrative | Revise cover page to reflect the current calendar year. |
| 2012 | 01/03/12 | 2. | Medical Policy | In General Information, Medical Certificates – AME Completion, revise language to clarify signature requirements. |
| 2011 | 12/13/11 | 1. | Medical Policy | In Examination Techniques, Item 52. Color Vision, revise to include Color Vision Testing Flowchart. |
| 2011 | 12/01/11 | 1. | Medical Policy | In Pharmaceuticals (Therapeutic Medications) section, change title of Antihistaminic and Desensitization Injections to include the word “Allergy.” |
| Also, change title of Diabetes Mellitus – Type II Medication Controlled to include “(Non Insulin).” This title was also changed in the AASI. | ||||
| 2011 | 12/01/11 | 2. | Medical Policy | In Pharmaceuticals (Therapeutic Medications) Acne Medications, revise page format to clarify policy. |
| 2011 | 11/16/11 | 1. | Medical Policy | In General Information, Disposition of Applications and Medical Examinations, Clarify to indicate that Student Pilot Applications and Examinations must be transmitted to AMCD within 7 days. |
| 2011 | 11/01/11 | 1. | Medical Policy | In Pharmaceuticals – Insulin, revise to clarify guidance on medication combinations. |
| 2011 | 10/24/11 | 1. | Administrative | In Aerospace Medical Dispositions, Item 49. Hearing, clarify guidance on hearing aids. |
| 2011 | 09/15/11 | 1. | Medical Policy | In Examination Techniques, Item 31 – 34. Eye - Orthokeratology, revise to clarify policy. |
| 2011 | 09/15/11 | 2. | Medical Policy | In Aerospace Medical Dispositions, Item 31. Eyes – General, revise to include information on Keratoconus. |
| 2011 | 09/15/11 | 3. | Medical Policy | In General Information, Equipment Requirements, revise to include equipment to measure height and weight. |
| 2011 | 09/12/11 | 1. | Medical Policy | In Aerospace Medical Dispositions, Item 47., Psychiatric Conditions – Use of Antidepressants, include SSRI Specification Sheet for guidance. |
| 2011 | 09/12/11 | 2. | Medical Policy | In Pharmaceuticals, Antidepressants, revise to clarify medical history, |
| protocol, and pharmaceutical considerations. | ||||
| 2011 | 09/12/11 | 3. | Administrative | In Table of Contents, renumber entries listed on pages iii and iv. |
| 2011 | 08/12/11 | 1. | Medical Policy | In Special Issuances, Third-Class AME Assisted – Valve Replacement, revise to include additional criteria for deferral (“the applicant develops emboli, thrombosis, etc.”). |
| 2011 | 08/12/11 | 2. | Medical Policy | In Special Issuances, AME Assisted – All Classes – Atrial Fibrillation, revise to include additional criteria for deferral (“bleeding that required medical intervention”). |
| 2011 | 08/12/11 | 3. | Medical Policy | In Special Issuances, AME Assisted – All Classes – Warfarin (Coumadin) Therapy for Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), and/ or Hypercouagulopathies, revise to include additional criteria for deferral (“bleeding that required medical intervention”). |
| 2011 | 08/12/11 | 4. | Medical Policy | In Special Issuances, Third-Class AME Assisted – Coronary Heart Disease, revise to include additional criteria for deferral (“bleeding that required medical intervention”). |
| 2011 | 08/09/11 | 1. | Medical Policy | In Disease Protocols, Coronary Heart Disease, correct in item A.1.b., “replacement” to “repair.” |
| 2011 | 08/09/11 | 2. | Administrative | In Pharmaceuticals – Antihypertensive, revise to clarify unacceptable medications. |
| 2011 | 08/09/11 | 3. | Administrative | In Examination Techniques, Item 36., Heart, revise to clarify unacceptable medications. |
| 2011 | 08/09/11 | 4. | Administrative | In Aerospace Medical Dispositions, Item 55., revise to clarify blood pressure limits. |
| 2011 | 08/09/11 | 5. | Administrative | In Aerospace Medical Dispositions, Item 47., Psychiatric Conditions, revise table to include information on depression requiring the use of antidepressant medications. |
| 2011 | 08/09/11 | 6. | Administrative | In Disease Protocols, Hypertension, revise to clarify unacceptable medications. |
| 2011 | 05/25/11 | 1. | Administrative | In Examination Techniques, Item 47., Psychiatric, revise SSRI Follow Up Chart to clarify procedure. |
| 2011 | 05/08/11 | 1. | Administrative | In Pharmaceuticals, reorganize and clarify the page content for Acne Medications, Antacids, Anticoagulants, Antihistaminic, Antihypertensive, Desensitization Injections, Diabetes – Type II Medication Controlled, Glaucoma Medications, and Insulin. |
| 2011 | 03/11/11 | 1. | Medical Policy | In Aerospace Medical Dispositions, Item 47., Psychiatric Conditions, clarify policy verbiage on Bipolar Disorder and Psychosis. |
| 2011 | 03/02/11 | 1. | Medical Policy | In Aerospace Medical Dispositions, Item 47., Psychiatric Conditions, add section titled “Use of Antidepressant Medication,” |
| to state revised policy on use of SSRIs. | ||||
| 2011 | 02/23/11 | 1. | Medical Policy | In Aerospace Medical Dispositions, Item 52., Color Vision, clarify pass criterion for OPTEC 900 Vision Tester. |
| 2011 | 02/03/11 | 1. | Medical Policy | In Medical History, Item 18. v., History of Arrest(s), Conviction(s), and/ or Administrative Action(s), reorder, revise, and clarify deferral and issuance criteria. |
| 2011 | 01/31/11 | 1. | Errata | Revise to correct transposed words in title: Decision Considerations, Disease Protocols – “Graded Exercise Stress Test – Bundle Branch Block Requirements.” |
| 2011 | 01/07/11 | 1. | Administrative | Revise cover page to reflect current calendar year. |
| 2010 | 11/23/10 | 1. | Medical Policy | In Exam Techniques, Item 26. Nose and Item 35. Lungs and Chest, revise and clarify criteria for hay fever medications. |
| 2010 | 11/23/10 | 2. | Medical Policy | In Pharmaceuticals (Therapeutic Medications) - Desensitization Injections, revise and clarify criteria for hay fever medications. |
| 2010 | 10/29/10 | 1. | Medical Policy | In Aerospace Medical Dispositions, Item 52. Color Vision, remove Titmus II Vision Tester (Model Nos. TII and TIIS) as an acceptable substitute for color vision testing. |
| 2010 | 09/20/10 | 1. | Medical Policy | In AASI Protocol for Arthritis, change title to “Arthritis and/or Psoriasis.” Clarify authorization and deferral criteria. |
| 2010 | 09/03/10 | 1. | Medical Policy | In Exam Techniques, Item 21-22 Height and Weight, add Body Mass Index Chart and Formula Table. |
| 2010 | 06/15/10 | 1. | Medical Policy | In Aerospace Medical Dispositions, Item 48, General Systemic, clarify disposition for Hyperthroydism and Hypothyrodism. First Special Issuance requires FAA decision. Guidance for Followup Special Issuance is found in AASI Protocol. |
| 2010 | 06/15/10 | 2. | Administrative | In AASI Protocol for Hyperthyroidism and Protocol for Hypothyroidism, clarify criteria for deferring and issuing. |
| 2010 | 05/20/10 | 1. | Administrative | In Aerospace Medical Dispositions, Item 47, Psychiatric Conditions Table of Medical Dispositions, clarify “see below” information in Evaluation Data column. |
| 2010 | 03/17/10 | 1. | Medical Policy | In Disease Protocols, Binocular Multifocal and Accommodating Devices, clarify criteria for adaptation period before certification. |
| 2010 | 03/17/10 | 2. | Medical Policy | In Applicant History, Item 17b, revise and clarify criteria regarding use of types of contact lenses. |
| 2010 | 03/17/10 | 3. | Medical Policy | In Exam Techniques, Items 31-34 Eye – Contact Lenses, revise and clarify criteria. |
| 2010 | 01/20/10 | 1. | Administrative | Revise cover page to reflect current calendar year. |
| 2010 | 01/20/10 | 2. | Medical Policy | In Applicant History, Item 18 Medical History, v. History of Arrest(s), Conviction(s), and/or Administrative Action(s), revise and clarify |
| deferral and issuance criteria. | ||||
| 2009 | 12/08/09 | 1. | Medical Policy | In Examination Techniques, Item 52. Color Vision, remove APT-5 as an acceptable color vision tester. |
| 2009 | 10/22/09 | 1. | Medical Policy | In Examination Techniques, Item 52. Color Vision, add note to Agency-Designated AMEs: “Not all tests approved for pilots are acceptable for FAA ATCSs. Contact RFS for current list.” |
| 2009 | 10/16/09 | 1. | Medical Policy | In Special Issuance, Diabetes Mellitus – Type II, Medication Controlled, revise to reflect further criteria required for AME reissuance: current status report from physician treating diabetes to include any history of hypoglycemic events and any cardiovascular, renal, neurologic or ophthalmologic complications; and HgA1c level performed within the last 30 days. |
| 2009 | 09/30/2009 | 1. | Medical Policy | In Disease Protocols, Diabetes Mellitus – Type I or Type II, Insulin Treated, add note to indicate that insulin pumps are acceptable. |
| 2009 | 09/30/2009 | 2. | Medical Policy | In Disease Protocols, revise main listing to reflect addition of “Diabetes Mellitus and Metabolic Syndrome – Diet Controlled” and “Metabolic Syndrome (Glucose Intolerance, Impaired Glucose tolerance, Impaired Fasting Glucose, Insulin Resistance, and Pre-Diabetes) - Medication Controlled.” |
| 2009 | 09/30/2009 | 3. | Medical Policy | In Aerospace Medical Dispositions, Item 48. General Systemic – Diabetes, Metabolic Syndrome, and/or Insulin Resistance, revise table to reflect addition of “Diabetes Mellitus and Metabolic Syndrome – Diet Controlled” and “Metabolic Syndrome (Glucose Intolerance, Impaired Glucose tolerance, Impaired Fasting Glucose, Insulin Resistance, and Pre-Diabetes) - Medication Controlled.” |
| 2009 | 09/30/2009 | 4. | Medical Policy | In Disease Protocols, add new protocol outlining Metabolic Syndrome, Medication Controlled. |
| 2009 | 09/30/2009 | 5. | Medical Policy | In Disease Protocols, Diabetes Mellitus – Diet Controlled, revise to reflect Diabetes Mellitus and Metabolic Syndrome (Glucose Intolerance, Impaired Glucose tolerance, Impaired Fasting Glucose, Insulin Resistance, and Pre-Diabetes) - Diet Controlled |
| 2009 | 09/21/2009 | 1. | Errata | In Disease Protocols, Substances of Dependence/Abuse (Drugs and Alcohol), change “personnel statement” to “personal statement.” |
| 2009 | 09/21/2009 | 2. | Medical Policy | In Special Issuance, Colon Cancer; Chronic Lymphocytic Leukemia; Diabetes Mellitus – Type II, Medication Controlled; and Lymphoma and Hodgkin’s Disease, add if “Any new treatment is initiated” – to |
| criteria for deferment to AMCD or Region. | ||||
| 2009 | 09/21/2009 | 3. | Medical Policy | In Aerospace Medical Dispositions, Item 48. General Systemic, Diabetes– change title to “Diabetes, Metabolic Syndrome, and/or Insulin Resistance.” Also add new table entry to reflect criteria for “Metabolic Syndrome or Insulin Resistance.” |
| 2009 | 09/21/2009 | 4. | Medical Policy | In AME Assisted Special Issuance, All Classes – added entry and criteria for Metabolic Syndrome (Glucose Intolerance, Impaired Glucose Tolerance, Impaired Fasting Glucose, Insulin Resistance, and Pre-Diabetes). Also added entry on AASI Certificate Issuance sheet. |
| 2009 | 09/21/2009 | 5. | Administrative | In General Information, Who May Be Certified, b. Language Requirements – added information to clarify guidance on certification and reporting process. |
| 2009 | 07/30/2009 | 1. | Medical Policy | In Pharmaceuticals, Acne Medications, add language to further clarify instructions for deferral and restrictions. |
| 2009 | 07/09/2009 | 1. | Medical Policy | In Pharmaceuticals, Diabetes Mellitus – Type II, Medication Controlled, revise to remove amlynomimetics from allowable combinations. |
| 2009 | 07/09/2009 | 2. | Medical Policy | In AASI, Diabetes Mellitus – Type II, Medication Controlled, revise criteria for deferring to AMCD or region. |
| 2009 | 05/13/2009 | 1. | Medical Policy | In General Information, Equipment Requirements and Examination Equipment and Techniques, Item 52. |
| Color Vision, add OPTEC 2500 as acceptable vision testing substitute. | ||||
| 2009 | 04/30/2009 | 1. | Errata | In Examination Techniques, Item 31-34. Eye, correct typographical error in form number. Revised to reflect “8500-7.” |
| 2009 | 04/24/2009 | 1. | Medical Policy | In AASI, Diabetes Mellitus – Type II, Medication Controlled; and Pharmaceuticals, Diabetes Mellitus - Type II, Medication Controlled - revise to clarify criteria for deferring to AMCD or region also to clarify allowable medication combinations. |
| 2009 | 02/04/2009 | 1. | Administrative | Revise cover page to reflect current calendar year. |
| 2008 | 12/11/2008 | 1. | Medical Policy | In Examination Techniques, Item 52. Color Vision, revise language to specify that AME-administered aviation Signal Light Gun test is prohibited. |
| 2008 | 10/30/2008 | 1. | Errata | In Examination Techniques and Aerospace Medical Dispositions, Item 52. Color vision, revise to list correct testing plates for Richmond HRR, 4th Edition. |
| 2008 | 10/10/2008 | 1. | Administrative | In General Information, create new section 12. “Medical Certificates – AME Completion.” |
| 2008 | 10/10/2008 | 2. | Administrative | In Table Of Contents, General Information, adjust and renumber listings to reflect inclusion of Medical Certificates – AME Completion. |
| 2008 | 10/10/2008 | 3. | Medical Policy | In Examination Techniques, Item 52., Color Vision, add new vision tester. |
| 2008 | 10/10/2008 | 4. | Medical Policy | In Aerospace Medical Disposition, Item 52. Color Vision, revise section A., All Classes, to include standard for new vision tester. |
| 2008 | 09/17/2008 | 1. | Medical Policy | Change Applicant History, 18. v. Conviction and/or Administrative Action History to “History of Arrest(s), Conviction(s), and/or Administrative Action(s). Revise language within 18. v. to include reference to arrests. |
| 2008 | 09/17/2008 | 2. | Medical Policy | Revise Applicant History to create a new section, 18.y. Medical Disability Benefits. |
| 2008 | 09/17/2008 | 3. | Medical Policy | Revise Entire Guide to replace any usage of term “Urinalysis” with “Urine Test(s).” |
| 2008 | 09/05/2008 | 1. | Administrative | Change cover page to remove “Version V” title. Change title to reflect current calendar year. |
| 2008 | 09/05/2008 | 2. | Medical Policy | In General Information, Equipment Requirements, and in Examination Techniques Items 50, 51, and 54, revise acceptable vision testing equipment requirements. |
| 2008 | 09/05/2008 | 3. | Medical Policy | In Aerospace Medical Dispositions, Item 52., Color Vision, revise to provide guidance on Specialized Operational Medical Tests: the Operational Color Vision |
| Test and the Medical Flight Test. Also, update list of acceptable and unacceptable color vision testing equipment. | ||||
| V. | 07/31/2008 | 1. | Medical Policy | In General Information, Equipment Requirements, and in Examination Techniques (Items 50-52 and 54), revise acceptable vision testing equipment. |
| V. | 07/16/2008 | 1. | Medical Policy | In General Information, Validity of Medical Certificates, revise thirdclass duration standards for airmen under age 40. |
| V. | 07/16/2008 | 2. | Medical Policy | In General Information, Requests for Assistance, revise to remove references to international and military examiners. |
| V. | 07/16/2008 | 3. | Administrative | In General Information, Classes of Medical Certificates, revise to clarify “flying activities” to “privileges.” |
| V. | 07/16/2008 | 4. | Medical Policy | In Special Issuances, revise to include language requiring airman to carry Authorization when exercising pilot privileges. |
| V. | 07/16/2008 | 5 | Medical Policy | In Applicant History, Guidance for Positive Identification of Airmen, revise to include link to 14 CFR §67.4. Applicants must show proof of age and identity. |
| V. | 04/1/2008 | 1. | Administrative | In General Information, Who May Be Certified, add guidance on ICAO standard for English Proficiency, Operational Level 4. |
| V. | 04/01/2008 | 2. | Medical Policy | In General information, Equipment Requirements, revise list of acceptable |
| equipment, particularly acceptable substitute equipment for vision testing. | ||||
| V. | 04/01/2008 | 3. | Medical Policy | In Exam Techniques, Item 50, Distant Vision, revise equipment list of acceptable substitutes. |
| V. | 04/01/2008 | 4. | Medical Policy | In Exam Techniques, Item 51. Near and Intermediate Vision, revise equipment table of acceptable substitutes. |
| V. | 04/01/2008 | 5. | Medical Policy | In Exam Techniques, Item 54. Heterophoria, revise equipment table of acceptable substitutes. |
| V. | 02/01/2008 | 1. | Medical Policy | In Exam Techniques, Item. 52. Color Vision, revise Section E., which clarifies unacceptable tests. |
| V. | 01/11/2008 | 1. | Medical Policy | In AME Assisted Special Issuance (AASI), add section on Warfarin (Coumadin) Therapy for Deep Venous Thrombosis, Pulmonary Embolism, and/ or Hypercoagulopathies. |
| V. | 01/11/2008 | 2. | Medical Policy | Revise AASI coversheet to include box for Warfarin (Coumadin) Therapy for Deep Venous Thrombosis, Pulmonary Embolism, and/or Hypercoagulopathies. |
| V. | 11/26/2007 | 1. | Administrative | In General Information, Validity of Medical Certificates, delete note for “Flight outside the airspace of the United States of America.” |
| V. | 11/26/2007 | 2. | Administrative | In Disease Protocols, Conductive Keratoplasty (CK), revise description of CK procedure. |
| V. | 11/26/2007 | 3. | Errata | In Aerospace Medical Dispositions, Item 31. Eye, correct typographical error. |
| V. | 11/26/2007 | 4. | Medical Policy | In Pharmaceuticals, add “Malaria Medications.” |
| V. | 11/26/2007 | 5. | Medical Policy | In Exam Techniques, Item 51. Near and Intermediate vision, add Keystone Orthoscope and Keystone Telebinocular. |
| V. | 11/26/2007 | 6. | Administrative | In Airman Certification Forms, add note regarding International Standards on Personnel Licensing. |
| V. | 11/26/2007 | 7. | Administrative | In General Information, Equipment Requirements, add note regarding the possession and maintenance of equipment. |
| V. | 11/26/2007 | 8. | Administrative | In General Information, Privacy of Medical Information, add note on the protection of privacy information. |
| V. | 11/26/2007 | 9. | Administrative | In General Information, Disposition of Applications, add note to include electronic submission by international AME’s. |
| V. | 11/26/2007 | 10. | Medical Policy | In Exam Techniques and Criteria, 31-34 Eye, Refractive Procedures, revise to include Wavefrontguided LASIK. |
| V. | 09/01/2007 | 1. | Administrative | Revise title of Disease Protocols, “Antihistamines” to “Allergies, Severe.” |
| V. | 09/01/2007 | 2. | Administrative | In Pharmaceuticals, add “Acne Medications” and “Glaucoma Medications.” |
| V. | 09/01/2007 | 3. | Medical Policy | Add policy regarding use of isotretinoin (Accutane) in Pharmaceuticals; Aerospace Medical Dispositions, Item 40. Skin; and Examination Techniques and Criteria for Qualification, Item. 40 Skin |
| V. | 09/01/2007 | 4. | Errata | Revise Protocol for Maximal Graded Exercise Stress Test Requirements to change “8 minutes” to “9 minutes.” |
| V. | 09/01/2007 | 5. | Errata | In Aerospace Medical Dispositions, Item. 36. Heart– Atrial Fibrillation - change “CHD Protocol with ECHO and 24-hour Holter” to read “See CVE Protocol with EST, Echo, and 24-hour Holter.” |
| V. | 09/01/2007 | 6. | Medical Policy | Revise Aerospace Medical Dispositions, Item 36. Heart - Syncope. |
| V. | 09/01/2007 | 7. | Medical Policy | Revise Examination Techniques and Criteria for Qualification, Item. 36 Heart– Auscultation. |
| V. | 09/01/2007 | 8. | Administrative | In Pharmaceuticals, Antihypertensive, V. Pharmaceutical Considerations – remove “D. AME Assisted – All Classes, Atrial Fibrillation.” |
| V. | 09/01/2007 | 9. | Administrative | In Pharmaceuticals, Antihistaminic, V. Pharmaceutical Considerations – add “C. Aerospace Medical Dispositions, Item 35. Lungs and Chest.” |
| V. | 09/01/2007 | 10. | Medical Policy | Revise Disease Protocols, Coronary Heart Disease to clarify requirements for consideration for any class of airman medical certification. |
| V. | 09/01/2007 | 11. | Errata | Revise Disease Protocols, Coronary Heart Disease to remove “Limited to Flight Engineer Duties.” |
| V. | 04/25/2007 | 1. | Administrative | Move Leukemia, Acute and Chronic from Aerospace Medical Dispositions Item 48. General Systemic to Item 48. General Systemic, Blood |
| and Blood-Forming Tissue Disease. | ||||
| V. | 04/25/2007 | 2. | Administrative | Revise Aerospace Medical Dispositions Item 48. General Systemic to include disposition table titled “Neoplasms.” |
| V. | 04/25/2007 | 3. | Administrative | Move Breast Cancer from Aerospace Medical Dispositions Item 38. Abdomen and Viscera - Malignancies to Item 48. General Systemic, Neoplasms. Also, move Colitis (Ulcerative, Regional Enteritis or Crohn's disease) and Peptic Ulcer from Aerospace Medical Dispositions Item 38. Abdomen and Viscera – Malignancies to Item 38. Abdomen and Viscera and Anus Conditions. |
| V. | 04/25/2007 | 4. | Administrative | Update individual Pharmaceutical pages to include “Pharmaceutical Considerations.” |
| V. | 11/20/2006 | 1. | Medical Policy | Insert into Disease Protocols a new section on Cardiac Transplant for Class III certificates only. |
| V. | 11/20/2006 | 2. | Errata | Corrected AASI on Mitral or Aortic Insufficiency to read “mean gradient.” |
| V. | 08/23/2006 | 1. | Errata | INR values for mechanical valves should have read between 2.5 and 3.5, except for certain types of bileaflet valves in the aortic position. |
| V. | 08/23/2006 | 2. | Administrative | Clarified the Hypertension Protocol regarding initiation and change of medication and the suspension of pilot duties. |
| V. | 08/23/2006 | 3. | Errata | Maximal graded exercise stress test requirement for under age 60 corrected to 9 minutes. |
| V. | 08/23/2006 | 4. | Medical Policy | Remove prohibition on bifocal contact lenses or lenses that correct for near and/or intermediate vision in Items 31-34, Eyes; Section 5, Contact Lenses. |
| V. | 08/23/2006 | 5. | Medical Policy | Update Neurological Conditions Disposition Table and Footnote #21 with guidance on Rolandic Seizure. |
| V. | 08/23/2006 | 6. | Administrative | Clarified language in General Information, Item 9. Who May Be Certified; a. Age Requirements. |
| V. | 04/03/2006 | 1. | Administrative | Redesign the appearance and navigable format of the Guide for Aviation Medical Examiners |
| V. | 04/03/2006 | 2. | Administrative | Install a Search Engine located in the Navigation Bar |
| V. | 04/03/2006 | 3. | Administrative | Revise Heading Titles for Chapters 2, 3, and 4 |
| V. | 04/03/2006 | 4. | Administrative | Insert a Special Issuances section located in the Navigation Bar and into the General Information section |
| V. | 04/03/2006 | 5. | Administrative | Insert a Policy Updates section to post new and revised Administrative and Medical Policies |
| V. | 04/03/2006 | 6. | Medical Policy | Insert into the AME Assisted Special Issuance (AASI) section a Testicular Carcinoma AASI |
| V. | 04/03/2006 | 7. | Medical Policy | Revise Atrial Fibrillation AASI |
| V. | 04/03/2006 | 8. | Medical Policy | Revise Asthma AASI |
| V. | 04/03/2006 | 9. | Medical Policy | Revise Hyperthyroidism and Hypothyroidism AASIs |
| V. | 04/03/2006 | 10. | Medical Policy | Insert a new AASI subsection containing Coronary Heart Disease and Single Valve Replacement applicable for Third-Class only |
| V. | 04/03/2006 | 11. | Medical Policy | Insert into the Disease Protocols section a new Coronary Heart Disease and Graded Exercise Stress Test Protocol, and revise the Valve Replacement Protocol |
| V. | 04/03/2006 | 12. | Administrative | Insert Items 49 – 58 into the Examination Techniques section |
| V. | 04/03/2006 | 13. | Medical Policy | Revise Item 35. Lungs and Chest, Asthma, Aerospace Medical Disposition Table |
| V. | 04/03/2006 | 14. | Medical Policy | Revise Item 36. Heart, Atrial Fibrillation, Aerospace Medical Disposition Table |
| V. | 04/03/2006 | 15. | Medical Policy | Revise Item 36. Heart, Coronary Heart Disease, Aerospace Medical Disposition Table |
| V. | 04/03/2006 | 16. | Medical Policy | Revise Item 36. Heart, Valvular Disease, Aerospace Medical Disposition Table |
| V. | 04/03/2006 | 17. | Medical Policy | Revise Item 48. General Systemic, Hyperthyroidism and Hypothyroidism, Aerospace Medical Disposition Table |
| V. | 04/03/2006 | 18. | Medical Policy | Revise all Oral Medications - Diabetes Mellitus, Type II references |
| V. | 04/03/2006 | 19. | Medical Policy | Revise FAA Form 8500-7, Report of Eye Evaluation |
| IV. | 07/31/2005 | 1. | Administrative | Redesign the appearance and navigable format of the Guide for Aviation Medical Examiners |
| IV. | 07/31/2005 | 2. | Administrative | Revise Section 9., Refractive Surgery heading in Items 31-34. Eyes, to Refractive Procedures |
| IV. | 07/31/2005 | 3. | Medical Policy | Insert Conductive Keratoplasty into Section 9, Items 31-34, Eyes, and into Item 31’s Aerospace Medical Disposition Table |
| IV. | 07/31/2005 | 4. | Administrative | Replace optometrist or ophthmologist reference(s) to “eye specialist” |
| IV. | 07/31/2005 | 5. | Medical Policy | Insert Pulmonary Embolism into Item 35, Lungs and Chest, Aerospace Medical Disposition Table |
| IV. | 07/31/2005 | 6. | Medical Policy | Insert Deep Vein Thrombosis and Pulmonary Embolism into Item 37, Vascular System, Aerospace Medical Disposition Table |
| IV. | 07/31/2005 | 7. | Medical Policy | Insert Deep Vein Thrombosis and Pulmonary Embolism into the Thromboembolic Protocol. |
| IV. | 01/16/2006 | 1.. | Medical Policy | In Disease Protocols, added Conductive Keratoplasty Protocol. |
| IV. | 01/16/2006 | 1. | Medical Policy | Delete a paragraph located in Item 31-34. Eye, Section 4. Monocular vision |
| IV. | 01/16/2006 | 1. | Medical Policy | In Disease Protocols, added Binocular Multifocal and Accommodating Devices Protocol. |
| IV. | 01/16/2006 | 1. | Medical Policy | In AME Assisted Special Issuance (AASI) section, added Bladder, Breast, Melanoma, and Renal Carcinoma AASI’s |
| III. | 11/01/2004 | 1. | Medical Policy | Revise AASI Process to include First- and Secondclass Airman Medical Certification |
| III. | 11/01/2004 | 2. | Administrative | Insert into General Information, a new Section 10 that provides Sport Pilot Provisions |
| III. | 11/01/2004 | 3. | Administrative | Update revised Title 14, Code of Federal Regulations, §61.53 |
| III. | 11/01/2004 | 4. | Administrative | Insert a link to download a revised AME Letter of Denial |
| III. | 11/01/2004 | 5. | Administrative | Insert a link to download a printable AASI Certificate Coversheet |
| II. | 02/13/2004 | 1. | Administrative | Install Search Engine located in the Navigation Bar |
| II. | 02/13/2004 | 2. | Administrative | Insert a WHAT’S NEW link located in the Navigation Bar |
| II. | 02/13/2004 | 3. | Administrative | The “Instructions” site of the 2003 Guide is deleted and incorporated into the “Introduction” and “Available Downloads” located in the Navigation Bar |
| II. | 02/13/2004 | 4. | Administrative | Insert an “Available Downloads” site located in the Navigation Bar |
| II. | 02/13/2004 | 5. | Administrative | Insert a Table of Contents and an Index into the pdf version of the 2004 Guide |
| II. | 02/13/2004 | 6. | Administrative | Insert a one-page synopsis of the Medical Standards located in the Navigation Bar |
| II. | 02/13/2004 | 7. | Medical Policy | Insert Section 6. Orthokeratology into Items 31-34. Eye |
| II. | 02/13/2004 | 8. | Administrative | Relocate Item 46. Footnote # 21 from Head Trauma to Footnote #19, Headaches |
| II. | 02/13/2004 | 9. | Administrative | Insert Attention Deficit Disorder into Item 47’s, Aerospace Medical Disposition Table |
| II. | 02/13/2004 | 10. | Medical Policy | Revise Item 60; Comments on History and Findings |
| II. | 02/13/2004 | 11. | Medical Policy | Revise Item 63; Disqualifying Defects |
| II. | 02/13/2004 | 12. | Medical Policy | Delete from AASI’s a History of Monocularity |
| II. | 02/13/2004 | 13. | Administrative | Insert an Archives located in the Navigation Bar |
| II. | 09/16/2004 | 14. | Administrative | Insert CAD Ultrasound into Item 37. Aerospace Medical Disposition Table |
| I. | 09/24/2003 | 1. | Introduction of the 2003 Guide for Aviation Medical Examiners Website |